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Abstract 
KRIS I. FORD: Applied Magnetic Forces Enhance Nanoparticle Based Gene Delivery 
and Characterize Intracellular Rheology and Transport 
(Under the direction of Richard Superfine) 
 
 Magnetically applied forces present the ability to manipulate paramagnetic 
nanoparticles for a wide variety of biomedical applications.  In vivo gene delivery offers 
the promise of new ways to treat disease at a genetic level, but it unfortunately suffers 
from low efficiencies.  Nanoparticles present a platform for non-viral gene therapy but 
delivery must be optimized to make them a viable option for treatment.  This work 
describes how magnetic forces can be applied to paramagnetic nanoparticles to enhance 
the delivery of antisense oligonucleotides for correction of mRNA splicing errors.  
Applied oscillating forces can be used to stimulate certain endocytic pathways, which 
acts to more than double transfection efficiency.  Once a nanoparticle enters the cell, it is 
surrounded by the complex intracellular environment.  To understand the environment 
that the nanoparticle enters, intracellular rheology is probed with paramagnetic 
microbeads.  A protocol for introducing 1 micron microbeads into cells is presented.  By 
manipulation with 3-dimensional force microscopy, the mechanical features of the cell 
can be characterized.  Additionally, the in vivo transport due to molecular motors is also 
characterized.  Stall force on an intracellular 1 micron bead, caused by dynein motors, is 
determined.  This represents the force exerted on a vesicle by the motors, as it is being 
transported towards the nucleus, the target of the oligonucleotide delivery. 
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Chapter 1 
 
Introduction 
 Cell transfection involves the introduction of exogenous genes into a cell of 
interest for the purpose of affecting some aspect of the cell’s gene expression.  
Introduction of exogenous genes is done to up-regulate the expression of a gene, 
knockdown expression of a gene, or correct a pre-existing genetic error.  The use of 
magnetic nanoparticles offers the possibility of targeted localized delivery to cells and 
tissues.  To fulfill the promise of this technology, the aspects of transport and delivery 
must be fully understood to be optimized for clinical applications. 
1.1 Thesis Statement and Contributions 
 
 The two primary areas of focus of this dissertation involve transfection of cells 
using paramagnetic nanoparticles and their active transport once in the intracellular 
environment.  The process begins with the proper selection and functionalization of 
nanoparticles to serve as non-viral vectors.  The paramagnetic nanoparticles are loaded 
with genes and magnetic fields are applied to them to manipulate their transport to cells 
and influence their uptake into cells.  I present the first data using lithographically 
produced size-uniform metallic nanoparticles as transfection reagents. Oscillating 
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magnetic fields have been shown to enhance transfection efficiency of paramagnetic 
nanoparticles, and I present a protocol to better study the phenomenon.  I demonstrate 
frequency dependence and show for the first time that oscillating forces enhance 
transfection by stimulating certain endocytic pathways. 
 The second area of focus examines the active transport of a nanoparticle once it is 
in the intracellular environment.  I present a method for introducing 1m microbeads to 
the interior of cells.  I characterize transport of microbeads by kinesin and dynein 
molecular motors and its temperature dependence.  I present for the first time 
characteristic responses that occur when attempting to stall molecular motors in vivo.  I 
also show for the first time the maximal force exerted by dynein motors on microbeads as 
it is transported towards the nucleus, a primary target for gene delivery.  I will also 
present data on the rheology of the cell interior, which help to describe the environment 
that surround the nanoparticle after internalization.    
1.2 Outline 
 
 This work is outlined as follows: 
 Chapter 2 introduces the selection and functionalization of paramagnetic 
nanoparticles to use as non-viral vectors.  I quantify their ability to bind DNA and show 
their effectiveness in delivering antisense oligonucleotides to cells.  I show the first time 
that size-uniform 200nm lithographically produced metallic nanoparticles are used as 
transfection reagents. 
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 Chapter 3 details the development of a device to apply oscillating magnetic fields 
to nanoparticles in cell cultures.  This device is designed to apply oscillating fields of 
varying frequencies to enhance the transfection of paramagnetic nanoparticles. 
 Chapter 4 presents the protocol to effectively study oscillating field effects on 
nanoparticle transfection.  The frequency dependence on transfection efficiency is 
established. 
 Chapter 5 discusses the enhancement of transfection with oscillating forces 
through specific endocytic pathways.  I show for the first time that certain pathways are 
sensitive to force stimulation and propose mechanisms to explain how the enhancement is 
achieved. 
 Chapter 6 presents the data on the active transport of microbeads after they have 
been internalized into cells.  I characterize the displacements and velocities of 
microbeads transported via molecular motors.  I demonstrate for the first time transport 
phenomena that can occur when externally applied forces are applied to transported 
microbeads in vivo.  I also characterize the maximum forces applied to a microbead by 
dynein motors in vivo, which are responsible for transporting cargoes to the nucleus. 
 Chapter 7 describes some of the rheology data that has been collected in the midst 
of motor stalling experiments and descriptions of phenomena that could be of interest in 
future studies.      
 
 
 
  
 
Chapter 2 
Paramagnetic Nanoparticle Transfection 
2.1 Overview 
  
 In this chapter I will detail the selection and functionalization of non-viral vectors 
for delivery of antisense oligonucleotides.  I will describe the necessary considerations 
that go into the proper selection of vectors.  Taking unmodified nanoparticles, I am able 
to select an appropriate moiety and conjugate it with the nanoparticle, turning it into a 
gene binding non-viral vector.  I then characterize its binding capacity as well as its 
ability to release the genes after introduction into the cell culture.  I show how the 
particles are effective for delivery to HeLa EGFP-654 for correction of splice altering 
mutations.  I also describe a novel variety of 200nm Fe3O4 nanoparticles that have the 
unique feature of being size-uniform, a feature that is difficult to achieve for particles in 
that size range.  This work represents the first instance in which metal evaporation onto 
post structures was used for the formation of released shape-defined metal particles. Also, 
our work represents the first use of lithographically defined particles as agents of 
magnetofection. 
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 Nanoparticles can be used in biomedical research as vectors for gene delivery and 
as probes of intracellular rheology.  Nanoparticles can be fabricated in a variety of 
materials, sizes, and a multiplicity of functionalizations.  The proper selection of vector is 
a key step in any experiment, as the wrong vector can produce unfavorable or misleading 
results.  The nanoparticle must be must be designed for the particular biomedical 
application in order to be successful for the chosen purpose.  For gaining entry into the 
cell, size is a key feature in achieving entry into the cell.  For gene delivery, the ability to 
conjugate polymers and nucleic acids is the significant feature of concern.  Proper 
attention to these details is the beginning steps to successful non-viral vector delivery. 
 Paramagnetic nanoparticles offer the potential to exert control over non-viral 
vectors by applying a magnetic field and field gradient to the particle, focusing particles 
for transfection to a site of interest.  Magnetofection, as it has been termed, was 
introduced in the early 2000’s as a means to transfect a variety of cells types and show 
proof of concept of particle uptake in rats. (Scherer, Anton et al. 2002)  The basic concept 
of magnetofection is this: applying a magnetic force to the particle will cause it to 
sediment onto the cell membrane much more quickly than would occur due to 
gravitational attraction.  Once at the cell membrane, the nanoparticle is available to the 
cell for uptake though one of the several endocytosis mechanisms that are constantly 
active in the cell.  So with the paramagnetic particle one important issue regarding the use 
of non-viral vectors can be solved.  It is possible to use a magnet to localize the vectors to 
a region of interest so that they are not completely at the mercy of the in vivo system.  
The ability to do so is a function of the fields and gradients that can be produced at the 
site of delivery, which becomes an issue with tissues deep within the body, but at least in 
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theory a sufficient magnetic force can achieve this localization.  So then it becomes 
possible to optimize delivery of the vectors to the desired cells, while minimizing the 
amount of vector that is lost to untargeted sites.  Moreover, in the case of a deleterious 
drug or gene, the reagent can be localized at the site of interest, reducing unintended side 
effects to other cells.  For example, chemotherapy to treat cancer is delivered 
systemically to patients, and the compounds, which target rapidly reproducing cells, 
target cancer cells (the intended target) as well as cells of the bone marrow, digestive 
tract, and hair follicles (the healthy, unintended targets).  These effects produce a number 
of harmful side effects to the patient making the treatment often extremely difficult to 
undergo.  Potentially, such effects could be localized to the site of the tumor, leaving 
healthy cells unharmed, and increasing the effectiveness in treating the tumor. 
The second thing that the non-viral vector must be able to do is gain entry into the 
cell.  A particle of sufficiently small diameter (~1m or less) can come into contact with 
a cell membrane and gain entry to the lumen of the cell via endocytosis.  A particle 
contact one of the regions of the membrane that is designed for endocytosis and becomes 
engulfed in a portion of the cell membrane that invaginates itself into the cell and 
becomes pinched off into the cytoplasm.  This vesicle encapsulates the particle in what is 
called an early endosome.  Proton pumps that were once directed to the extracellular 
space are now directed inwardly to the early endosome.  H
+
 ions from the cytoplasm are 
pumped into the lumen of the early endosome resulting in a lowering of the internal pH.  
Vesicles from the endoplasmic reticulum containing digestive enzymes merge with the 
endosome and this vesicle becomes a lysosome.  The digestive enzymes combined with 
low pH, work to digest any foreign particle that has gained access to the cell interior in 
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this way.  Any particle that is intended to act as a non-viral gene vector must be able to, 
at some point, escape this digestive pathway in order to effectively deliver the gene 
payload.  If it does not, the genes to be delivered will be subject to lysosomal degradation 
and unable to effect the expression they are meant to produce or modify. 
2.2 Vector Selection 
 
In order to transfect cells non-virally, an appropriate vector must be chosen.  At 
the beginning of the transfection project a wide variety of particles and sizes were 
considered as possible vectors.  There are a number of companies that commercially 
produce nanoparticles.  All particles are not created equal however, and there will be 
differences in uniformity, functionalization, and composition.  Size-uniformity is ideal in 
particle fabrication, but difficult to achieve in particles less than 500nm.  Although ideal, 
size-uniformity is not necessary to achieve transfection.  Based on the fabrication 
process, nanoparticles will have differences in iron oxide percent composition, and as 
such will vary in magnetization.  The ability for nanoparticles to bind moieties is also not 
the same among all varieties.  For this reason a reasonably broad selection of particles is 
chosen to determine which types will be effective for transfection.  Particles should 
generally be smaller than 1 micron in diameter in order to be effective for uptake into the 
cell. (Desai, Labhasetwar et al. 1997; Prabha, Zhou et al. 2002)  Particles larger than this 
are generally be excluded for endocytosis, with the exception being phagocytic cells. 
I chose the following particles, shown in Table 2.1.  Scanning electron 
micrographs are shown in Figure 2.1. 
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Brand Size Functionalization 
Micromod Nanomag 20,50,100,130, 250nm COOH, (1 type of 250nm 
made with PEI) 
Spherotech 200, 510nm COOH 
Dynal Dynabeads 1m COOH 
Kisker 50nm COOH 
Chemicell PolyMag 100nm PEI 
Table 2.1.  Nanoparticle selection for initial transfection experiments 
  
   
   
Figure 2.1 Sample micrographs of the particles used in transfection experiments.  (Top 
Left) Dynal 1m Dynabeads.  (Top Middle) Spherotech 510nm.  (Top Right) Micromod 
250nm COOH. (Bottom Left) Micromod 250nm PEI. (Bottom Middle) Micromod 
130nm.  (Bottom Right) Chemicell 100nm.  At the 100nm level and smaller, clear images 
were difficult to acquire. 
Particles were selected from Invitrogen (Dynal), Micromod, Spherotech, Kisker, 
and Chemicell.  I chose a wide selection from several companies because there is a great 
deal of variability in the composition and functionalization among nanoparticles.  The 
magnetic susceptibility will vary among them, based on the size and density of iron 
oxide.  The level of carboxyl functionalization will vary and thus will affect my ability to 
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bind additional moieties to the surface.  The sizes ranged from 20-1000nm in diameter 
and were carboxyl group functionalized on the surface.  The carboxyl functionalization 
was chosen to enable a wide variety of secondary functionalizations, such as proteins or 
polymers, especially with its ability to form amine bonds. 
2.2.1 Particle Functionalization 
 
In order to be effective as a non-viral vector these particles need to be further 
surface functionalized with a moiety to bind DNA.  Reviewing literature revealed 2 
potential options for DNA binding, poly-lysine and polyethylenimine (PEI).  Poly-lysine 
is a homopolymer consisting of the amino acid L-lysine.  It has been shown to be 
effective as a transfection reagent and a valid option for functionalizing with a carboxyl 
group.  PEI is also shown to be effective as a transfection reagent. (Boussif, Lezoualch et 
al. 1995)  PEI also has the additional feature of helping a so-coated particle to escape the 
lysosomal degradative pathway. (Akinc, Thomas et al. 2005)  PEI was chosen as the 
polymer of choice because of this feature.  The nanoparticles were functionalized via an 
EDAC reaction as is described in the appendix in section 2.6.1. 
2.2.2 DNA Binding Verification 
 
To verify that PEI labeled beads were effective at binding DNA, 1m MyOne 
microbeads were functionalized with PEI and mixed with calf thymus DNA 
(InvitrogenTM).  Twenty-five l of 1 mg/ml MyOne beads were mixed with 50 l of calf 
thymus and rotated for 2 hours.  After rotating, the beads are spun down in a centrifuge, 
decanted, and re-suspended in 50l of MES buffer.  To these beads are added 100 l of 
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Sytox Green Nucleic Acid Stain (Invitrogen
TM
, 5mM concentration in DMSO) at a 
1/1000 concentration.  These beads are then washed twice and re-suspended in 50 l of 
MES.  Another sample of beads, without calf thymus DNA, also is mixed with Sytox 
Green, at similar volume and concentration.  This sample is also washed twice and re-
suspended in MES.  The Sytox Green Nucleic Acid Stain is designed to adhere to nucleic 
acids and fluoresce.  Beads with the DNA will fluoresce green and those without DNA 
will not.  This is shown in Figure 2.2: 
 
Figure 2.2 (A) Bright field image of 1m beads functionalized with PEI, DNA, and Sytox 
Green.  (B) Fluorescent image of same field of view as (A) verifying attachment of DNA 
to the beads.  (C)  Bright field image of 1m beads mixed with DNA and Sytox Green.  
Without the PEI functionalization, no DNA is seen attached to the beads 
 
The images on the left are bright field images taken at 100X magnification.  On the right 
are fluorescent images taken of the exact same field of view as the bright field images.  
The sample of beads that were mixed with DNA show clear fluorescence localized at the 
beads from the nucleic acid stain.  The beads without the DNA do not show any 
D. C. 
B. A. 
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fluorescence from the stain.  This experiment verified that my protocol of binding DNA 
to beads was effective. 
2.2.3 DNA Binding Quantification 
 
An important question to answer regarding the efficacy of a particle for oligo 
delivery is the capacity of the individual particle to bind the oligo effectively.  A particle 
is meant to enter the cytoplasm of a cell and release some portion of its payload to the 
cytoplasm, making it available for gene correction in the cell.  The bead must bind the 
molecules strongly enough to remain attached while suspended in fluid, such as blood or 
cell culture media.  On the other hand, it must not bind to them so strongly so as to 
prevent their release into the cell.  To determine the extent to which the PEI coated 
particles bind the oligos, I performed a series of experiments to empirically determine the 
average number of oligonucleotide molecules attached to the bead and the average 
number released over the duration of a typical experiment.  Absorbance of DNA in the 
electromagnetic spectrum is at a maximum for the UV wavelength.  This enables the use 
of UV-vis spectrophotometry for measurement of DNA concentrations experimental 
samples.  The Beer-Lambert law states that the transmission of light through a substance 
is logarithmically dependent on the product of the absorption coefficient of the substance 
and the path length of the light through the substance.  This can be shown in the below 
equation.  
    
 
  
       (2.1) 
Here, I0 and I are the intensities of the incident and transmitted light respectively,  is the 
absorption coefficient of the liquid, and l is the path length of the light.  The absorption 
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coefficient of the light can be expressed as the product of the extinction coefficient () of 
the absorbing molecules and their concentration (c) in solution. 
       (2.2) 
Taking the log of the Beer-Lambert equation yields the quantity known as absorbance A. 
 
        
 
  
     (2.3) 
Therefore if path length and extinction coefficient are known, the concentration of the 
absorbing molecule can be determined. 
For our studies, the oligonucleotide is provided at 5250 g/mL or 210 OD/mL.  A 
sample is drawn from this stock and diluted to 50 M.  Ten l of the 50 M is added to 
990 l for a dilution factor 100.  Theoretically this formulation should give an absorbance 
reading of 0.1155 on a UV spectrophotometer set to read at 260nm.  From this same 
stock 10 l of DNA are added to 20 and 30 l of the magnetic particles that are at a mass 
density of 1 mg/ml.  PBS is added to make a total volume of 260 l and this is allowed to 
rotate for 1 hour.  The beads are spun down in a centrifuge to separate the beads from the 
unattached molecules.  The supernatant is removed from the spun down beads and to this 
is added 740l of TE (Tris/EDTA 10:1) buffer, making a total volume of 1ml.  The beads 
are re-suspended in 1 mL of TE buffer and allowed to rotate for 24 hours.  This re-
suspension done to represent the introduction of the particle/oligo complexes being 
introduced cell culture media.  At the end of the 24 hour period the beads are drawn down 
and the supernatant is removed.  The fraction of oligos in the supernatant is 
representative of the oligos that would be released over the duration of the transfection 
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experiment.  The original DNA formulation is measured at 260nm as a standard.  The 
supernatant of the initial binding to the particles is measured and by subtraction with the 
standard formulation a determination is made of how much of the DNA has been bound 
to the particles.  The 24 hour supernatant is measured and a determination is made of how 
much of the DNA is released after 24 hours.  Results are shown in Figure 2.3. 
 
Figure 2.3 Plot of average oligos bound and released per 130nm nanoparticle 
Data show that on average 1710±155 (mean±SE) molecules were bound to a single 
130nm particle, and that over a 24 hour duration, 921±207 molecules were released per 
particle.  This resulted in an average bioavailability of 52% of the oligos originally bound 
to the particle. 
2.2.4 Polyethylenimine Properties 
 
To achieve gene binding to the particles and effective intracellular release, the 
polymer polyethylenimine (PEI, 60,000 MW, Sigma Aldrich) was chosen.  This 
substance is a highly branched polymer that has been used effectively as a transfection 
agent due to its ability to electrostatically bind to the sugar phosphate backbones of 
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nucleic acids.  PEI has been also found to be one of the compounds able to escape 
lysosomal degradation via the so-called “proton sponge effect”. (Akinc, Thomas et al. 
2005)  PEI is a highly branched polymer containing amine groups able to accept H
+
 ions.  
Because of this PEI possesses a high buffering capacity and acts as a buffering agent 
within the endosome.  Proton pumps, which were once facing the extracellular space, are 
now pointed into the interior of the early endosome once the particle is fully enveloped 
into the endosome.  The buffering capacity of the PEI, combined with the continued 
influx of H
+
 from the proton pumps, causes the endosome to osmotically swell, to the 
point of rupturing the membrane.  This enables the particle and genes to escape what 
would be inevitable degradation.  This capability also makes PEI useful reagent for 
delivery of genes.  This is not to say that PEI is without issues.  In spite of its promise, 
this PEI has been shown to induce cytotoxicity based on in-sample concentration and 
polymer structure. (Kafil and Omidi 2011)  Modifications to polymer structure have been 
shown to improve cytotoxicity and improve delivery, (Kafil and Omidi 2011) so properly 
balanced, PEI can be an incredibly useful carrier.  
2.3 Size Dependent Nanoparticle Transfection 
 
  All of the particles listed in section 2.2 were used initially to determine which 
would be useful for transfection experiments.  Chemicell PolyMag particles were 
acquired and were the only particles that were pre-functionalized for use as a non-viral 
vector.  The Micromod PEI 250nm particles were used without further functionalization 
to their surface. 
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2.3.1 Permanent Magnet Array 
 
The array of permanent magnets was constructed from the lid of a one of the 12-
well cell culture plates.  Twelve circular magnets of diameter 3/4 inches and thickness of 
1/32 inches were affixed such that when placed under the 12-well plate the magnets 
would be underneath each well.  The magnets are approximately 2 mm from the cells.  
The magnetic field of the magnets were measured at the centers with a F.W. Bell Model 
5080 gaussmeter and was found to be 77.4  3.5 mT(mean SE).  The magnets were 
measured at the z-height of the level of the cells, which is approximate 2mm.  To place 
the gaussmeter probe into the wells of the plate, a Dremel hand tool was used to remove 
portions of the sides of the plate to allow access of the probe.  The magnetic field at this 
height was found to be 18.1  3.4mT.  This results in a magnetic gradient of 29.7 T/m.  
The array is depicted schematically in Figure 2.4. 
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Figure 2.4 Schematic of a 12-well cell culture plate and 12-magnet array used in early 
transfection experiments.  Modeled after commercially available kits, the magnets were 
approximately the same diameter as the cell culture wells. 
2.3.2 Nanoparticle/Lipofectamine Dosage 
 
A full description of the nanoparticle/oligo binding protocol is described in the 
appendix in sections 8.3.6.  Cell culturing is described in section 8.3.2.  Each well was 
dosed with a 500nM concentration of oligo except for the Chemicell sample which 
contained 250nM.  The Lipofectamine 2000 sample was dosed at a 50nM concentration.  
This was a standard control dosage for transfection experiments as was explained during 
my training with Mike Fisher of the UNC pharmacology department. (Ming, Sato et al. 
2011)  This dosage was not meant to directly correlate to the nanoparticle dosages but to 
serve as a positive control for the experiment in general.  The dosages and nanoparticle to 
oligo ratios were not optimized at the time of these experiments, but as this was an early 
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stage in my attempts these variables were still being fine tuned.  All transfections were 
performed in the presence of Opti-MEM media, as described in section 8.3.2. 
The first cell plate was placed over the magnetic plate and both cell plates were 
placed in an incubator at 37°C.  The plates were placed at different ends of the incubator 
on separate shelves to negate the influence of the magnets on the control samples.  After 
4 hours media was replaced with 1 ml of DMEM and allowed to incubate for another 20 
hours.  The total incubation time was 24 hours.  The magnets were present for the 
duration of the 24 hour incubation period. 
2.3.3 The Sub-200nm Particles are Most Effective for Oligo Delivery 
 
Transfection results are shown in Figure 2.5: 
 
Figure 2.5 Luciferase expression from transfection of multiple nanoparticle sizes.  The 
sub-200nm particles achieve the best delivery. 
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The 1m and 500nm particle samples produced higher transfection rates in the non 
magnetic controls (magnetic samples 24086 and 5238 respectively versus non-magnetic 
51400 and 20711).  The reason for this is the ability of the particles of this size to 
sediment over the 4 hours of the transfection.  The second reason would be the geometry 
of the magnetic plate.  The magnets are roughly the diameter of the cell culture well.  As 
they are disk magnets the regions of highest field and gradient are near the circumference 
of the disk.  Microspheres of this size have significantly more volume than their smaller 
counterparts (0.53 m3 for 1 micron particle vs. 0.00053 m3 for a 100nm particle, a 
factor of 1000 difference) producing an increase in the V component of equation 3.5.  
This combined with the high fields and gradients would tend to draw the microspheres to 
the outer edge of the well preferentially, with fewer vectors going to the rest of the well.  
The 250nm and 200nm samples produced no transfection result whatsoever.  I believed 
this to be due to the inability of the particles to bind with the PEI, perhaps due to issues 
with their carboxyl coating.  The EDAC protocol worked for the other particle types so 
the reagents were not believed to be the cause of the failure to transfect.  The 250nm PEI 
were not functionalized with further PEI, so it can be concluded that they are not suitable 
to transfect particles in their native state.  The 20-130nm particle sizes all produced a 
promising transfection result with the greatest result occurring at the 20nm size level.  
This is to be expected as the 20nm particles should be the easiest particles to achieve 
uptake by the cell, due to their small size.  As a result this is the range of particle sizes 
that is focused on for future transfections, to the exclusion of the others.  The 1m 
microspheres showed promise as a potential vector, particularly with modification to the 
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dosage and magnet geometry.  However, in practical terms, as a model for potential in 
vivo application, the smaller sized particles are better suited as a vector choice. 
2.4 130nm Nanoparticle Dosage Response 
 
A dosage response is necessary to understand the optimal dose to achieve 
transfection.  As dosage is increased it should be expected that the expression level of the 
target gene should also increase.  There is a point at which optimal levels of expression 
are reached and beyond this point diminishing returns would be expected as the dosage is 
increased.  Additionally, transfection reagents, as with any drug or compound, will 
become toxic in a cell culture and cells will begin to die from the exposure.   
The 130nm Micromod particles were selected for usage in continuing transfection 
experiments based on the previous results.  All of the carboxylic acid particles are 
functionalized with PEI via a similar protocol, however, the 130nm particles were chosen 
for several reasons.  In the process of binding with PEI, the particles must be spun down 
several times with a centrifuge and re-suspended.  The 130nm particles were easiest to 
spin down with the smaller sizes being more difficult to spin down and decant without 
significant loss of particles.  Additionally, to characterize the oligo binding, the particles 
must be removed from concentration to leave unbound oligonucleotides in the 
supernatant.  This step was difficult using the 100nm and smaller particles, so the 130nm 
particles became the particle of choice.  It will be shown in future experiments that these 
particles are well suited as non-viral vectors. 
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2.4.1 Transfection 
 
One cell culture dish was placed over the array of permanent magnets and the 
other did not receive any magnet application.  This array is different than the previous 
array instead of a single magnet underneath the cell culture dish; this array was composed 
of an array of smaller magnets arrayed such that there are 4 underneath each well.  They 
are arranged in strictly alternating polarity.  This was done to increase the dispersion of 
the particles more evenly throughout the well.  Experimental observations of particle 
distribution in the well due to the single larger diameter magnets confirmed that the 
particles did in fact sediment preferentially towards the outer perimeter of the well.  This 
led me to use smaller magnets to produce more even delivery of the particles.  It would 
be expected that an array of a greater number of smaller diameter magnets would produce 
a more even distribution of the particles, but for my purposes 4 magnets per well would 
be suitable.  This is depicted in Figure 2.6. 
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Figure 2.6 Schematic of a 12-well cell culture plate and 4 magnet array 
As in the previous magnetic array, the magnets are arranged in a strictly alternating 
polarity. 
Both 12 well plates were placed in an incubator at 37°C and 5% CO2 for a period 
of 1 hour.  At the end of 1 hour the magnetic plate is removed and the Opti-MEM media 
in both plates was replaced with DMEM with 10% FBS.  After 24 hours the cells are then 
ready to be assayed for transfection results. 
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2.4.2 BCA Results 
 
The results of the BCA test are shown in Table 2.2: 
 
Table 2.2.  BCA Results of Dose Response.  Toxicity was observed above 125nM 
 
 
No significant toxicity is observed in the nanoparticle samples for the 6.25nM-100nM 
concentrations, based on scanning the wells through bright field microscopy.  Toxicity is 
observed in the 125-500nM samples, as evidenced by a decreased number of healthy cells 
in those wells. 
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2.4.3 A 50-100nM Dosage Yields Optimal Results with Minimal Toxicity 
 
 The results of the nanoparticle dose response are shown in Figure 2.7. 
 
Figure 2.7 Dose response of 130nm particles.  Best results were seen in the 50-100nM 
dosages 
The data show significant Luciferase expression levels for the 2.5-125nM samples 
receiving the magnetic field application.  All samples in this range showed significant 
increase in Luciferase expression over the non-magnetic controls.  The greatest percent 
increase in transfection over the non-magnetic control is seen at the lowest concentration, 
2.5nM (860.6%), and this improvement remains high for the rest of the samples but 
decreases monotonically with increasing dose (506% for 12.5nM, 234% for 25nM, 127% 
for 100nM, and 61% for 125nM).  Non-magnetic controls were unfortunately not 
performed for the 50 and 75nM due to insufficient volume of nanoparticle reagent at the 
time of the experiment, although theoretical values could be interpolated based on the 
other data points.  The 50nM magnetic treatment exceeded the expression level of the 
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comparable Lipofectamine dosage (345516 versus 275121 RLU/g protein, a 26% 
improvement).  For the 250 and 500 nM dosages, the no magnet controls exceeded the 
magnet samples.  This is due to the high dosages of particles in those samples causing 
significant toxicity and reducing the overall transfection.  The high dosage combined 
with the increased sedimentation by the magnets induces high levels of toxicity and is 
likely harsher on the cells than the non-magnetic sample.  This study established the 
optimal dosage range for transfecting with 130nm particles.  Prior experimentation was 
focused on establishing the capacity of various particle types to transfect the antisense 
oligos.  This study informed for the first time the appropriate dosage to achieve 
expression and minimize toxicity. 
2.5 Transfection with Size-Uniform 200nm Fe Post Particles 
 
A novel type of size uniform Fe post particles was fabricated as described in 
section 2.6.10.  This work represents the first instance in which metal evaporation onto 
post structures was used for the formation of released, shape-defined metal particles.  
This was the first use of lithographically defined particles as agents of magnetofection 
(Mair, Ford et al. 2009).   
2.5.1 Transfection 
 
The cells were treated for 1 hour with a 200 nM dose of antisense ODN complexed 
with 200 nm Fe nanoparticles with and without a permanent magnetic field.  Control 
experiments were performed using untreated and Lipofectamine treated (no particles) 
HeLa EGFP-654 cells in order to compare the efficacy of gene transfection using these 
particles.  Also, in order to assess the differences between free-floating PEI-ODN 
complex and particle and Lipofectamine transfections, PEI (50% w/w, 60,000 MW) was 
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diluted 1:5000 and conjugated with the antisense oligonucleotide.  It was also added to 
the cell culture at 200 nM and allowed to incubate for 1 hour, at which time the media 
was replaced with fresh media.  For magnetic nanoparticle transfections one sample was 
placed over the NdFeB magnets for 1 hour and a second sample did not receive an 
external magnetic field.  The media was changed in all samples to D-MEM F-12 with 
10% FBS after 1 hour.  Replacing media after the field application removed free-floating 
ODN-laden particles from the solution, as well as any free ODN remaining in solution.  
The cells were incubated for an additional 23 hours before imaging.  The total duration of 
the experiment was 24 hours.  After 24 hours fluorescence microscopy was used to 
quantify the transfection efficacy.  The imaging and segmentation process is described in 
section 2.6.9.  
2.5.2 Our Size-Uniform Nanoparticle Effectively Delivery the Antisense Oligos 
 
Figure 2.8 shows representative images from each treatment course along with 
segmentation data. 
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Figure 2.8 Representatives images of cells transfected with PEI-ODN, Lipofectamine, 
and nanoparticles with and without an applied magnetic field.  Oligonucleotide 
concentrations were all 200 nM.  Average fluorescence intensities are calculated based on 
image segmentation collected across the wells. 
The efficacy of magnetofection using our post-particles is clearly evidenced by the 
increased expression of EGFP. The increased fluorescence is a product of particles 
penetrating the cell membrane, delivering antisense ODNs to the cell nucleus, and 
aberrant splicing of EGFP pre-mRNA being corrected. Results from segmentation 
analysis of EGFP-expressing cells indicate a 76% increase in fluorescence intensity of 
ODN-loaded magnetic particles (with magnetic gradient applied) over Lipofectamine as 
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well as a 139% increase in intensity over the non-magnetic control. Also, as evidenced by 
images taken throughout the well, the rate of transfection was significantly higher in the 
magnetic sample over the non-magnetic control. Magnetofection experiments exhibited 
only low levels of cell death (less than 5% overall) as observed through bright field 
microscopy and no evidence was seen that our particles increased cytotoxicity. However, 
our transfection times were 1 hour, and as such, possibly not a long enough time frame to 
accurately gauge toxicity levels. Toxicity experiments performed over extended periods 
would provide greater information regarding the comparative toxicity of our particles. 
Likewise, untreated HeLa EGFP-654 cells were unresponsive to the applied magnetic 
field and showed no visible signs of increased cytotoxicity during the experiment. It has 
been noted previously that an applied magnetic field enhances the transfection rate. The 
general mechanism by which this increased endocytosis is not clear.  It is clear that the 
process of magnetofection decreases the time necessary for cell particle interactions to 
occur by magnetically placing the ODN-laden particles onto the cell membrane.  The 
next phase in the evolution of this field is the use of magnetic fields to enhance delivery 
of non-viral vectors beyond increased sedimentation time.  This is explored in the 
following chapters. 
 
 
 
 
 
 
 
  
 
Chapter 3 
Development of an Oscillating Magnetic Field Transfection Device 
3.1 Overview 
 
Ideally, an oscillating magnetic force system should apply forces in a uniform 
fashion across the cell culture dish.  It should also be able to probe a significant range of 
frequencies in order to adequately study frequency dependence.  A commercially 
available oscillating magnetic field system exists that has been used in several published 
studies of how oscillating fields affect nanoparticle transfection. (McBain, Griesenbach et 
al. 2008; Pickard and Chari 2010; Jenkins, Pickard et al. 2011)  Although this system has 
yielded enhanced nanoparticle transfections, it is limited in the frequency and amplitude 
of the oscillation it can probe, which limits its effectiveness.  It is also unable to apply 
uniform forces across the entire cell culture dish, which means that only a subset of the 
cell culture receives the maximum force application.  It is limited in frequency range, and 
is only able to probe 1-5Hz.  A better testing range would incorporate a more logarithmic 
scale, for instance 1, 10, and 100Hz.  This gives a more thorough examination of any 
frequency dependence that may exist.  In this chapter I will describe the design of my
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own oscillating magnetic force device.  My first iteration was modeled after the 
commercially available device as I attempted to improve upon its design.  This device 
produced the initial results presented in section 4.5.2.  My second iteration sought to 
improve upon this, and was designed to produce uniform forces across the well and the 
desired higher frequency range.  This device produced all of the transfection results after 
section 4.5.2.   
To design a platform to test the effects of alternating fields on non-viral magnetic 
particle transfection, a crucial factor in the design is the distance of the magnets from the 
cell culture.  The magnetic force exerted on a paramagnetic bead is governed by the 
equation: 
   
   
   
 
    
    
       (3.1) 
where   is force,   is the diameter of the bead,    is the permeability of free space (in SI 
units),    is the relative permeability of the bead, and   is the magnetic field.  A bead’s 
permeability is related to its susceptibility by the equation: 
             (3.2) 
where    is the volumetric susceptibility of the bead.  According to equation 3.1, there 
are 3 ways to increase the force on a particle.  First, the diameter of the bead can be 
increased.  A greater diameter will result in a greater volume, and therefore more 
magnetic material to respond to an external magnetic field.  Microbeads can be produced 
to be tens of microns in diameter; however beads on this size scale would be ineffective 
for gene delivery.  Their size will exclude them from entry into the cell.  Beads or 
particles for drug delivery are typically sub-micron in diameter.  Secondly, the relative 
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permeability of the particle can be adjusted to increase force.  This is done by adjusting 
the material composition of the particles.  As the relative permeability    increases, the 
limit of the quantity 
    
      
 increases asymptotically to 1, placing an upper bound on the 
contribution permeability makes to the overall force.  Lastly the force is dependent upon 
the field and field gradient.  In order to apply a force to a paramagnetic particle a 
magnetic field alone is not sufficient to induce translational motion a field gradient must 
also be present.  To achieve this, the magnet must be placed in closest practical proximity 
to the sample in order to be in the region of highest gradient.   
 The importance of distance from the magnetic pole can be shown in the equation: 
       
    
  
 (3.3) 
where r is the distance between the magnetic pole and the bead.  The force on a bead 
decays by a factor of 1/r
5
 so the distance between pole and sample is one of the primary 
factors when designing such a system. 
3.2 Oscillating Magnetic Force Transfection Device 
 
I designed a device to apply oscillating magnetic fields to enhance nanoparticle 
transfection.  It is comprised of a holder for the cell culture plate and an array of 
permanent magnets to be oscillated underneath the cell culture.  The first magnetic array 
oscillates magnets laterally under the cell culture and the second one rotates the magnets.  
Both served to enhance transfection but for several reasons the rotating array provides a 
more effective treatment, for reasons that will be explained in the following sections. 
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3.2.1 Cell Culture Holder 
 
To control the distance of the cell culture and the magnetic plate, I employed an 
XYZ translation stage.  I used a Thorlabs ½” XYZ translation stage as a basis for the 
transfection device.  A stage was designed to hold standard 6 or 12 well tissue culture 
dishes.  It is designed to allow access to the bottom of the cell culture dish, enabling the 
magnets to physically contact the bottom of the wells.  It is screwed into the translator 
stage and the distance between the dish and the magnets can be vertically adjusted with 
the micrometer.  The micrometers have a resolution of 10 m and the distance of the 
travel can be shown by the tick marks labeling the micrometer.  This enables easily 
reproducible adjustments for z-distance between the plate and magnets, and allows us to 
bring the cell culture dish as close to the magnets as possible and still allow for free 
translation of the magnetic plate. 
 
 
 
 
Figure 3.1 (A) Isometric view of cell culture plate holder. (B) Side view. (C) Front view. 
(D) Top view. 
A. B. 
C. D. 
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3.2.2 Magnet Geometry 
 
The magnetic plate is composed of a lid of a standard 6-well tissue culture dish.  
Its similarity in size to the tissue culture plate made it a simple yet effective component 
for making the plate.  Magnets were acquired from K and J Magnetics Inc. (Jamison, PA).  
The magnets chosen were axially magnetized 0.25" diameter by 0.2" height cylindrical 
magnets.  These magnets’ diameters are significantly smaller than the diameter of a 6-
well (~1.4”) or 12-well (~0.9”) plate.  These magnets are rare earth magnets composed of 
Neodymium, Iron, and Boron (Nd2Fe14B) with nickel-copper composite plating.  Other 
commercially available magnetic plates offer plates that have a single magnet designated 
for a single cell culture well.  For example if you desired to do a transfection in a 12-well 
plate, the commercial product would have a magnets of the same diameter positioned in 
the same conformation as the dish.  Such plates are able to enhance transfection, however 
I contend that this is not the most favorable geometry for transfection in cell culture 
dishes of this size.  The gradient of the cylindrical magnet is greatest around the edge of 
the magnet.  This can be seen in the calibration of 1” disk magnet shown in Figure 3.2. 
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Figure 3.2 (Top) Disk magnet calibrated across the diameter.  The probe is actually in 
contact with the surface during measurement. (Bottom Left) Magnetic field along the top 
surface of a 1” neodymium magnet, along the diameter.  (Bottom Right)  Calculation of 
the magnetic gradient.  The biggest changes in field and gradient occur at the edges of the 
magnet. 
Each data point is 250m apart which is smaller than the reported magnet displacement 
of 200m.  While the change in gradient is relatively high at the edges of the magnet, for 
roughly 75% of the diameter of the magnet the change in gradient on average is only 5 
T/m.  Therefore, oscillating a magnet with an amplitude of 200m would only produce a 
minimal change in force application for the majority of the cells which are not at the 
periphery of the magnet edge.  This does not optimize the field effects.  Alternately, 
sweeping a magnet underneath the entire cell culture will allow all of the cells to 
experience the full range of magnetic gradients from the maximum to zero.  The 
oscillating effect, that is, changing the force application upon the magnetic vectors, is 
only optimized by applying the full range forces including the zero force range.  
Otherwise, the change in gradient will be orders of magnitude smaller for the majority of 
the cells. 
If the magnet of the same diameter as the cell culture well, then the points of 
greatest attraction for the particles will be around the perimeter of the dish, away from the 
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vast majority of the cells.  It stands to reason that a more favorable geometry would be 
composed of a series of smaller magnets arrayed over the surface of the well.  This would 
provide for higher gradients throughout a greater percentage of the cell culture and thus 
higher forces applied to more particles over a greater portion of the well. 
3.2.3 Force Calibration 
 
To calibrate the forces on a particle by a magnet it is standard to mix the particles 
into a Newtonian fluid, and measure the velocity and calculate the force based on Stokes’ 
law: 
          (3.4) 
However, the particles used in these transfection experiments are below the diffraction 
limit of an optical microscope (200nm).  So we refer to physical laws of magnetism to 
give us estimations for the forces the particles experience.  We do this based on the 
equation: 
    
    
   
       (3.5) 
which tells us that the force on a particle depends on its volume (V), volume magnetic 
susceptibility (), the permeability of free space (), the magnetic field (B), and field 
gradient.  The particles are not perfectly spherical, but for calculation purposes, we will 
treat them as an idealized sphere of volume: 
          
 
 
    (3.6) 
The magnetization of the 130nm particles is reported by the manufacturer as 53 emu/g 
(electromagnetic units per gram) when H = 1000 Oe (Oersted).  The conversion to SI 
units, magnetization is one to one, so this is equivalent to 53 Am
2
/kg (Amperes meters 
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squared per meter).  To convert the H field, 1 Oe = 1000/4A/m so then 1000 Oe is equal 
to 250000/ A/m.  Magnetization is described mathematically by: 
        (3.7) 
where m is the mass magnetic susceptibility and H is the magnetic field.  Solving for 
susceptibility yields: 
    
   
      
 
  
  
 (3.8) 
 
The conversion for volumetric susceptibility is: 
     
  
 
 (3.9) 
The bead density is 3.0 g/ml
3
 (3,000,000 g/m
3
) as reported by the manufacturer.  This 
yields a susceptibility of: 
         (3.10) 
In order to calculate the force we must also know the field and the field gradient of the 
applied magnetic field.  To do this I used a F.W. Bell Model 5080 gaussmeter to measure 
the field at 250 m increments from the face of the magnet.  A plot of the magnetic field 
vs. distance is shown in Figure 3.3: 
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Figure 3.3 (Left) Magnetic field is measured from the center of the disk magnet.  (Right) 
Field vs. distance of single 0.25" diameter by 0.2" height cylindrical magnets 
 
Taking the particle to be an idealized sphere of radius 65nm yields a volume of 1.15x10
-
21
 m
3
.  To calculate the gradient we use a five point stencil method: 
        
                                 
   
 (3.11) 
The permeability of free space  = 4 x10
-7
 Vs/(Am).  The theoretical force is then 
calculated and shown below. 
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Figure 3.4 Force vs. distance of single 0.25" diameter by 0.2" height cylindrical magnets. 
The magnets were arrayed in such a manner that an equal number of magnets would be 
underneath each well.  For the 6-well cell culture dish, the magnetic plate had 9 equally 
spaced magnets arranged under each well.  The magnets are positioned in alternating 
north/south polarity, with no two poles being similar in an adjacent left/right or up/down 
position. 
The magnetic plate is attached to a linear induction motor to produce the 
oscillations in the X-Y plane.  A stage was designed to screw into the motor that would 
hold the magnetic plate in place underneath the cell plate.  The linear motor is controlled 
using a Wavtek Model 801 50MHz Pulse Generator.  Connections are made to the motor 
using fully insulated 5/16” alligator clips via the 50output connector.  With the device 
fully assembled, testing was performed to test the magnitude and frequency that the 
motor would drive the plate.  A square wave signal was sent to the motor and the width 
was varied from 10s to 100ms.  The delay was set to 0s, and the period was adjusted 
from 10s to 100ms.  One minute of video was captured of the magnetic plate 
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undergoing oscillating motions while driven by the pulse generator at different settings.  
Video was taken using a Sony Cyber-shot W510 digital camera.  Video was captured at 
30 frames per second and analyzed using Video Spot Tracker. 
3.2.4 Rotating Magnetic Array 
 
An alternate means of producing the oscillating magnetic field was produced 
using a rotating DC motor.  Previous studies have reported enhanced transfection 
producing an oscillating field with a rotating magnet array. (D. Vainauska 2011)  In light 
of the issues faced with the previous set up, this methodology proved to be a way to 
continue experiments without significant loss of time.  The motor is connected as 
previously described to the Wavtek pulse generator.  The magnetic array consists of 4 
Neodymium block magnets arranged at 45 angles at the vertices and along the diagonals 
of a square.  The block magnets are rectangular prism with dimensions of 1” ¼”  ½” 
(lwh).  Magnets are arranged in an alternating polarity configuration.  A diagram is 
shown in Figure 3.5 with an image and schematic of the experimental setup. 
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Figure 3.5 (A) Top view of magnet array (B) Image of magnetic system as it is setup in 
the cell culture incubator (C) Schematic of experiment in 96 well plate. 
 
3.2.5 Frequency Calibration 
 
The motor is driven between 8.2 and 12 volts and video is captured at 30 fps 
while it is operating.  The video is tracked using video spot tracker.  From tracking the 
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video, the dependence of voltage vs. rotational frequency is established.  A plot of this is 
shown below. 
 
Figure 3.6 Calibration of motor to determine rotational frequency vs. voltage.  Because 
there are 4 magnets attached to the motor, magnets actually pass under the sample at 4X 
the calibrated frequency. 
 
The frequency of rotation was shown to be between 0.5Hz and 5.5Hz.  Because of the 
positioning of the magnets the sample receives a magnetic field 4 times per rotation of 
the motor. Therefore the frequencies at which the magnets pass under the sample range 
between 2 Hz and 22Hz as shown in the Figure 3.7.  
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Figure 3.7 Magnet frequency vs. voltage 
3.2.6 Force Determination 
 
The magnets are calibrated with a F.W. Bell Model 5080 gaussmeter to measure 
the field at 250 m increments from the face of the magnet.  This gives information about 
the point that the particles experience the greatest z-component of the force.  A plot of the 
magnetic field vs. distance is shown below: 
 
 
Figure 3.8 Vertical component of magnetic field of single rectangular magnet 
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Because of the rotation of the motor the magnetic field, force, and gradient at the sample 
follow a periodic wave pattern.  The distance between the magnets and the underside of 
the cell culture dish is determined to be 0.015”.  This is determined by placing the magnet 
underneath a sample 96 well plate, and then using the micrometer to move the plate down 
to the magnets to the point at which the plate contacts the magnets.  The Thorlabs MT3 
XYZ translation stage has micrometers with tick marks that provide 0.001” resolution.  
The NUNC 96-well plate specifications indicate that the thickness of the polymer surface 
is 0.01”, and therefore the sum of these measurements gives us the total of 0.025” or 
6.35mm distance between the magnets and the cells.   
The magnets are moving radially about the axis of the motor, so that the field at 
the sample has time dependence.  To calibrate for this feature of the magnets must be 
calibrated not only in the z direction, but radially in the X-Y plane.  To do this the motor 
is clamped to a stage at the vertex of a protractor.  A small ruler is affixed to the motor, as 
if extending from the axis of rotation of the motor.  This enables me to measure the angle 
of the motor as it turns about the vertex of the protractor.  The gaussmeter probe is placed 
over the center of the magnet.  The magnet is then turned at angles which are multiples of 
7.5  Following each 7.5 measurement, a second measurement is done 3 from that 
measurement.  The field is then measured at 0 3 7.5 10.5, 15, 18and so on through 
45  Due to the symmetry of the magnet geometry, and uniformity of the individual 
magnets it is clear that continuing through a full 90 or even 360 would produce results 
similar to the measurements made through the 45 sweep, the only difference being the 
alternating polarity of the magnets.  Therefore for purposes of approximating the forces 
on the particles I take the measurements taken through 45 and extend it through the full 
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360. These measurements were done at the z-height of the magnet and at a height twice 
the distance the magnets would be from the cells in an experiment.  This was done so that 
a z-gradient could be calculated at the location of the cells during an experiment.  Given 
this field and gradient is calculated as previously described. (Figure 3.9) 
  
Figure 3.9 Measurements of the magnetic field vs. rotation angle.  (Right)  Calculation of 
the magnetic gradient vs. rotation angle.  The two peaks are a result of high field and 
gradient at the top two edges of the rectangular magnet. 
 
Force vs. time is also calculated. (Figure 3.10) 
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Figure 3.10 Derived vertical magnetic force vs. time.  (A) 2Hz (B) 4Hz (C) 10Hz (D) 
20Hz 
The magnetic field gradient reached a peak of 154.8 (T/m).  The point of highest gradient 
is of course the place where the highest force is achieved.  The force on the particles due 
to the magnetic field and gradient reached a peak of 43.4 fN and reached a minimum of 
essentially zero.   
The magnetic array also contributes a horizontal component of force on the X-Y 
plane.  To calibrate this, the gauss meter probe is turned 90to measure the horizontal 
component of the magnetic field.  The probe is placed in contact with the magnet the 
closest possible distance achievable to get the sensor in range of where the cell culture 
would be.  The motor was then rotated underneath the probe in the same manner as 
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described for the vertical calibration.  The field is measured and the gradient is calculated 
and shown in Figure 3.11: 
 
 
Figure 3.11 (Left) Measurements of the horizontal magnetic field vs. rotation angle.  
(Right)  Calculation of the horizontal magnetic gradient vs. rotation angle. 
 
The horizontal component of force is also calculated. (Figure 3.12) 
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Figure 3.12 Calculated horizontal magnetic force vs. time.  (A) 2Hz (B) 4Hz (C) 10Hz 
(D) 20Hz 
The force in the XY plane reaches a maximum of 7.9 fN.  The plots of force go into the 
negative values showing that the direction of the force reverses direction as the magnet 
passes over the sample.  So in addition to the oscillation of force in the Z-direction, a 
significant component of the oscillation is also produced in the lateral direction. 
To put this force regime in perspective, it can be contrasted with the force exerted 
on the particle due to gravity.  The bead density is reported by the manufacturer as 3 
g/cm
3
, (Teller and Grüttner 2012) which is equal to 3000000 g/m
3
.  Treating the particle 
as an idealized sphere, the volume of the particle is 1.15x10
-21
 m
3 
as shown previously.  
The mass of the particle is the found using 
      (3.12) 
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Where m is the mass,  is the density, and V is the volume.  Therefore the mass is 
calculated to be 3.45x10
-15
 g (3.45x10
-18
 kg).  The force on an object due to gravity is 
given by Newton’s law of universal gravitation: 
     
     
  
 (3.13) 
Where G is the gravitational constant (6.674x10
-18
 Nm
2
kg
-2
), m1 is the mass of the first 
object (in this case the earth, 5.9742x10
24
 kg), m2 is the mass of the second object (in this 
case the particle, 3.45x10
-18
 kg), and r is the distance between the centers of the 2 masses, 
(in this case the radius of the earth 6,378,100 m).  Calculating the gravitational force 
yields 3.38x10
-17
 N, 3 orders of magnitude less than magnetic force.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter 4 
Transfection is Enhanced with Oscillating Magnetic Fields 
4.1  Overview 
 
 To deliver non-viral gene vectors in vitro or in vivo there are two main aspects 
that must be considered once the vector is introduced into the cell culture, tissue, or 
organism.  The first is the transport to the cells or tissue which the vectors are intended to 
affect.  Magnetic force can be applied to paramagnetic particles to induce a velocity in 
the particle in the direction of the magnetic gradient.  Secondly, the vector must gain 
entry into the cell after contacting the cell membrane.  in vivo cell transfections suffer 
from low efficiencies, so in order for non-viral delivery to be a viable therapy, 
improvements must be made to both aspects of delivery.  Oscillating magnetic fields have 
shown promise in their ability to enhance transfection efficiency with magnetic 
nanoparticle delivery to cells.  The effects of oscillating forces on nanoparticle 
transfection are not fully understood, but must be to make non-viral delivery a viable 
option as a therapeutic treatment. 
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 This chapter details the use of the oscillating magnetic field device described in 
chapter 3 to enhance transfection of HeLa cells.  Using a range of oscillation frequencies 
EGFP expression levels are increased, and I show that the effect behaves like a band pass 
filter.  How oscillating forces actually produce enhanced transfection efficiencies has 
been a previously unanswered question in the field.  I detail a modification to published 
transfection protocols that allow me to better distinguish what phases of the transfection 
are affected by the oscillating forces, and therefore get closer to the reasons why the 
forces are actually beneficial.   
4.2 Published Oscillating Field Transfections have not Revealed Mechanisms 
Responsible for Enhancing Effects 
 
 Several studies have been performed to test the effects of oscillating fields on 
transfection.  Kamau et.al applied oscillating fields to multiple cell types to test the 
effects of oscillating fields on transfection. (Kamau, Hassa et al. 2006)  In their study 
they applied a 50Hz pulse with a field and gradient and gradient of 27mT and 10 T/m.  
This paper showed that oscillating fields could increase the transfection efficiency for 
delivery of nanoparticles.  Other papers have investigated the effects of oscillating fields 
on transfection.  The same group published a paper applying pulsed magnetic fields to 
transfect primary cells of multiple types. (Chapman, Hassa et al. 2008)  Another paper 
presented mixed results applying a horizontally oscillating array of permanent magnets 
with a frequency of 2Hz and amplitude of oscillation of only 200m. (McBain, 
Griesenbach et al. 2008)  Some data presented here showed an enhanced effect from the 
oscillating field, some of the data did not have an enhanced effect.  Other papers have 
shown enhanced effects with horizontally oscillating arrays, testing frequencies between 
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1 and 5Hz, with a similarly low amplitude of 200m. (Pickard and Chari 2010)  There 
are other studies that have investigated this effect, but overall the number of published 
articles is quite low, with around 10 total papers at the time of this writing.  All of these 
papers have shown that there exists an enhancement to transfection due to an oscillating 
magnetic field, but they also all contain one fundamental issue in understanding the 
nature of the effect.  These experiments do not distinguish between the transport and 
post-transport phases of delivery, because there are nanoparticles still free-floating in 
culture during the application on the oscillating fields.  While this may result in improved 
transfections, it does not lead to a clearer understanding of how oscillating fields improve 
transfection rates. 
4.3 Protocol to Effectively Study Oscillating Force Effects   
 
As mentioned before, there are in effect two components to the delivery of a gene 
to the cell.  First the gene vector must be transported through the cell culture media to the 
cell membrane.  The paramagnetic nanoparticles are distributed throughout the cell 
culture media, moving around via Brownian diffusion, eventually settling to the bottom 
of the well via gravitational sedimentation.  This sedimentation would be considered the 
transport stage of transfection, which would be enhanced by a sufficient magnetic field 
and gradient.  Secondly, there must be uptake of the vector by the cell in order to 
introduce the gene to the interior of the cell, where it will be available for to the intended 
intracellular target.  In all of the papers that use oscillating magnetic fields the data 
reported do not distinguish between these two phenomena, making it impossible to know 
by what mechanism the oscillating fields are actually influencing the transfection.  The 
typical process is depicted in Figure 4.1.   
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Figure 4.1 Schematic of a typical oscillating field Magnetofection experiment in 
literature.  Oscillating fields are applied as nanoparticles are still freely floating in the cell 
culture, making it impossible to distinguish transport to the cell from post-transport 
effects. 
 
Even in studies where both static and oscillating fields are applied, the effect is obscured 
because the nanoparticle containing cell culture media is not changed in between 
applications of the different field types.  When media is not changed before application of 
the oscillating field, nanoparticles are still being transported to the cells from the culture 
media while at the same time particles are also experiencing uptake.  To examine the 
effect of the oscillating field on the uptake cell media must be changed prior to the 
application of the field.  My protocol is displayed graphically in Figure 4.2.  All 
experiments are performed at 37.0°C. 
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Figure 4.2a Schematic of the oscillating (AC) field transfection protocol (referred to as 
“Static+2Hz”, or 2Hz, 4Hz, 20Hz).  1. Oligo bearing nanoparticles are dosed into the 
sample and exposed to a permanent magnet for 30 minutes.  2. Cell culture media is 
changed to remove excess nanoparticles from solution.  3.  An oscillating field is applied 
to the sample for an additional 30 minutes.  4.  The cell culture is incubated for 23 hours.  
5.  Cells are imaged for EGFP expression. 
 
 
Figure 4.2b Schematic of the static field (“Static Only”) transfection protocol.  1. Oligo 
bearing nanoparticles are dosed into the sample and exposed to a permanent magnet for 
30 minutes.  2. Cell culture media is changed to remove excess nanoparticles from 
solution.  3.  The cell culture is incubated for 23 hours.  4.  Cells are imaged for EGFP 
expression 
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Figure 4.2c Schematic of the “No Field” transfection protocol.  1. Oligo bearing 
nanoparticles are dosed into the sample and incubate for 30 minutes.  2. Cell culture 
media is changed to remove excess nanoparticles from solution.  3.  The cell culture is 
incubated for 23 hours.  4.  Cells are imaged for EGFP expression 
 
This simple step is not done in any of the current literature of the field and the resulting 
data are presented here for the first time in these experiments.  These data will show 
definitively that the oscillating field has a distinct effect on the post-transport phase of the 
transfection, an effect separate from the transport, with implications for future work and 
in vivo therapeutic applications. 
4.4 Frequency Response Experiments 
 
 Since an oscillating magnetic field has the effect of enhancing transfection results, 
then it must be the case that there is a dependence on the frequency of the oscillation.  
Several papers have performed frequency response studies using oscillating fields.  In the 
Chari group papers from Keele University (Pickard and Chari 2010; Jenkins, Pickard et 
al. 2011) they tested the frequency effects on transfection of astrocytes and 
oligodendrocytes.  The frequencies tested were 1, 3, and 5Hz, and 1 and 4Hz for the 
respective papers.  These frequencies were undoubtedly chosen due to limitations of the 
magnetic device they were using.  The nanoTherics Ltd. Website, makers of the 
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Magnefect nano transfection system, report that the maximum operating frequency for 
the system is 5 Hz.   It also reports that the amplitude is 0.2mm.  The problems with these 
limitations are two-fold.  First an optimal approach for probing frequency dependence 
would test frequencies along a wider range, beyond 1-5Hz.  The peak in efficiency may 
exist outside of this limited range.  Secondly, the amplitude of oscillation is 0.2mm.  
While the 0.2mm is much larger than the average length of the cell, across the face of a 
cylindrical disk magnet there is not much change in the magnetic field gradient over 200 
microns.  This is shown by the calibration of a typical neodymium disk magnet in Figure 
4.3. 
  
Figure 4.3 (Left) Calibration along the surface of a 1” neodymium magnet.  (Right)  
Calculation of the magnetic gradient.  The biggest changes in field and gradient occur at 
the edges of the magnet, so an oscillation of only 200m only affects a small portion of 
the cell culture. 
 
Each data point is 250m apart which is smaller than the reported magnet displacement 
of 200m.  While the change in gradient is relatively high at the edges of the magnet, for 
roughly 75% of the diameter of the magnet the change in gradient, on average, is only 5 
T/m.  Therefore oscillating a magnet with an amplitude of 200m would only produce a 
minimal change in force application for the majority of the cells which are not at the 
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periphery of the magnet edge.  This does not optimize the field effects   Alternately, 
sweeping a magnet underneath the entire cell culture will allow all of the cells to 
experience the full range of magnetic gradients from the maximum to zero.  The 
oscillating effect, that is, changing the force application upon the magnetic vectors, is 
only optimized by applying the full range forces including the zero force range.  
Otherwise, the change in gradient will be orders of magnitude smaller for the majority of 
the cells. 
4.5  Oscillating Field Transfections      
 
 The oscillating field transfection experiments will be described in this section. 
4.5.1 Magnetic Field Application   
 
 For the nanoparticle dosed wells, some wells receive an initial magnetic field 
application to sediment particles to the cell layer and some do not.  After the 
sedimentation time, the media is changed to remove excess particles in solution.  This is a 
key step in the study of this phenomenon that is not performed in current papers focusing 
on the effects of AC fields on transfection.  Current published studies do not change the 
media in between applications of DC and AC fields.  As mentioned previously, 
transfection is composed of two components, the transport of the vector to the cell 
membrane as well as the transport of the vector through the membrane.  When the media 
is unchanged during the experiment, the line is blurred as to the effect the oscillating field 
is actually having in the process of transfection.  If particles remain in the solution when 
the AC fields are applied, the fields will have an effect on continued transport of particles 
to the cell, as well as an effect on particles that are on the membrane and already along 
the endocytosis pathway.  So while it is true that papers can report increased transfection 
 
 
56 
using oscillating fields, their data do not elucidate the reasons the AC field produce this 
effect.  The reasons for these results are often only qualitatively addressed in discussion.  
By changing the media we focus our experiment to examine the effects of the AC fields 
on transport of particles through the cell membrane. 
After the media is changed, some samples receive an additional DC field, AC 
field, or no field application.  The additional fields are applied for 20 minutes.  A chart 
depicting the samples is shown below. 
Name Vector 
 Dosage 
(nM) 
10 min 
DC 
Media 
 changed 
Additional 20 
 min DC field 
Additional 20 
 min AC field 
Untreated None 0 NO NO NO NO 
Beads only 130nm particles 50 NO YES NO NO 
DC only 130nm particles 50 YES YES NO NO 
DC + DC 130nm particles 50 YES YES YES NO 
DC + AC 130nm particles 50 YES YES NO YES 
Lipo+623 Lipofectamine 2000 50 NO YES NO NO 
 
The magnets are oscillated horizontally underneath the cell culture plate at a frequency of 
approximately 2 Hz.  In addition to the z-component of force due to the magnetic 
gradient, this oscillation produces a lateral component to the motion of the particle.  It is 
theorized that for particles in solution this additional component promotes increased 
particle sedimentation although no data to this effect has been published to confirm this 
hypothesis. (McBain, Griesenbach et al. 2008)  It is also thought that this lateral 
component of force the application also serves to stimulate increased particle uptake. 
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4.5.2 2Hz Oscillation Produces an Increase in Relative Fluorescence Intensity of 
Transfected Cells  
 
To analyze the data, images were captured of the cells via fluorescence 
microscopy, and were segmented in Metamorph to measure the mean intensity of EGFP 
expression cells.  We auto-threshold for light objects and adjust the threshold as needed 
to capture the entirety of the cells in the image.  An average and standard error is 
calculated from 30-50 images from each sample.  The data are normalized with respect to 
Lipofectamine.  The Lipofectamine expression level is normalized to a value of 1000, 
and the other averages are adjusted to the same scale.  The results of the first experiment 
are shown below.  Data are reported in Figure 4.4 as mean relative intensity SE. 
 
Figure 4.4 Images from the transfection experiment.  (Top Left to Right) The images 
show untreated, nanoparticles with no magnet, nanoparticles with a static field 
 
 
58 
application, nanoparticles with static plus oscillating field, and a Lipofectamine control. 
(Bottom) Image segmentation results from transfection. 
The relative fluorescence intensity of the 10 minute static field (DC) application was 701 
25 as compared to the non-magnetic particle dosage which measured 600 46.  It 
should be noted that there was a clear difference in the number of expressing cells 
between the DC application and the no magnet sample.  Transfection efficiency was not 
measured in these experiments, but qualitatively, finding fluorescent cells in the non-
magnet sample required significantly more scanning of the well between fluorescent 
cells, meaning the transfection efficiency is lower in that sample.  Additionally, from a 
qualitative sense, the DC+AC samples had a higher efficiency than the other nanoparticle 
dosed samples.  Transfection efficiency will be examined in later studies.  After changing 
cell media, an additional application of an oscillating (AC) field measured a relative 
fluorescent intensity score of 901 44.  These cells were on average 28.5% brighter than 
the cells from the DC application.  These data indicate that the oscillating field has a 
direct impact on the endosomal uptake of the particle once it is on the membrane.  These 
data are distinct from previous reports, because the effect of the uptake specifically has 
been isolated by the methodology of the experiment. 
4.5.3 Frequency Response Transfection   
 
Prior to transfection, the cell media is replaced with Opti-MEM reduced serum 
media.  Nanoparticle/oligo solution is added to the cell cultures to achieve 200M 
concentrations.  The samples are “No Field”, “Static Only”, and “Static+ 2, 4, 10, or 
20Hz” as depicted in Figure 4.2.   The cells are plated in a square of 4 adjacent cells, over 
the magnet array such that the length of the bar magnet sweeps over the bottom of all the 
wells, as shown in Figure 4.5. 
 
 
59 
 
Figure 4.5 Cells are plated in 4 adjacent wells so that all cells receive the most uniform 
field application possible. 
  
This allows each well to receive the most uniform field application possible.  After the 
oscillating field application the cells are allowed to incubate for 24 hours.  Prior to 
imaging, cells are stained with Syto 82 nucleic acid stain to enable counting of the entire 
cell population.  Cells are then imaged to assay for EGFP expression.  The entire assay is 
described in section 8.4.3. 
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4.5.4 Oscillating Field Enhancement is Frequency Dependent, and Peaks at 10Hz  
 
Example images and a plot of the transfection efficiency are shown in Figure 4.6. 
 
 
Figure 4.6 (Top) Images of HeLa EGFP-654 cells after transfection.  Cells are imaged in 
the Texas Red (Syto 82) and GFP channels and merged together.  (Bottom) Cells are 
counted and transfection efficiency calculated.  Peak transfection efficiency is achieved at 
10 Hz.  (*) indicates significant difference between the static only sample, (**) indicates 
significant difference between the 10Hz and 20Hz samples, and (***) indicates 
significance between the static and non-magnetic samples. 
A definite dependence of transfection rate on frequency can be seen in the 
analysis of the data.  The sample which received the 2 Hz oscillating field showed 
 
 
61 
essentially no improvement over the sample which received only the static field 
sedimentation (10.05%1.77 versus 9.49% 2.44).  This indicates that 2 Hz is below 
the threshold that can enhance the transfection.  A significant increase can be seen at the 
4 Hz frequency level.  The transfection rate at 4 Hz is 15.76% 2.16, which is a 66% 
improvement over the static field only sample.  An even larger improvement is seen at 
the 10 Hz level.  The 10 Hz produced a transfection rate of 22.41% 1.78, a 136% 
improvement over the static field only sample.  An interesting phenomenon is observed 
when the sample is exposed to the 20 Hz oscillating field.  Up to 10 Hz the transfection 
efficiency steadily increased.  However with the 20 Hz application the efficiency actually 
decreased below that of the 10 Hz sample.  The 20 Hz sample produced a transfection 
efficiency of 18.22% 1.01.  While still an improvement over the DC only sample (92% 
increase in efficiency) it is not an improvement over the 10 Hz sample.  This type of 
result is similar to one reported by Chari et.al where they achieved a maximum 
transfection efficiency at only the 1 Hz level, but saw steady decreases in expression for 
the 3 and 5 Hz samples.  There are differences in magnet geometry between that system 
and the one used here, as well as differences in cell type and non-viral vector that may 
account for the variations with my data.  External force stimulation at particular 
frequencies appears to be able to elicit increased activity by one or more endocytic 
pathways.  The affects of oscillating forces on endocytic pathways are examined in 
Chapter 5. 
  
 
Chapter 5 
Oscillating Magnetic Field Transfection and Endocytosis Pathway Dependence 
5.1  Overview 
 
 In order for cells to sustain themselves, they must intake nutrients from its 
environment.  The cell membrane is studded with trans-membrane transport proteins that 
allow for passage of ions and other molecules such as glucose.  Cells are also capable 
taking in other, larger particles from the extracellular environment that contact the 
membrane.  When a particle comes into contact with the membrane, the membrane will 
begin to invaginate around the particle, and eventually the particle is drawn into the cell 
and entrapped in a vesicle formed from a pinched off portion of the membrane.  This 
process of uptake of particles by the cell is referred to generally as endocytosis.  
Endocytosis can take place along one of several pathways, which are generally 
categorized into 5 main areas.  These are clathrin-mediated endocytosis, caveolae-
mediated endocytosis, macropinocytosis, phagocytosis, and non-caveolae/non-clathrin 
dependent pathways. 
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 This chapter details for the first time an endocytic pathway dependence involved 
in oscillating magnetic field nanoparticle transfection.  For the first time I identify the 
pathways that are highly sensitive to oscillating force application, that are able to increase 
transfection efficiency by as much as 2.3X.  I present the first evidence to demonstrate 
that oscillating forces are a way to preferentially target certain pathways, without the 
need for specialized ligand-receptor modification to the nanoparticles.  These results 
show the most detailed data of how forces influence transfection.  I propose mechanisms 
that may be affected by forces to explain how they transfection is enhanced.  The 
applications from these discoveries have an impact on future in vivo drug delivery and 
may be a means to overcome drug resistance in resistant cells. 
5.2 Endocytosis Pathways 
 
Figure 5.1 Illustration of endocytosis pathways 
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 Figure 5.1 illustrates the various endocytosis pathways that are involved in 
transfection, used courtesy of Rudy Juliano of University of North Carolina at Chapel 
Hill. (Juliano, Ming et al. 2012)  This section will discuss the pathways important in 
nanoparticle transfection. 
5.2.1 Clathrin Mediated Endocytosis 
 
 Clathrin coated pits were first reported in 1964 in a paper by Roth and Porter. 
(Roth and Porter 1964)  The existence of the clathrin coated lattice was first reported in 
1976 by Pearse, in which coated vesicles were purified from several cell lines and imaged 
with electron microscopy.  The clathrin protein is bound to the luminal side of the cell 
membrane in a complex with the adaptin protein.  As a cargo molecule binds to a cargo 
receptor protein, the cell membrane begins to invaginate, beginning the process of 
transport into the cell.  As this continues, the invagination begins to take on a more 
spherical conformation.  As this enclosure is formed, dynamin and actin are recruited to 
this region and act to pinch it off from the cell membrane, creating a newly formed 
intracellular vesicle.  This is referred to as a clathrin coated vesicle.  The clathrin proteins 
form a lattice around the exterior of the vesicle and as such are generally restricted in size 
in the 85-110nm range for mean diameter.  At some point after becoming fully engulfed 
into the cytosol, the clathrin coat releases from the vesicle, and the clathrin triskelions are 
recycled back to the luminal side of the cell membrane, where the process can continue.   
5.2.2 Caveolae Mediated Endocytosis 
 
 Caveolae dependent endocytosis initiates at the caveolae of the cell membrane.  
This pathway was first described in the 1950s by Palade and Yamada. (Pelkmans and 
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Helenius 2002)  These caveolae are formed from lipid rafts in the cell membrane, 
comprised of cholesterol, glycosphingolipids, and Glycosylphosphatidylinositol 
(GPI) anchored proteins.  The primary protein constituent is the caveolin protein.  
Dynamin is shown to be part of the caveolae complex, a protein associated with the 
pinching off of vesicles at the end of the endocytic process.  Lipids in the cell membrane, 
including the lipid rafts in caveolae, have lateral mobility across the membrane which is a 
function of the composition of the lipid raft. (Hancock 2006) 
5.2.3  Macropinocytosis 
 
 Macropinocytosis is a third form of cellular uptake that cells use to bring nutrients 
from the extracellular milieu to the cytosol.  First observed by Warren Lewis in 1931, the 
entry point for the vesicles (macropinosomes) in macropinocytosis occurs in the regions 
of ruffling that occurs at the periphery of spread attached cells. (Swanson and Watts 
1995)  This ruffling can be described as planar or circular extensions of the cell 
membrane which protrude out and then fold back into the membrane.  This process 
results in the formation of the characteristic vesicles.  These macropinosomes can be as 
large as 5m, (Fawcett 1965) significantly larger than the vesicles involved in clathrin 
mediated endocytosis.  The ruffles are the result of actin filaments protruding and causing 
the membrane to ruffle, or appear to ruffle when viewed at an increased frame rate. 
5.2.4 Non-Caveolae/Clathrin Mediated Endocytosis  
 
There is an additional pathway that is caveolae and clathrin independent.  This is a 
more general category which includes several pathways that have the common feature of 
not relying on clathrin or caveolae for uptake.  Like the other pathways, they can be 
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dynamin dependent or independent.  Flotillin is a protein that has been shown to be key 
in one of these pathways and is in some sense forms its own unique pathway.  These 
pathways are also categorized based on the types of ligands are cargo that they are known 
for trafficking.   
5.3 Experiment 
 
To test the pathway dependence, cells are treated with one of several inhibitor 
drugs to block a specific uptake pathway prior to transfection.  The purpose is to 
determine which pathways are most affected by the application of oscillating forces, to 
elucidate the reasons why the forces produce the observed effect. 
5.4 Actin Inhibition of Transfection 
 
 Lipofectamine is a lipid based transfection reagent that allows DNA to fuse with 
the cell membrane, overcoming the electrostatic repulsion between the gene and 
membrane.  I wanted to test whether the oscillating forces were in some way enabling a 
type of membrane fusion, where the oscillating force is physically perturbing the 
nanoparticle to move through the membrane.  This would allow the nanoparticle to gain 
entry into the cell independent of the traditional endocytic pathways.  Nanoparticles gain 
entry into the cell through multiple pathways but it was possible that the membrane 
fusion hypothesis explained the enhancement of transfection efficiency by oscillating 
fields. 
 Actin plays a vital role in many endocytic pathways, (Juliano, Ming et al. 2012) 
including macropinocytosis, clathrin, and caveolae-mediated pathways.  The 
nanoparticles gain entry to the cell via one of the many endocytic pathways which depend 
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on actin for their activity.  Therefore, if actin activity is knocked down temporarily in the 
cell, nanoparticle transfection should be severely decreased, if not eliminated all together.  
Applying an oscillating magnetic field for transfection increases the expression in the 
cells for reasons that are not well understood.  However, if the oscillating field influences 
transfection in ways that are dependent from actin activity, i.e. membrane fusion, this 
would explain why oscillating the field increases transfection efficiency. 
5.4.1 Latrunculin B Dose Determination 
 
To this end, to test the impact of AC field transfection on non-actin dependent 
pathways, we must knock down actin activity in the cells.  Latrunculin B is a cell-
permeant macrolide marine toxin derived from sponges and nudibranches. (Pawlik 1993)  
This compound acts to disrupt actin polymerization by binding one-to-one with G-actin 
monomers.  With actin knocked down, normal cell morphology is disrupted, and the cells 
take on a more rounded-up, less spread morphology.  Cells were dosed with 
concentrations of Latrunculin B of 1, 5, 50, and 250 M.  The difference in morphology 
can be seen in Figure 5.2. 
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Figure 5.2 Bright field images of cells treated with Latrunculin B for 1 hour. 
 
This change in morphology is evidence of the Latrunculin B treatment.  After 1 hour of 
incubation with Latrunculin B, all samples exhibited cells showing a more rounded 
morphology, in contrast to the untreated cells.  The 50 and 250 M samples qualitatively 
exhibited the highest level of morphology change.  After the hour incubation with 
Latrunculin B the media is replaced with DMEM/F12 with 10% FBS.  After 24 hour 
incubation the cells were imaged to observe effects post Latrunculin B treatment.  The 1 
and 5 M recovered normal morphology after treatment.  The 50 M cells retained 
viability but exhibited abnormalities in cell morphology.  The 250 M dosage was highly 
toxic for the cells and all were dead 24 hours later.  For AC experiments the 5 M dosage 
was selected for effectiveness of actin knockdown and recovery of morphology after 24 
hours. 
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5.4.2 Determination of Lat B Incubation Time 
 
 In order to knock down the actin activity for the initial incubation period of the 
transfection, the transfection must not only be performed in the presence of Latrunculin 
B, but also the Latrunculin B must remain in the media for a period of time after the 
initial transfection time.  Removal of Latrunculin B immediately following the initial 
sedimentation of the particles results in the recovery of particle uptake and expression of 
EGFP.  This is proven by an experiment to understand an appropriate incubation time to 
achieve knockdown of nanoparticle transfection.  The cells were dosed with Latrunculin 
B for 1 hour and then transfected for 30 minutes with the nanoparticles.  At the end of the 
transfection the media was replaced with DMEM without Latrunculin B.  Even with the 
90 minute incubation with Latrunculin B, actin activity and nanoparticle uptake were 
recovered following replacement of the media.  This recovery is shown by the 
fluorescence activity in the Latrunculin B experiment in Figure 5.3. 
 
Figure 5.3: Fluorescent images of transfected HeLa EGFP 654 cells.  The images on 
the left are not treated with Latrunculin B.  Cell on the right show expression of EGFP, 
indicating recovery of nanoparticle uptake after dosing immediately after Lat B 
removal. 
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The goal of the Latrunculin B was to significantly reduce the expression levels by 
inhibiting endocytosis but it was clear from imaging that the Latrunculin B sample was 
expressing.  It was evident that the Latrunculin B would have to remain in the cell culture 
in the time immediately following the transfection period. 
5.4.3 Expression is Restored Unless Lat B Remains in Culture Several Hours after 
Transfection 
 
To prepare the cells for transfection, Latrunculin B is diluted in Opti-MEM cell 
culture media to achieve a 5M concentration. Prior to transfection, cell media is 
removed and replaced with the 5M Latrunculin B Opti-MEM solution.  This solution is 
allowed to remain in the cell culture for at least 1 hour in the incubator before 
transfection reagents are dosed to the cells.  While the cells are incubating with the 
Latrunculin B, 130nm particles (1mg/ml) are mixed with the oligonucleotide (50M) and 
phosphate buffered saline at a 25:5:70 volume ratio.  Simultaneously, oligos are 
complexed with Lipofectamine 2000 and Opti-MEM at a 5:5:90 ratio by volume.  After 
the 1 hour incubation with Latrunculin B, the cells are dosed with the nanoparticle and 
Lipofectamine solutions in their respective wells to achieve 50nM concentrations.  Cells 
are dosed with the transfection reagents in the presence of 5M Latrunculin B.  Initially 
the effects of Latrunculin B are tested on the standard nanoparticle delivery.  That is to 
say, I first test them on the standard DC magnetic field transfection, without application 
of oscillating fields.  Cells are dosed with nanoparticles for 30 minutes with and without a 
static magnetic field.  Cells are also dosed with the Lipofectamine 2000 solution for 30 
minutes.  These dosages are applied to cells that have been treated with Latrunculin B 
and without Latrunculin B as controls.  After 30 minute incubation at 37.0°C, the static 
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field is removed and media is removed in all samples and replaced with DMEM/F12 with 
10% fetal bovine serum.    Cells are allowed to incubate for 24 hours before being imaged 
for EGFP expression.  Cells are imaged at 36X on an Olympus IX81 motorized inverted 
microscope.  Imaging is acquired with a QImaging Rolera EM-C
2
 emccd 14-bit digital 
camera.  The microscope, filters, shutters, and camera are all controlled via Metamorph 
from Molecular Devices. 
Images of this transfection are shown in Figure 5.4.   
  
Figure 5.4 Representative images of Lat B Transfections.  (Left) 0M Latrunculin B 
sample (Right) 5M Latrunculin B sample.  The majority of transfection is knocked 
down in the 5M sample when the Lat B is left in the culture several hours after initial 
dosage. 
These data confirm that the Latrunculin B protocol did in fact inhibit transfection of the 
nanoparticles.  Latrunculin B did not inhibit transfection of the Lipofectamine 2000 
treated cells, as Lipofectamine transfection depends on membrane fusion and not an actin 
dependent endocytic pathway.  Having confirmed the knockdown of the nanoparticle 
transfection the testing of the AC effects can be tested. 
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5.4.4 Oscillating Fields do not Enhance Transfection via Membrane Fusion 
 
 Lipofectamine is a lipid based transfection reagent that allows DNA to fuse with 
the cell membrane, overcoming the electrostatic repulsion between the gene and 
membrane.  We wanted to test whether the oscillating forces were in some way enabling a 
type of membrane fusion, where the oscillating force is physically perturbing the 
nanoparticle to move through the membrane.  This would allow the nanoparticle to gain 
entry into the cell independent of the traditional endocytic pathways.  Nanoparticles gain 
entry into the cell through multiple pathways but it was possible that the membrane 
fusion hypothesis explained the enhancement of transfection efficiency by oscillating 
fields.   
Actin plays a vital role in many endocytic pathways, (Juliano, Ming et al. 2012) 
including macropinocytosis, clathrin, and caveolae-mediated pathways.  Without the 
ability to polymerize actin these processes cannot occur in the cell.  To test whether the 
oscillating field affect can be explained via a membrane fusion process, the actin 
polymerization is arrested with Latrunculin B, a drug which binds to actin monomers. 
(Schmoller, Semmrich et al.)  Cells were transfected in the presence of 5M Latrunculin 
B.  In addition to the nanoparticles, cells were also transfected with Lipofectamine 2000 
as an additional control. 
Cells are plated at a density of 17,000 cells per well in a 96 well cell culture plate 
24 hours prior to transfection.  One hour before transfection the cell media is replaced 
with Opti-MEM supplemented with 5 M Latrunculin B.  After 1 hour of Latrunculin B 
incubation, the cells were dosed to achieve a 200 M dosage of the antisense 
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oligonucleotides.  The plates were placed over a permanent magnet to sediment the 
particles.  The cells were washed once with phosphate buffered saline and replaced with 
Opti-Mem supplemented with 5 M Latrunculin B.  Some samples received no further 
magnetic field application, others received an additional static field, and other samples 
received a 4 Hz oscillating magnetic field application.  After this application the samples 
are removed from the magnets and allowed to incubate for an additional 2 hours in the 
presence of Latrunculin B.  Identical samples are similarly treated without Latrunculin B 
treatment.  Figure 5.5 shows the Lat B treatment schematically. 
 
Figure 5.5 5M Latrunculin B is added to the cell culture 30 minutes before transfection, 
and remains for a total of 3.5 hours.  The Latrunculin B treatment is performed for the 
“No Field”, “Static Only”, and “Static+4Hz” conditions.  Lipofectamine is also included 
as a control. 
After a total of 3.5 hours of incubation with Latrunculin B the cell culture is replaced 
with DMEM/F12 with 10% FBS and supplemented with antibiotic/antimycotic without 
Latrunculin B. 
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5.4.5 Actin Inhibition Results 
 
The results of the Latrunculin B transfection are shown in Figure 5.6. 
 
 
Figure 5.6 (Top) Images of HeLa EGFP-654 cells after transfection.  Cells are imaged in 
the Texas Red and GFP channels and merged together.  (Bottom) Transfection results of 
actin inhibition study.  Cells are counted and transfection efficiency is calculated.  
Latrunculin B treatment effectively inhibited the nanoparticle transfection, resulting in 
low levels of EGFP expression.  Latrunculin B did not show an inhibitory effect on the 
Lipofectamine 2000 treatment.  Significance testing is performed at p<0.05 significance 
level. 
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In imaging the results, no toxicity was observed in any of the wells.  The 
oscillating 4 Hz sample produced a transfection rate of 19.11% on par with the 
Lipofectamine result, 20.02%.  The 4 Hz sample exceeded the DC only and 0 Hz results, 
13.6% and 12.8% respectively.  Latrunculin B knocked down transfection of the 
nanoparticles in all of the respective wells.  The 4 Hz oscillating field did not produce 
any significant expression as shown by the 1.15% transfection rate, not dissimilar from 
the Lat B DC only and 0 Hz samples (0.43% and 3.2% respectively.  These data indicate 
that the oscillating magnetic field does not initiate a non-actin dependent pathway for 
uptake of the nanoparticles.  If it did, one would expect a significant level or expressing 
cells over the other samples in the presence of the Latrunculin B.  These data show no 
increase with application of the oscillating field.  The non-magnetic application showed 
essentially no transfection for Latrunculin B and non-Latrunculin samples (0.45% and 
0.25% respectively).   
There is no designed specificity for the uptake of the nanoparticles.  That is to 
say, no functionalization has been performed to the cells to cause them to enter the cells 
through a specific endocytosis pathway.  In general, cells can ingest particles such as the 
paramagnetic nanoparticles through any of the understood pathways of endocytosis; 
clathrin-mediated, caveolae-mediated, macropinocytosis, non-clathrin or caveolae 
dependent, and phagocytosis (for specialized cell types).  It could be postulated that the 
AC field could be affecting an aspect of cell endocytosis that is independent from these 
pathways.  That is, it could be moving the particle through the cell membrane merely via 
the application of sufficient force.  It seems reasonable that a sufficiently high force 
would be able to penetrate the cell bilayer, forcing the particle from the extracellular 
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space into the lumen of the cell.  If this were the case it would be expected that 
transfection could be achieved regardless of any inhibition of endocytosis.  However the 
Latrunculin B knockdown of actin activity showed that essentially no expression of 
EGFP was detected above that of the background.  The maximum force that the particles 
experience in the z-direction is 43 fN as determined by the force calculation of section 
3.2.6.  It stands to reason that this force is below the theoretical force that would be 
required to penetrate the cell interior absent of any cellular uptake mechanism.  Therefore 
the enhancement in transfection efficiency that the oscillating field produces is still 
dependent on actin dependent uptake mechanisms.  Significantly higher gradients will 
have to be produced if endocytosis independent entry of the nanoparticles is to be 
achieved, although the effect of forcing multiple particles through a membrane in this 
fashion is not known.  This has implications for potential in vivo gene delivery using 
paramagnetic nanoparticles.  A tissue is composed of multiple layers of cells in a matrix 
of extracellular matrix.  In order to deliver genes to a tissue using non-viral vectors, the 
particles would have to penetrate multiple layers of these cells, if that would be required 
to attain the therapeutic effect.  In an in vivo system, a permanent field could be used to 
attract gene bearing nanoparticles to the site of interest, causing particles to sediment onto 
the epithelial layer.  After sufficient application with the permanent field, an oscillating 
field would be applied to enhance uptake of the particles to the cells.  The data presented 
here have shown improvements in transfection rate as high as 136% which would 
contribute significantly for improving in vivo efficiencies.  This physical control over the 
localization and uptake would reduce the exposure time for the vectors to the hazards of 
the in vivo environment, minimizing the systemic responses by the body.  The application 
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of the oscillating field would have the effect of increasing the effective dosage of the 
drug or gene, increasing the therapeutic effect. 
5.5 Endocytic Pathway Inhibition 
 
 For inhibition studies, drugs were diluted in Opti-MEM prior to experimentation.  
Chlorpromazine hydrochloride (MW 355.33) was acquired from Sigma Aldrich and 
diluted to 14M concentration.  Amiloride hydrochloride hydrate (MW 266.09) was 
acquired from Sigma Aldrich and diluted to 100M concentration.  Dynasore hydrate 
(322.31) was acquired from Sigma Aldrich and diluted to 80M concentration.  Nystatin 
suspension (10,000IU/ml) was acquired from Invitrogen and diluted to 200IU/ml.  For 
transfection experiments, cell culture media is replaced with the respective drug 30 
minutes prior to transfection.  The inhibitors remain in culture during the 30 minute 
transfection, and 2.5 hours post-transfection, as shown in Figure 5.7. 
 
Figure 5.7 Schematic for pathway inhibition studies.  Inhibitors remained in the cell 
culture before, during, and after transfection. 
Cell cultures are incubated with inhibitor drugs for a total of 3.5 hours at which time the 
media is replaced with fresh DMEM/F12.  Incubation with these drugs for extended 
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periods of time results in cell death and no toxicity was observed via light microscope 
inspection.  Nystatin was well tolerated by the cells and remained in the cell cultures 
overnight.  No toxicity was observed in these cell cultures. 
5.5.1 No Inhibitors were Toxic in any Samples 
 
Endocytic inhibitor drugs are effective at blocking pathways at appropriate 
dosages, but as with all drugs, they can become toxic beyond acceptable dosages and 
incubation times.  To determine toxicity of the drug dosages, cells were stained with a 
calcein live/dead stain obtained from Invitrogen.  Cells were transfected with 
nanoparticles as described in section 5.6.3 and treated with the selected inhibitory drugs 
at the respective concentrations.  The experiments were the same as the static only 
transfections, with the exception that oligonucleotides were not used.  Controls were 
performed in the presence of drugs and without nanoparticle dosing.  The calcein stain 
was prepared according to the manufacturers specifications and added to the cell cultures 
24 hours after transfection.  Calcein stains live cells green and ethidium homodimer-1 
stains dead cells red.  Cells were imaged for fluorescence and counted in ImageJ.  A 
minimum of 400 cells were counted for each sample and the percentage cell viability and 
standard error are calculated.  The results are tabulated in Figure 5.8. 
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Figure 5.8 Cell viability as determined with calcein live/dead stain.  “Untransfected” 
samples were not dosed with nanoparticles and “Transfected” samples are the results of a 
“static only” transfection.  Toxicity was not observed in any of the samples.  From left to 
right Untreated (no inhibitor drug) U = 96.2% 0.05 T = 94.6% 3.3.  Lat B U = 
92.6% 2.7 T = 89.6% 1.3.  Chlorpromazine U = 94.4% 3.7 T = 96.4% 0.03.  
Amiloride U = 96.6% 0.3 T = 96.6% 2.2.  Dynasore U = 97.5% .9 T = 95.6% 
1.3.  Nystatin U = 93.5% 1.9 T = 95.7% 0.3. 
No significant toxicity was observed in any of the samples, indicating that the dosages of 
nanoparticles and drugs were not harmful to the cells. 
5.5.2 Endocytic Inhibition Results 
 
 As with prior experiments, the application of the oscillating field yielded a 
distinct improvement over applying only a static field (19.2 2.0% for static + 10Hz 
versus 9.9 0.85% for static only).  The 10Hz field improved transfection efficiency by a 
factor of 1.94X, almost a doubling of efficiency.  The no-field sample and the 
Lipofectamine treated samples yielded expression levels of 6.8 3.0% and 8.6 1.9% 
respectively.  Data are shown in Figure 5.9 and 5.10. 
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Figure 5.9 Transfection efficiency from of untreated cell samples.  No field 6.8% 3.0, 
Static field 9.9% 0.85, Static + 10Hz field 19.2% 2.0, and Lipofectamine 2000 8.7% 
1.9. The additional application of the 10Hz field yielded a significant improvement 
(94.2%) in transfection efficiency over the static only sample.  These data serve as a 
baseline for endocytosis pathway inhibition results shown in Figure 5.10. 
These controls are used as the baselines to measure the relative effect of the drug 
treatments.  The results of each are shown in Figure 5.10 and 5.11. 
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Figure 5.10 Relative transfection efficiencies after inhibition of endocytosis pathways.  
The untreated control samples are normalized to 100%.  (A) Static + 10Hz field 
Untreated: 100% 10.6, Chlorpromazine: 92.8% 12.2, Amiloride 46.4% 7.2, 
Dynasore 12.4 2.6, Nystatin: 49.7 5.6.  (B) Static field Untreated: 100% 8.6, 
Chlorpromazine: 73.8% 8.9, Amiloride 86.3% 9.7, Dynasore 35.4 2.4, Nystatin: 
70.5 10.0.  (C) No field Untreated: 100% 44.2, Chlorpromazine: 94.7% 9.3, 
Amiloride 98.4% 28.8, Dynasore 51.8 2.4, Nystatin: 85.9 8.1.  (D) No field 
Untreated: 100% 21.6, Chlorpromazine: 135.0% .0, Amiloride 49.7% 6.4, 
Dynasore 13.8 .1, Nystatin: 123.5 11.0. 
 
Figure 5.11.  Absolute transfection efficiency data, showing impact of oscillating fields 
on endocytic pathway.  From left (static + 10Hz) to right (static) Untreated 19.2 2.0% 
and 9.9 0.9%, Chlorpromazine: 17.9 2.3% and 7.30.9%, Amiloride 8.9 1.4% and 
8.5 1.0%, Dynasore 2.4  0.5% and 3.5  1.2%, Nystatin: 9.6 1.1% and 7.0 1.0%.  
Neither of the amiloride samples are significantly different from one another, indicating 
that macropinocytosis is enhanced by the force oscillations caused by the 10Hz 
application.  Lipid raft-mediated (Nystatin) pathways are also impacted by the application 
of oscillating forces.  The clathrin-mediated pathway (Chlorpromazine) doesn’t appear to 
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be influenced significantly by force application.  Dynamin (Dynasore) inhibition shuts 
down the majority of all transfections, with the oscillating force having no effect.  
Significance testing is performed at p<0.05 significance level. 
5.5.3 Macropinocytosis is Up-Regulated by Oscillating Forces, and does not 
Contribute to Transfection Efficiency Without Them 
 
The inhibition of macropinocytosis accounted for a 54% reduction in relative 
expression (19.2 2.0% decreased to 8.9 1.4%).  This shows that macropinocytosis is 
particularly sensitive to an applied external oscillating force.  Supporting this, the static 
only Amiloride sample is not statistically different from the untreated static only control, 
indicating that macropinocytosis is not an active contributor to the transfection during the 
30 minute incubation time (8.5 1.0% for amiloride and 9.9 0.9% for the untreated 
control).  Were macropinocytosis a significant contributor in the absence of an external 
stimulus, these data points would be significantly different.  The transfection efficiencies 
for the amiloride treated static only and static + 10Hz are not significantly different from 
one another (8.5 1.0% and 8.9 1.4% respectively), further verifying that 
macropinocytosis stimulation is a major contributor to the improved efficiency.  These 
data indicate that macropinocytosis is up-regulated or hyper-activated by the additional 
perturbation of oscillating forces. 
5.5.4 Caveolae/Lipid raft Pathways Increase in Efficiency due Oscillating Forces 
 
Treatment with Nystatin reduced EGFP expression by 50%, a significant decrease 
in transfection efficiency from the control (19.2 2.0% for 10Hz decreased to 
9.61.1%).  The nystatin treated oscillating field sample is not different from the 
untreated static control, indicating that no enhancement was produced in the presence of 
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the inhibitor.  Similarly, there is no difference between the two Nystatin treated samples.  
Caveolae/lipid rafts are therefore also sensitive to or benefit from oscillating forces 
exerted on nanoparticles during transfection. 
5.5.5 Clathrin-Mediated Endocytosis is not Affected by Oscillating Forces 
   
Inhibition of clathrin in the static + 10Hz sample did not produce a statistically 
significant change in expression levels from the control, (19.2 2.0% compared with 
17.92.3%).  If the clathrin pathway was affected by the oscillating force effects, we 
would expect a significant decrease in the Chlorpromazine treated samples.  The 
reduction in the static field sample was statistically significant (9.9 0.85% decreased to 
7.3 0.88%) which indicates that clathrin is involved in the transfection of these cells.  
While it has been shown that the clathrin pathway is an available pathway for 
nanoparticle uptake, (Hsu, Ho et al. 2012) here it does not appear that it was affected by 
an oscillating magnetic force.  Based on the previous conjecture of increasing the MSD 
of a particle on the cell membrane, it is not clear why this does not seem to affect the 
clathrin-mediated pathway. 
5.5.6 Oscillating Force Enhancement is not seen without Dynamin  
 Inhibition of Dynamin resulted in the largest inhibition of transfection for all 
samples.  Dynamin is motor protein involved in pinching off invaginations as they 
become internalized vesicles, as is shown in the clathrin and caveolae-mediated 
pathways. (Juliano, Ming et al. 2012)  Of the non-caveolae non-clathrin dependent 
pathways, some are known to be dynamin dependent and others dynamin independent.  
Macropinocytosis and phagocytosis are not believed to depend upon dynamin for 
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internalization of vesicles.  Undoubtedly due to the effects on multiple pathways, 
dynamin inhibition reduced transfection efficiency by 88% for the 10Hz magnetic field 
sample (19.2 2.0% decreased to 2.4 0.49%).  The efficiency of the static field sample 
went from 9.9 0.85% to 3.5 1.2%, a reduction of 65%.  The Dynasore inhibition 
essentially negated any effect of from the oscillating field, with the transfection 
efficiencies of the static + 10Hz and static only samples within a standard error of the 
mean of each other.  The severe reduction in expression does not account for the dynamin 
independent pathways which, based on the macropinocytosis inhibition, should account 
for more than 2.4% transfection efficiency.  In spite of this it is clear that the 
enhancement due to oscillating fields is dependent upon dynamin activity to be effective. 
5.5.7 “No Field” and Lipofectamine Controls  
 The relative transfection efficiency of the no field samples were not remarkably 
different from one another with the exception of the Dynasore treated one (Untreated: 
100 44.2%, Chlorpromazine: 94.7 9.3%, Amiloride 98.4 28.8%, Dynasore 51.8 
2.4%, Nystatin: 85.9 8.1%).  Thirty minutes incubation time is not a sufficient time 
for the sedimentation of colloidal nanoparticles of this size and these data are intended as 
a control showing the effects of increased sedimentation in the static field samples.  A 
longer time course would be needed for a comparison with non-magnetic delivery.   
 For treatment with Lipofectamine 2000, a 30-minute incubation time is short 
relative to a typical transfection (Ming, Sato et al. 2011) but delivery is still achieved.  
The clathrin and the lipid-raft mediated pathways showed no reduction in transfection 
efficiency with treatment of inhibitory drugs.  A high level of reduction was shown with 
macropinocytosis inhibition (~50% decrease from the control), indicating that this is an 
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important pathway for lipid based delivery.  Lipid based gene delivery is known to occur 
through a membrane fusion process (Chesnoy and Huang 2000), where the lipid-DNA 
complexes bind to the cell membrane, merging the two.  This allows the DNA to pass 
through into the interior of the cell, making it available for expression.  However, the 
dependence on macropinocytosis is consistent with other studies that have shown that this 
pathway is an important mechanism for lipid transfection. (Zhang, Allen et al. 2011; De 
Haes, Van Mol et al. 2012)  Macropinocytosis showed little activity in the static only 
nanoparticle transfections, but since it is inhibiting a portion of the Lipofectamine 
delivery, we know that it is active during the 30 minute transfection period.  This further 
supports the idea that the oscillating field is in some way hyper-activating this pathway to 
take up the nanoparticles.  Dynamin inhibition effectively blocked the vast majority of 
transfection (~86% reduction).  It is clear that active processes are involved in lipid-based 
transfection, but a more thorough study would be needed to fully examine this 
dependence.  The activity of all of the pathways, including the membrane fusion process, 
does not occur at the same rates relative to each other.  Over different time scales, certain 
pathways may predominate in the overall transfection.  For this study, Lipofectamine 
transfection serves as a positive control for the efficacy of the oligonucleotides. 
5.5.8 Possible Mechanisms of Force Sensitivity: Flexing of Membrane Ruffles 
   
Applying oscillating forces to a ruffle associated nanoparticles may stimulate 
bending of the ruffles to induce closure into vesicles.  The entry point for the vesicles 
(macropinosomes) in macropinocytosis occurs in the regions of ruffling that occur at the 
periphery of spread attached cells. (Mukherjee, Ghosh et al. 1997)  The forces applied on 
the nanoparticles are within the range needed to buckle actin filaments of sufficient 
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length, (Footer, Kerssemakers et al. 2007) particularly given the likelihood of particles 
being aggregated. 
The ruffling typical of macropinocytosis is dependent upon the polymerization 
and de-polymerization of actin in the form of F-actin filaments. (Lee and Knecht 2002)  
As a filament polymerizes next to a load it exerts a pushing force against it as monomers 
are added.  This event can be modeled as an elastic slender rod that is clamped at one end 
and free at the other.  The slender rod also has a characteristic flexural rigidity.  The 
flexural rigidity of is a property which describes the ability of the rod to bend given an 
applied moment.  The flexural rigidity of a single actin filament has been determined to 
be 0.06 pN*m2. (Yasuda, Miyata et al. 1996)  For a rod of circular cross section 
clamped at one end, the force needed to buckle the rod is characterized by the equation: 
 
    
  
 
      (5.1) 
where k is the flexural rigidity and L is the length of the rod. (Howard 2001; Footer, 
Kerssemakers et al. 2007)  Taking the flexural rigidity reported in literature we can 
produce a plot of buckling force versus length of the actin filament. 
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Figure 5.12 Theoretical buckling force an actin polymer versus length of the polymer.  
Force applied to an aggregate of 10 nanoparticles is sufficient to buckle filaments greater 
than 550nm. 
 
The force applied on a theoretical aggregate of 10 nanoparticles (~0.5pN) is sufficient to 
buckle actin filaments greater than 550nm.  Actin filaments aligned in parallel would 
cause the force to be divided among all of the filaments.  Therefore a force that would 
buckle a single 550nm filament would buckle 10 filaments 1.75m in length.  
Experimentally, forces of 0.2-0.8pN were shown to buckle actin bundles in the range of 
400-900nm in length, which were comprised of, on average, 4-10 filaments.  For 
sufficiently long actin filaments, it is possible for these force regimes to apply sufficient 
buckling forces on multiple filaments in parallel arrangement, which form the membrane 
ruffle.  Additionally, the ruffling that occurs at the membrane periphery does not 
necessarily result in the formation of a macropinosome.  That is, the ruffle can recede 
back into the membrane without forming an enclosure or vesicle. (Swanson and Watts 
1995)  Applying forces laterally and normally (relative to the plane of the cell) to a ruffle-
associated nanoparticle could induce the necessary folding and enclosing process, 
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perhaps increasing the number of vesicles that form due to macropinocytosis.  The cell 
membrane/cortex is resistant to deformation and it known that the conformational shape 
changes characteristic of endocytosis occur with a significant energy cost (Liu, Sun et al. 
2009) which may be overcome with the externally applied force. 
 It is possible that these force regimes are sufficient to stimulate increased activity 
of the cell surface ruffles by bending or flexing the membrane ruffles.  This could assist 
in the closure of the ruffles to form the early vesicle as illustrated in Figure 5.13. 
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Figure 5.13 Proposed mechanism for enhancement of macropinocytosis with oscillating 
forces.  1.  Nanoparticle is attached to a membrane ruffle.  2-5. Oscillating forces cause 
flexing of the ruffle.  6-8. Forces cause the folding over and closure of the ruffle, forming 
the early vesicle.  9. Macropinosome moves into the cell. 
 
Work has begun (not presented here) to test this hypothesis.  I am currently attempting to 
co-localize membrane ruffles/macropinosomes and nanoparticles on individual cells.  
Fluorescent dextran is being used to locate macropinosomes or membrane ruffles since it 
is known that dextran enters the cell preferentially through this pathway. (Zenni, Giardina 
et al. 2000)  By visualizing particles and dextran, I hope to quantify the degree of 
association nanoparticles with macropinosomes, with and without a magnetic application.  
I also plan to apply oscillating forces with the 3-dimensional force microscope to observe 
the degree of movement that is associated with the nanoparticle/ruffle/vesicle complexes.  
This would verify whether the oscillating forces were sufficient to manipulate this 
process.  
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5.5.9 Possible Mechanisms of Force Sensitivity: Increased and Faster Binding with 
Trans-membrane Proteins 
 
There are several possible explanations as to why caveolae/lipid rafts are affected 
by oscillating fields.  Caveolae have been shown to be associated with a variety of 
receptors and trans-membrane proteins (Yamamoto, Toya et al. 1998; Simons and Toomre 
2000; Chini and Parenti 2004) which are implicated in cell signaling.  Perturbing a 
nanoparticle in a caveolae may cause it to increase the number of contacts with receptor 
proteins, initiating trans-membrane signaling which leads to internalization, which is 
illustrated in Figure 5.14. 
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Figure 5.14 Proposed mechanism for oscillating force enhancement in caveolae/lipid 
rafts.  1. Bead contacts caveolae.  2.  Oscillating forces begin to roll the nanoparticle 
across the caveolae.  3-4. The oscillations cause the particle to make contacts with trans-
membrane proteins responsible for initiating endocytosis.  5-6. With trans-membrane 
contacts made, dynamin, actin, and other protein recruitment begins, and the particle is 
enveloped.  The oscillating forces may cause this process to occur more quickly and at a 
greater percentage over the surface of the cell. 
 
Additionally, it may increase the rate at which the contacts are made, causing the 
internalization process to commence at an earlier time.  Without the perturbation the 
binding of any particular nanoparticle may not occur at all or may occur at a slower rate 
so as to delay the onset of expression.  Simian virus 40 (SV40) has been shown to utilize 
caveolae-mediated endocytosis to gain entry into the cell. (Pelkmans, Puntener et al. 
2002)  It was shown that the SV40 viruses concentrated at caveolae and are internalized 
whereas empty caveolae did not become internalized. (Pelkmans, Kartenbeck et al. 2001)  
Some manner of perturbation is needed in accessing this pathway, which we may be 
assisting with the oscillating magnetic force. 
To verify this, fluorescent caveolae/lipid rafts would be dosed with fluorescent 
nanoparticles.  Imaging would be performed to measure the degree of co-localization 
between nanoparticles and caveolae with and without magnetic application.  If the 
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oscillating forces cause a greater incidence of nanoparticle binding to caveolae, this 
should be evident in changes to percent co-localization.  
5.5.10 Possible Mechanisms of Force Sensitivity: Improved Transport Through the 
Glycocalyx 
 
Applying external force to a nanoparticle can also increase the mean square 
displacement of a nanoparticle on the membrane, possibly giving it a greater probability 
of reaching the lipid rafts or membrane ruffles.  HeLa cells have a glycocalyx layer above 
the cell membrane which acts as a barrier for macromolecule transfer. (Zhou, Xiong et al. 
2011)  Many epithelial cell types produce this layer of proteoglycans, glycoproteins and 
glycolipids that sheaths the outer layer of the cell membrane. (Reitsma, Slaaf et al. 2007)  
This layer is a gel-like matrix that has been shown to be as much as several microns in 
thickness. (Weinbaum, Tarbell et al. 2007)  This layer can act as a selective barrier for 
macromolecules from blood to the cells. (Henry and Duling 1999)  This also presents a 
barrier to non-viral vectors for entry into the cell.  A nanoparticle must traverse this 
region and in order to achieve successful delivery which presents a possible reason for 
how an oscillating magnetic field can impact the transfection.   
Several studies have investigated the rheology of the glycocalyx by introducing 
nanoparticles and observing and tracking the displacements. (Nijenhuis, Mizuno et al. ; 
Zhou, Xiong et al. 2011)  Calculating the mean square displacement is used to determine 
a diffusion constant, which describes how quickly a particle will move through the 
material.  The diffusion constant of glycocaylx in HeLa cells was experimentally 
determined to be 0.15±0.014 m2/s. (Zhou, Xiong et al. 2011)  The Stokes-Einstein 
equation defines the diffusion coefficient (D) as: 
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 (5.2) 
where k is Boltzmann’s constant, T is temperature,  is viscosity, and r is the radius of the 
particle.  Taking the experimental diffusion constant, we can solve for viscosity and show 
it is equal to 0.0221 Pa·s.  The force applied to the particles can be used to determine the 
velocity based on Stokes’ equation of drag force on a particle: 
            (5.3) 
where Fd is the drag force,   is the radius of the bead,   is the viscosity of the Newtonian 
fluid, and   is the velocity of the bead.  The plots of velocity vs. force are shown in 
Figure 5.15. 
  
Figure 5.15 Theoretical velocity vs. force plots for 130nm nanoparticles in HeLa cell 
glycocalyx.  (Left) The vertical component of velocity.  (Right) The horizontal 
component of velocity.  The applied magnetic force can propel the nanoparticles through 
the glycocalyx at velocities comparable to organelles being transported inside of cells. 
  
A particle must traverse the glycocalyx in order to reach the cell membrane and be 
accessible to the endocytic pathways.  A particle undergoes a random walk due to 
diffusion in a gel.  As it takes the random walk, it encounters regions of the gel mesh.  
The gel mesh can vary in porosity, so the nanoparticle will encounter open areas through 
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which it can easily travel.  It can also encounter regions of more densely packed mesh.  In 
regions such as this, the particle can become entrained in the meshwork and sequester the 
nanoparticle away from the endocytic mechanisms.  Applying an oscillating force to a 
nanoparticle could free the particles from regions where it has become entrapped by 
increasing the mean square displacement of the particle. The horizontal component of 
velocity on a single nanoparticle is minimally 280nm/s and the vertical component is 
1.75m/s.  This velocity will increase for aggregates of nanoparticles, but these velocities 
are well within the range of organelles transported within the cell. (Hill, Plaza et al. 2004; 
Kural, Kim et al. 2005)  Organelles move through the viscoelastic environment of the 
cytoplasm at rates similar, so it is a reasonable conjecture that this magnitude of 
oscillating force is sufficient to move a particle through the glycocalyx.  Applying these 
forces to the nanoparticles increases the random walk that a particle undergoes, allowing 
it to take larger excursions than it would by diffusion alone.  A particle would be able 
traverse into and out of dense regions, escaping entrapment, and continuing on a path 
towards the cell membrane.  Otherwise, without the additional force, the particle would 
remain caught. 
This hypothesis could be tested through studies of nanoparticle transport through 
the glycocalyx, for which a methodology already exists. (Zhou, Xiong et al. 2011)  Using 
the 130nm particles as a tracer the diffusion coefficient would be measured with and 
without magnetic force application.   
5.5.11 Advantages to stimulating macropinocytosis and caveolae/lipid raft pathways 
 
Stimulating macropinocytosis can be particularly beneficial for cell types that 
have been shown to achieve transfection via this pathway. (Goncalves, Mennesson et al. 
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2004; Zhang, Allen et al. 2011)  This presents a way to target this pathway without the 
need for chemical modification to the vector.  Macropinosomes also present a potentially 
larger vehicle for carrying non-viral vectors.  Macropinosomes have been shown to range 
in diameter from 200nm to 10m. (Hewlett, Prescott et al. 1994; Swanson 2008)  
Vesicles resulting from the clathrin and caveolae-mediated pathways are typically smaller 
than 200nm. (Nanbo, Imai et al. ; Rejman, Oberle et al. 2004)  A macropinosome can 
contain a volume many orders of magnitude greater than these other vesicles, enabling 
many more vectors to be carried into the cell.  In a previous study of macropinocytosis 
inhibition it has been shown that macropinocytosis is a slower acting process. (Zhang, 
Allen et al. 2011)  This could be observed from the static only samples, which showed no 
difference when treated with amiloride.  Since macropinocytosis is accounting for a 
significant portion of the enhancing effect, the oscillating force seems to increase the rate 
at which this pathway operates.  This is potentially beneficial for in vivo applications 
where nucleases in the blood would degrade the genes.  The oscillating forces could be 
thought of as adding free energy into this endocytic pathway, enabling it to occur at a 
greater rate than the energy output of the cell alone would allow. 
It is advantageous to stimulate caveolae-mediated endocytosis because of the 
potential for achieving non-degradative delivery of the vectors.  Common fates for 
endocytic vesicles are lysosomal degradation or recycling of the vesicle back to the cell 
membrane. (Mukherjee, Ghosh et al. 1997)  Caveolae-mediated endocytosis has been 
found to produce some internalized vesicles that do not result in acidification and fusion 
with lysosomes. (Medina-Kauwe 2007; Kiss and Botos 2009)  Nanoparticles and viruses 
have been found in non-degradative compartments after uptake via caveolae (Medina-
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Kauwe 2007; Kiss and Botos 2009; Kim, Boylan et al. 2012) escaping lysosomal 
degradation.  This makes possible an increased bioavailability of the non-viral vectors 
and gene constructs, and thus a more efficient delivery.  Stimulating this pathway via 
oscillating force provides a method to target this pathway without the need for chemical 
modification to the vectors. 
5.6 Conclusion 
 
 In conclusion, these data reveal that oscillating magnetic fields enhance 
nanoparticle transfection by stimulating macropinocytosis and caveolae/lipid raft 
pathways.  Applying oscillating forces on nanoparticles is a way to target these pathways 
without specific ligand functionalization to the nanoparticle.  Optimal enhancement 
occurs at 10Hz, although this may vary depending on the cell type.  Oscillating a 
nanoparticle may be helping a nanoparticle reach lipid rafts and membrane ruffles by 
helping it to traverse the matrix of the glycocalyx.  Oscillating a nanoparticle may allow 
it to make increased trans-membrane receptor protein attachments, signaling the uptake 
cascade to occur at a faster rate or with greater frequency across the cell.  
Macropinocytosis is not a contributor to expression levels during a 30 minute 
transfection, but, upon application of an oscillating magnetic field this pathway becomes 
highly active, doubling expression levels.  Up-regulating a pathway that is largely 
ineffective over a short time scale could be the means to making transfection possible in 
cells that are resistant to vector uptake.  Caveolae-mediated delivery is improved with 
applied oscillating force stimulation also, potentially leading more vectors down a non-
degradative pathway.  This is potentially important for in vivo applications due to the low 
efficiencies involved with delivery in complex physiological environments.  Cells or 
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tissues previously resistant to vector or drug uptake could have pathways “activated” by 
the stimulation of oscillating forces, enhancing the effectiveness of the treatment.  Drug 
resistance is an issue in cancer treatment (Gao, Zhang et al.) and opening alternative 
pathways for delivery could offer improved efficacy in treatment.  There are many steps 
involved in the each of the endocytic pathways so further study will be needed to 
pinpoint where the oscillating force is most critical.  Continued studies will further 
elucidate the cellular mechanisms involved in magnetic nanoparticle delivery to realize 
its promise as a means of gene delivery for the treatment and possible curing of diseases. 
 
 
 
 
 
  
 
Chapter 6 
in vivo Molecular Motor Transport and Force Response 
6.1 Introduction 
 
 Once a nanoparticle enters the lumen of the cell, it is subject to the mechanics of 
the intracellular environment.  To characterize this environment, I have probed it with 
paramagnetic microbeads and manipulated them with a 3-dimensional force microscope.  
I developed a protocol to allow the microbeads to be internalized by the cells, when they 
would otherwise be size excluded.  I verify the position of the bead within the cell via 3-
D isosurfaces and tracking of intracellular active transport.  I describe how external 
forces change the molecular motor transport of the beads and for the first time 
characterize the different observed phenomena.  I have measured, for the first time, an 
approximate stall force on a 1m bead in vivo, and estimate the maximum number of 
dynein molecules attached to it.  My data demonstrate that the molecular motor transport 
behaves like a ratchet and gear, in that under maximal loads it can move only a set 
distance, but when it does so moves at the same velocity as an unloaded motor. 
 99 
 The intracellular environment was once believed to be akin to the water inside of 
a balloon.  As techniques developed that enabled insight into the biochemistry of the cell, 
it was discovered that the cell was in fact an extremely dense and diverse environment.  
The cytoplasm of the cell consists of the cytoskeletal network, organelles, proteins, and 
cytosol.  The intracellular transport must occur in this milieu in order to effectively 
distribute necessary components to different parts of the cell, and to control the 
distribution of organelles and cytoskeleton at different times of the cell cycle.  Molecular 
motors are the machines that work to manage the different transportation needs of the 
cell. 
 The movement of organelles began being characterized back in the late sixties as 
researchers observed saltatory displacements in a variety of cell types. (Freed and 
Lebowitz 1970)  The movement of organelles was shown to consist of long excursions 
that would frequently and rapidly change in direction and magnitude.  It was established 
that microtubules were the primary cytoskeletal constituent involved in this organelle 
transport, as the transport ceased with treatment of microtubule de-polymerization drugs.  
Dynein and kinesin are the primary motor proteins associated with microtubule based 
transport. Later studies would show that myosin via actin filaments was involved in 
organelle transport, though to a much lesser extent (Kulic, Brown et al. 2008) compared 
to microtubules.  The introduction of in vitro motility assays provided a novel and useful 
platform from which motor transport could be studied. (Sheetz and Spudich 1983)  In 
these systems, cytoskeletal filaments are purified and deposited onto a glass coverslip.  
Motor coated microbeads can be introduced to this coverslip and in the presence of ATP 
will undergo transport along these filaments.  These studies showed that both kinesin and 
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dynein were both processive motors (Reck-Peterson, Yildiz et al. 2006) along with some 
members of the myosin family of proteins. (Rosenfeld and Lee Sweeney 2004)  The 
processivity of a motor refers to the ability of a single motor to walk along a filament 
with multiple steps without detaching.  This system also allows forces to be applied to the 
motor coated beads to observe the change in behavior of the motor with respect to 
applied loads. (Svoboda and Block 1994) 
 Kinesin and dynein motors are proteins that drive intracellular transport along 
microtubules.  Each motor has 2 binding domains that have the ability to bind to tubule 
monomers in the microtubule.  To describe the functioning of the motor, I will start with 
both domains of the motor attached to the microtubule.  A domain of the motors, above 
the binding arms, binds ATP and is responsible for ATP hydrolysis.  This hydrolysis 
reaction causes the motor to undergo a conformational change (working stroke) which 
results in the rear binding domain detaching from the microtubule.  After this detachment 
the free binding domain progresses to the next binding site along the microtubule 
(recovery stroke).  This free domain then binds again to the microtubule, completing the 
cycle.  Repeating these steps allows a transported cargo along a microtubule, provided 
there is sufficient ATP, as governed by equations 6.1 and 6.2. 
              (6.1) 
 
    
             
       
          (6.2) 
The term Keq is the equilibrium constant of the comprised of the concentrations of 
adenosine diphosphate (ADP) and inorganic phosphate groups (Pi). 
 Kinesin and dynein will work in concert to transport organelles throughout the 
intracellular environment.  Kinesin transport is characterized as anterograde, as its 
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movement is in the direction of the plus-end of the microtubule, away from the nucleus.  
Dynein transport is characterized as retrograde, as it transports movements towards the 
negative end of the microtubule, towards the nucleus.  The in vitro speeds for kinesin and 
dynein have been shown to be 840 and 1250nm/s respectively. (Howard 2001)  The in 
vivo speeds for kinesin and dynein have been shown to be 1800 and 1100nm/s 
respectively.  These values represent the speeds of the motors in the absence of an 
external load. 
 To achieve this transport the motors must generate a force.  In vitro assays allow 
step sizes and forces to be measured through a number of modalities, including atomic 
force microscopes (AFM) and optical tweezers.  As stated before, the average step size of 
both motors is shown to be 8nm but it has been shown that step sizes can vary by factors 
of this step size.  Gelfand et al. showed that motors could take steps of 16, 24, 32, and 
more, which corresponds with the lengths of multiple 8nm tubulin monomers. (Kural, 
Serpinskaya et al. 2007)  The force exerted by an individual kinesin protein has been 
determined to be approximately 6 pN (Howard 2001) with other studies reporting forces 
between 4 and 8 pN.  The force exerted by an individual dynein motor has been shown to 
be in somewhat similar range, with report values as low as 1.1pN (Mallik, Carter et al. 
2004) and up to 7 pN. (Gennerich, Carter et al. 2007)  One common hypothesis as to how 
these motors manage to transport cargoes through the cytoplasm is the shared load model.  
In this model the load is distributed among several different motors, enabling greater 
forces to be generated as a collective unit.  As stated previously both motors act on the 
load to move the cargo in a bi-directional manner.  The mechanism for the “decision” of 
directionality is not clear in the current understanding of the field.  Several theories have 
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been proposed to explain the cooperative nature of the motors. (Jolly and Gelfand 2011)  
The theories are different but not necessarily mutually exclusive.  One theory suggests 
that recruitment, the binding of molecules, is the deciding factor as to which direction the 
load will travel.  The motor protein with the greater number of recruits will transport the 
load preferentially in the characteristic direction of that motor.  Another mechanism 
suggests that there is some manner of crosstalk between the motors that communicates 
when transport needs to occur in a particular direction.  One theory proposes that there is 
some type of motor coordinating complex that governs the switching of motors.  A fourth 
model suggests that there is a regulating stochastic mechanism that controls the motor 
activation or inactivation based on binding of different constituents or modifications to 
the motors.  These questions are still an area of great research interest and the answer is 
still sought. 
 While in vitro motor stalling has been successfully achieved, in vivo stalling has 
proven a more challenging proposition.  Optical tweezers have been widely used in in 
vitro studies and employed in some in vivo studies, but there have been challenges.  
Optical tweezers have been shown to be damaging to cells even with low power levels. 
(Banerjee, Chowdhury et al.)  Determining the force on an object depends on the size of 
the object trapped and vesicles/organelles inside of a cell can vary greatly in size.  
Attempting to track vesicles in vivo requires quick identification and focusing of the 
vesicle on the center of the target.  Some of these issues can be dealt with but the fact 
remains that lasers are damaging to cells, making optical tweezers a less than optimal 
modality.  In this chapter I present a study of intracellular microbead manipulation by 
way of 3-dimensional force microscopy.  I demonstrate the protocol for introducing 1m 
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paramagnetic polystyrene beads into the intracellular environment.  I will show that the 
microbeads undergo bi-directional active transport and describe the different phenomena 
that are observed when forces are applied in vivo.  I will show attempts to stall the 
microbead transport and the forces that are measured to achieve this.          
6.2 Intracellular Constituents 
 
 This section will give a brief overview of some of the specific components of the 
cytoskeleton which contribute to the structure of the cell and provide for intracellular 
transport.  It will describe several of the major organelles to give a general view for the 
many constituents of the environment.   
6.2.1 Actin 
 
 The actin network provides the cell with an underlying structure that provides the 
framework for the cell as well as a means for the cell to stretch and move around in its 
environment.  Actin monomers polymerize into long filaments which can wrap around 
each other in a helical fashion in a process called treadmilling.  These polymers are 
generally 5-9nm in diameter.  In the cytoskeleton the filaments combine into 
protofilaments that are connected end to end and lateral associations.  Larger filaments 
combine into stress fibers which can span larger lengths of the cell providing structural 
integrity. 
 Although actin filaments are dispersed throughout the cytoplasm, a substantial 
layer of actin exists underneath the cell membrane called cortical actin. (Alberts, Johnson 
et al. 2002)  This actin rich cortex allows the cell to adhere to a substrate and stretch out 
across it.  This actin forms protrusions called filopodia and lamellipodia which allow it to 
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sense around its immediate environment and migrate to different parts of the 
environment.  Actin is also involved in various phases of multiple endocytosis pathways.    
6.2.2 Microtubules 
 
 Microtubules are hollow tube-like structures of the cytoplasm. (Alberts, Johnson 
et al. 2002)  A single microtubule is composed of a total of 13 protofilaments, each 
comprised of individual  and  tubulin monomers, alternately arranged.  These 
protofilaments connect laterally to one another and wrap around in a cylindrical 
conformation of about 25nm diameter.  The microtubule network stretches throughout the 
cell, organizing around foci called microtubule organizing centers (MTOCs).  These 
MTOCs are situated in perinuclear locations in the cell and the network extends from the 
center to the periphery of the cell. 
 The microtubule network provides the pathways along which organelles are able 
to move through the different regions of the cell.  Organelles such as mitochondria and 
lysosomes are able to be transported along the microtubules through the action of 
molecular motors attached through them.  The cell is able to transport necessary 
constituents to various part of the cell as well as reorganize the distribution of organelles 
via this transport system.  The microtubules are shown to polymerize and de-polymerize 
at opposite ends causing microtubule to grow or shrink as befitting the needs of the cell.  
This phenomenon is known as dynamic instability.      
6.2.3 Intermediate Filaments 
 
 A third type of cytoskeletal polymer is the intermediate filament. (Alberts, 
Johnson et al. 2002)  This structure is less prevalent than the previous two but still found 
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in many metazoan cell types.  Intermediate filaments are ropelike fibers of 10nm 
diameter.  The subunits of intermediate filaments are comprised of two coiled-coil dimers 
of a 48nm polypeptide.  These subunits attach linearly and laterally and twist into a 
ropelike filament. 
 These filaments are involved in providing structural reinforcement to the cell.  
They have been shown to span the length of the cytoplasm, forming bonds with adjacent 
cells, giving increased structural integrity to a layer of cells.  Other filaments have been 
shown to provide structure to the cell nucleus.  
 Organelles in the cell each contribute a unique function to the cell.  In order for a 
cell to exist, numerous tasks must be performed to sustain the cell.  As with complex 
organisms such as mammals, a single cell must consume nutrients and eliminate waste. 
6.2.4 Organelles 
 
 The intracellular environment is divided into a wide variety of membrane bound 
compartments called organelles.  Each organelle type possesses its own unique 
characteristics which allow them to perform their respective functions.  The nucleus is the 
largest organelle which is responsible for containing the genome of the cell, protecting it 
from damage or degradation.  It provides an environment for transcription to occur.  The 
endoplasmic reticulum is an organelle that forms a network surrounding the nucleus.  The 
ER is involved in protein synthesis and membrane production.  Mitochondria are 
involved in the production of ATP, a source of energy for the cells.  Lysosomes and 
peroxisomes are responsible for the breakdown of foreign materials and wastes in the 
cell.  Ribosomes read mRNA transcripts to produce peptides and proteins.  The Golgi 
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body is responsible for the packaging of proteins for subsequent transport within the cell 
as well as outside of the cell.  These are several of the major organelles in the cell and are 
by no means an exhaustive list.  There are many others in the intracellular environment 
that account for all of the various functions that are needed for a cell to survive.  When 
probing the rheology and transport phenomenon of this environment all of these 
constituents have an effect on the observed phenomenon.  Molecular motors transport 
organelles through an environment packed with organelles, proteins, cytoskeleton, 
sugars, and many other components which affect the observed phenomenon.    
6.3 Process of Microbead Internalization and Intracellular Fate 
 
 I have not determined the specific endocytic pathway that the 1m microbead 
takes to gain entry into the cell but subsequent sections will describe the verification of 
the internalization of the bead.  The process of internalization can be thought of in 3 
general steps illustrated in Figure 6.1. 
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Figure 6.1 Generalized process of 1m microbead uptake.  Top Right:  A bead contacts 
the cell membrane and begins the process of invagination until it is fully engulfed.  
Bottom Left: Bead is inside of pinched of portion of vesicle forming an endosome.  
Molecular motors in the cytoplasm attach to the outside of the vesicle.  Bottom Right:  
The bead is then able to undergo transport along microtubules. 
First, the bead comes into contact with the cell membrane, thus initiating the process of 
internalization.  The uptake of the bead begins when the cell membrane begins to 
invaginate until the point that the bead is fully encapsulated by the cell.  At a certain point 
the encapsulating membrane is pinched off, often by a combination of motor proteins and 
actin working in concert, to become a vesicle in the cell called an endosome.  Motor 
proteins dynein and kinesin are floating around the cytoplasm and attach to the outer 
membrane.  This endosome can eventually come into contact with one of the many 
microtubules contained within the cell for organelle transport and intracellular re-
organization.  Once the motors on the endosome come into contact with the microtubules 
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the microbead will undergo active transport along the microtubule network just like the 
other organelles in the cell. 
6.4 Molecular Motor Transport Experiments 
 
 To characterize the rheology of the interior of the cell, I developed a protocol to 
introduce a probe into the cytoplasm of the cell.  One micron paramagnetic beads are 
specially functionalized to promote uptake into the cells.  Once inside, they can be 
visually tracked and manipulated with the 3-dimensional force microscope.  
6.4.1 1m Microsphere Functionalization to Achieve Internalization 
 
Dynabeads Tosyl-activated MyOne beads (Invitrogen, Carlsbad, CA) were used 
in experiments for intracellular cell studies.  These beads are 1m diameter uniform 
microspheres.  They are comprised of highly cross-linked polystyrene with interspersed 
magnetic material.  The surface of the microspheres are available functionalizations of 
carboxylic acid, amino groups, streptavidin, and tosyl groups, making it ideal for a 
variety of secondary functionalizations.  Scanning electron microscope images were 
taken to verify the uniformity of size of the MyOne beads, as shown in Figure 6.2. 
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Figure 6.2 SEM micrographs demonstrate the highly uniform, spherical shape of the 
entire population. 
 
The tosyl-activated MyOne beads were used in experiments for intracellular cell 
studies.  The surface of the beads is functionalized with p-Toluene-sulfonyl groups 
making it extremely useful for binding with a variety of molecules.  These beads were 
used for labeling with the Alexa Fluor® hydrazide fluorescent stains.  The MyOne tosyl-
activated super-paramagnetic beads were functionalized with Alexa Fluor
®
 568 hydrazide 
to make them visable through fluorescence microscopy.  A volume of 100l of Alexa 
Fluor
®
 568 hydrazide (100 M) solution is added to 20 l of 100 mg/ml MyOne tosyl-
activated beads.  This mixture is vortexed and placed on a rotator for 4 hours.  The beads 
are spun down in a centrifuge at 4000 rpm, supernatant is removed, and the beads are re-
suspended in 1 ml of PBS.  This washing step is performed twice.  Fluorescent 
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microscopy was used to verify the labeling of the beads with the Alexafluor, as shown in 
Figure 6.3. 
 
 
 
Figure 6.3 1m MyOne Tosyl-activated beads fluorescently labeled with Alexafluor 568 
 
To stimulate uptake of the beads into the cells, Lipofectamine 2000 transfection 
reagent is added to the beads.  Twenty microliters of Lipofectamine 2000 is added to the 
fluorescently labeled samples.  The sample is vortexed and placed on a rotator overnight.  
Section 6.4.2 and 6.4.3 will describe the verification of transport and internalization of 
the beads.  This protocol was shown to introduce the MyOne beads into cytoplasm of 
HeLa cells.  The tosyl-activated beads, unmodified, do not experience uptake into the 
cells.  The treatment of the microbeads is a necessary step to achieve internalization.  
This treatment has the added benefit of minimizing the amount of excess beads attached 
to the glass providing for a cleaner sample.  When the media is changed prior to imaging 
it is observed that there are almost no beads attached to the glass and all of the beads are 
associated with the cells.  Conversely, without functionalization, there are a high number 
of beads associated with the glass, and essentially none associated with the cells. 
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6.4.2 Microbeads are Tracked and Mean-Squared Displacement Can Show Driven 
vs. Passive Transport 
 
 Video is tracked with Video Spot Tracker (http://cismm.cs.unc.edu/downloads/) 
and edited in MATLAB.  A script called evt_GUI allows the data to be analyzed and 
plots of the tracks to be produced.  Among other analysis tools the program allows us to 
produce plots of mean-squared displacement (MSD).  Mean-squared displacement is a 
measure of the spatial extent of random motion.  It is a measure of the displacement 
squared versus the change in time ( = t).  The MSD is determined mathematically by 
Equation 6.3. 
                            (6.3) 
where x is the position of the bead and t is time.  The plot of MSD can be used to 
characterize the type of observed movement in the experiment (Kulic, Brown et al. 2008).  
The slope of an MSD curve reveals information about the displacement of the bead.  The 
slope in log-log space of an MSD plot is indicative of purely diffusive motions.  A slope 
between 0 and 1 is indicative of sub-diffusive behavior whereas a slope between 1 and 2 
is indicative of driven, sub-ballistic behavior.  A slope very close to 2 would be 
considered ballistic motion.  Applying this analysis to the tracks we can judge the type of 
motions that are observed in the internalized 1m beads.  An example a radial 
displacement of a transported bead is shown in the left column of Figure 6.4.  On the 
right column is the track of a bead in the same field of view that is stuck to the glass.  
Below each is the respective plot of mean squared displacement.   
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Figure 6.4 Left column shows the radial displacement plot of an internalized 1m bead 
along with plot of MSD.  The right column shows the same type of data for a 1m bead 
that is stuck to the glass.  Data are shown in blue.  In both MSD plots, a line of slope = 1 
is shown in black.  The internalized bead has a slope greater than one (m = 1.63), 
confirming the active transport.  The bead stuck to the glass substrate shows a slope less 
than 1 (m = 0.6), showing that it is not diffusing or transporting in any way. 
 
The transported bead shows a clear distinction from the stuck bead.  The bi-directional 
transport can be seen in the radial displacement plot.  The slope of the MSD plot is shown 
to be 1.63, in the sub-ballistic, driven transport regime.  The stuck bead shows no long-
scale displacement which is also shown in its MSD plot, where the slope of the curve is 
0.6, well within the sub-diffusive range.  It is clearly possible then to distinguish which 
beads are undergoing active transport from ones that are not using this methodology. 
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6.4.3 3-D Isosurfaces Can Show the Position of the Microbead and Verify 
Internalization 
 
 To visualize the internalization of the beads be the cells, HeLa wild types cells 
were transfected with Fluorescent Protein Cellular Labels: Cellular Lights™ Reagents.  
These reagents use baculoviruses to introduce DNA into the host cell that codes for the 
cytoskeletal monomer subunits with an attached fluorescent protein.  Cells were 
transfected with a GFP-Actin actin according to the manufacturer’s guidelines, and 
results were verified with fluorescence microscopy.  Stacks were taken on the Nikon 
epifluorescence microscope described previously.  The images in the stacks were taken in 
green and red and red channels consecutively at each z-height.  The stacks were then 
modeled into a 3D isosurface using Image Surfer software from CISMM 
(http://cismm.cs.unc.edu/downloads/).  The models depict the positioning of the beads 
relative to the membrane of the cell.  We are able to identify beads that are being 
transported by the cell and the 3D models can confirm that the beads are inside of the 
cell. 
   
a. b. c. 
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Figure 6.5 (a) Slice from a red-green stack of Hela GFP-Actin cell and Alexa Fluor 
Hydrazide 568 beads.  (b) Isosurface of combined red-green stack from ImageSurfer.  (c)  
Same isosurface as b. with the opacity of the green channel reduced.  Red 1m beads can 
be seen inside of the isosurface.  (d) Slice taken from another stack of a different cell.  (e)  
Isosurface of d.  (f)  View of isosurface from underneath the cell.  The 1m bead can be 
seen beneath the outer membrane in proximity to the nucleus. 
 
The isosurfaces depicted in Figure 6.5 show two examples of a bead internalized in a cell.  
The images in the left column are slices from the respective z-stacks.  The middle column 
of the figure shows the two stacks merged and rendered into an isosurface.  The top right 
image (c.) shows the isosurface of the top cell with the opacity of the green channel 
reduced so that the area beneath the membrane is visible.  The nucleus is visible and the 
red fluorescent 1 micron bead is visible at the lower right.  The bottom right image (e.) 
shows the isosurface rotated and so that the region underneath the membrane is visible.  
The 1 micron bead can be clearly seen in proximity to the nucleus.  Images like this 
confirm that the beads we identify as undergoing active transport are indeed internalized 
within the cell, and are suitable candidates for probing the intracellular environment. 
6.4.4 Active Microbead Transport is Temperature Dependent 
 
 The temperature dependence of organelle active transport was established in the 
seventies with the study of abdominal nerves of rhodnius prolixus (Heslop and Howes 
d. e. f. 
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1977).  This temperature dependence is also evident in the transport of the 1 micron 
microbeads.  Cells were plated as described above in section 6.3.2 and dosed with 
microbeads. 
 A single cell with an internalized bead being actively transported was identified.  
Video of this cell is captured at 60fps.  Video is first captured at room temperature, 
23.0°C.  Later, the cell culture is temperature is raised to 37.0°C to observe the difference 
in active transport.  The results are shown in Figure 6.6. 
23. 0°C 37. 0°C 
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Figure 6.6 Results from the temperature dependence of transport on a single microbead in 
the same cell.  The top two images are frames taken from the 60fps time-lapse.  The 
yellow circles indicate the same bead undergoing transport at the two temperature 
regimes.  Below the time-lapse images are the respective radial displacement plots.  The 
difference in transport between the two is significant, with the 23.0°C track showing 
essentially none of the bi-directional transport indicative of motor transport.  The 37.0°C 
sample shows a greatly increased level of activity. 
 
The temperature dependence is clearly shown in the radial displacement plots.  Tracking 
the microbead at 23.0°C showed very minimal displacement from the original 
displacement, especially when compared to the 37.0°C.  The 23.0°C sample displaced 
essentially 1 micron from its original position, whereas the 37.0°C displaced as much as 
5 microns from its original position and traveled a total distance of over 10 microns. 
 Data are taken and analysis is done on n = 17 and n = 21 beads for 23.0°C and 
37.0°C respectively.  The mean displacements, velocities, and excursion times are 
calculated to further characterize the temperature dependence on active transport.  
Displacements are characterized as anterograde or retrograde based on the direction the 
bead is moving relative to the nucleus.  Anterograde transport involves movement away 
from the nucleus and retrograde displacement involves movement towards the nucleus.  
An “excursion” is characterized as a persistent displacement of the bead until the velocity 
of the bead equals zero.  When the bead resumes transport, that movement is counted as a 
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new excursion.  For each of excursion the displacement, velocity, and excursion time is 
measured.  The results are shown in Figure 6.7 and Table 6.1. 
  
  
Figure 6.7a Intracellular 1m microspheres undergo active transport at 23.0°C and 
37.0°C.  Shown are plots of mean and max anterograde/retrograde velocity. 
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Figure 6.7b Intracellular 1m microspheres undergo active transport at 23.0°C and 
37.0°C.  Shown are plots of mean and max anterograde/retrograde velocity. 
  
  
Figure 6.7c Intracellular 1m microspheres undergo active transport at 23.0°C and 
37.0°C.  Shown are plots of mean and max anterograde/retrograde excursion time. 
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Table 6.1: Displacements/velocities/excursion times for intracellular transport of 1m 
microbeads at 23.0°C and 37.0°C 
 23.0°C 37.0°C % Increase 
Mean Anterograde 
Displacement 
12.5 .1 57.7 5.4 363% 
Max Anterograde 
Displacement 
103.1 .4 1194 253 253% 
Mean Anterograde 
Velocity 
49.5 3.17 133.9 5.1 170.7% 
Max Anterograde 
Velocity 
118.4 8.4 708 .5 497.7% 
Mean Anterograde 
Excursion Time 
0.26 0.01 0.37 0.02 42.4% 
Max Anterograde 
Excursion Time 
1.3 .23 3.24 0.2 149.6% 
Mean Retrograde 
Displacement 
12.5 1.1 56.9 6.78 354.1% 
Max Retrograde 
Displacement 
70.5 6.45 1000 6.78 1320% 
Mean Retrograde 
Velocity 
49.1 3.4 129.4 6.45 163.8% 
Max Retrograde 
Velocity 
113.4 9.2 687.5 1.4 507.0% 
Mean Retrograde 
Excursion Time 
0.26 0.1 0.36 0.02 39.4% 
Max Retrograde 
Excursion Time 
1.04 0.1 2.87 0.24 177.6% 
 
The mean and max displacements, velocities, and excursion times all experience 
significant increases at 37.0°C over 23.0°C.  Mean displacements increased by greater 
than 350% along with excursion times seeing an improvement of 150% and greater.  The 
temperature dependence is clear and significant and must be taken into account in the 
planning of intracellular rheology experiments. 
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6.4.5 The Probability Distribution of a Diffusing Bead Shows that the Microbead 
Transport is Active 
 
 A microbead in a sample can be observed undergoing movements due to thermal 
fluctuations which will cause it to displace due to the motions of the surrounding fluid.  
This phenomenon is referred to as diffusion.  All things being equal, a particle will move 
in any direction from its equilibrium position with an equal probability to diffuse in any 
direction.  The amount diffusivity of a particle in a fluid is quantified by a constant of 
proportionality called the diffusion coefficient.  It is defined mathematically by Equation 
6.1 
    
  
 
 (6.1) 
where k is the Boltzmann constant, T is temperature in K, and  is the drag coefficient.  
The drag coefficient is a value that is proportional to the velocity () a particle will 
experience given an applied force (F), as shown in equation 6.2.  
       (6.2) 
For a spherical particle the drag coefficient is defined as: 
         (6.3) 
where  is the viscosity (Pa·s) of the fluid and r is the radius (m) of the spherical particle.  
Substituting this into equation yields an alternative equation for the diffusion coefficient 
in Equation 6.4 
    
  
    
 (6.4) 
The intracellular environment is a very heterogeneous environment.  Unlike a Newtonian 
fluid, no single value of viscosity would be accurate to describe the fluid nature of the 
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cell.  The intracellular environment is constantly remodeling, moving, and changing such 
that assigning a single viscosity value to a cell is insufficient for characterizing the fluid 
nature. 
 For the purposes of determining active transport we can determine the diffusion 
coefficient based on experimentally determined values of viscosity.  With methods that 
will be demonstrated in Chapter 7, we can determine a value of intracellular viscosity to 
be 0.69 Pa·s.  This value is determined from a single HeLa EGFP-654 cell and it should 
be stated again that this value can vary from cell to cell and within the same cell.  But this 
value is within the range of viscosity for this cell type that will be shown later.  Inserting 
this value into equation 6.4 yields a diffusion constant of:    
                   (6.5) 
This value correlates the size of the particle and the frequency of the diffusive step sizes 
that are indicative of the random motions.  The higher the diffusion constant, the greater 
the amount of diffusion will be observed in a system.  This is evident when observing 
increased diffusion in solutions of high temperature and low viscosity.  Also the smaller 
the particle, the more it will diffuse in the same system. 
 A microbead that is undergoing active transport in a cell is transported along 
filaments of the cytoskeleton, primarily microtubules.  Given the size of the microbead 
and the vertical height of the cell, it is largely restricted to a 2-dimensional plane to move 
in, which relatively limited movement in the z-direction.  When considering individual 
movements along a cytoskeletal filament, we can consider the movements to be 1-
dimensional, with movement being either anterograde or retrograde.  So for 
simplification we can look at this as a one-dimensional problem, and compare the 
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microbead movements with diffusion in 1 dimension.  If a particle is diffusing in 1 
dimension it has only two directions for displacement to occur.  Because the diffusion is 
random, there is a probability associated with finding the particle at some position x from 
its starting point after a given time t.  This probability is defined by the distribution 
function in Equation 6.6: 
         
 
     
  
  
            (6.6) 
where D is the previously defined diffusion coefficient, t is time, and x is the particle 
displacement.  If a particle is observed moving in a system, if it is undergoing diffusion, 
it should not, on average, undergo average displacements beyond what is typical of the 
above distribution.  Of course the longer a particle is diffusing, the further more chance it 
has to move farther distances.  Using the diffusion coefficient in Eq. 6.5, we can see that 
change when considering time scales of 0.1, 1.0, and 10 seconds.  The probability 
distributions are shown in Figure 6.8. 
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Figure 6.8 Probability distribution functions for 1-D diffusion of a bead for a 1m bead 
with diffusion coefficient of 6.58   10-3.  The times indicated are 0.1, 1, and 10 seconds.  
As a particle has more time to diffuse, it is likelier to traverse a greater distance. 
 
As the microbead has more time to diffuse, of course there is greater probability of it 
displacing farther distances, as indicated by the above plots.  It was shown that the mean 
anterograde displacement is 57.7nm with a mean excursion time of 0.37s.  Plugging this 
time into the distribution, we can calculate the probability that the bead would diffuse this 
distance over this time scale. Setting the limits of integration appropriately, we integrate 
as shown in equation 6.7. 
   
 
                  
 
 
  
                   
 
      
 (6.7) 
The integration is multiplied by 2 to calculate the 2-tailed probability, shown in Figure 
6.9. 
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Figure 6.9 Probability distribution for the 1-dimensional diffusion of a 1m microbead.  
The red indicates the calculated area under the curve, the result of Equation 6.7.  The 
probability of the bead diffusing a distance greater than 57.7nm is 0.9%, which indicates 
that the transport that is being observed is not diffusive, but active transport. 
The integration yields P(|x| > 0.0577) = 0.009 which shows that the bead movements are 
not diffusive but must be due to active transport.  This confirms the internalized state of 
the microbeads and further confirms the selection of a selected bead as a probe for 
intracellular rheology. 
6.5 in vivo Motor Stalling Results in Different Microbead Displacement 
Phenomena 
 
 To test forces being exerted by the molecular motors, forces are exerted on the 
microbeads with the 3-dimensional force microscope.  The HeLa EGFP-654 cells are 
plated as described previously and dosed with the 1m paramagnetic microbeads.  The 
samples are placed in the environmental chamber previously set to 37.0°C.  The sample 
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is visually scanned to find a suitable cell on which to collect data.  As mentioned before, 
the cell will need to have at least 1 microbead in it that can be confirmed as undergoing 
active transport.  Once this cell is identified, the motorized stage controls are used to 
lower the 3DFM pole tip down into position.  The pole tip is generally lowered to a 
height of 10-50m above the cell culture.  The typical sample would appear similarly to 
what is depicted Figure 6.10. 
  
Figure 6.10 The image on the left shows a typical 3DFM experiment.  On the left side of 
the image, the end of the magnetic pole tip is visible.  The cell is shown roughly off 
center in the field of view.  The outline of the cell is traced in yellow.  Several 
microbeads can be observed in this cell undergoing active transport, making it suitable 
for experimentation. 
 
With the pole tip in position forces are exerted on the microbeads.  The force calibration 
of the pole tip is done prior to the experiment and is described in Chapter 8. 
 When attempting to stall motors in vivo with the 3DFM I attempted to apply 
forces in a pulsed periodic manner.  There is no real way with which to predict the 
directionality of a bead that is undergoing active transport.  The bead moves in a bi-
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directional manner under the power of the respective molecular motors.  Isolation of 
anterograde or retrograde transport can be achieved by selective knock down of kinesin 
or dynein activity during the experiment. (Loschi, Leishman et al. 2009)  ATP 
concentrations can be altered to bias the transport of organelles in the anterograde or 
retrograde directions. (Nilsson, Steffen et al. 2001)  Barring these treatments the transport 
occurs in a stochastic manner.   
 First attempts to stall the microbeads in vivo involved the application of pulsed 
forces in an attempt to halt the procession of the bead.  The magnetic forces were pulsed 
at frequencies in the range of 0.2-0.5Hz.  The intent was to apply a force at the exact right 
time when a bead is undergoing an excursion away from the pole tip.  While it is possible 
to manually actuate the force, the speed at which a bead can change direction, combined 
with the duration of the excursion in one direction, make it virtually impossible to time 
the force application with the transport of the bead.  Ideally, the tracking of the bead 
would occur in real time, and when the bead began travelling away from the pole tip, the 
computer would activate force at the appropriate time and level to stall the bead.  
Otherwise force must be applied with the hope of coinciding with one of these events.  
 Classically stalling the beads in vivo proved to be a challenging proposition.  
Ideally the bead would undergo an excursion with some velocity, a force is applied 
bringing the velocity to zero, and once the force is removed the bead continues along at 
its previous trajectory.  Achieving this in reality turned out to be an extremely rare.  
There were actually a variety of different phenomena that I observed from attempts to 
stall a motor in vivo which I will describe. 
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6.5.1 Case 1: The Motor Stall 
 
 I have one instance of a classical stall.  This is out of thousands of pulls on 
microbeads over the years.  In this case the 3DFM was pulsed at a frequency of 0.2Hz.  
The level of the force application was in the 4-5 pN range, a force comparable to the stall 
force of a single dynein motor.  The force was applied for a total of 12 times over 2 
minutes.  Data are shown in Figure 6.11. 
 
 
Figure 6.11 The above plot shows a displacement plot of a motor stalling experiment.  
The 3DFM was pulsed for 5 seconds on/off over 2 minutes.  The force regime was in the 
4-5pN range.  The plus symbols indicate where the force is turned on.  The top right 
shows a zoom-in of the plot showing where motor stalling is occurring.  At the time that 
the force is turned on (4.27pN) the bead is taking an excursion away from the pole tip and 
its progress is halted.  After the cessation of force the bead continues on its previous 
trajectory. 
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The plot in Figure 6.11 shows that prior to the sixth application of force the bead is 
undergoing an excursion away from the pole tip.  When the force is turned on the 
progress is halted and the bead is stalled.  The force applied is 4.27pN.  The zoomed in 
portion of Figure 6.11 shows how the velocity becomes zero as the slope of the 
displacement becomes zero.  After the force is turned off the bead continued along its 
previous trajectory.  This represents the best example of in vivo stalling from the 
thousands of pulls that comprise this study.  Roughly speaking it is less than 1/10
th
 of 1% 
of all of the pulls, indicating the difficulty of achieving this feat. 
6.5.2 Case 2: The Viscoelastic Response 
 
 The majority of the cases of bead pulling result in the classical viscoelastic 
response.  This is true for high force regimes (for these purposes we will call high force a 
force > 50pN) as well as low force regimes (1-30pN).  The viscoelastic nature of the 
cytoplasm will be discussed more quantitatively in Chapter 7.  Generally speaking a 
viscoelastic material is a material that possesses both viscous and elastic properties.  
When a bead is pulled through a viscoelastic material, after the force is removed, the 
bead regresses backward, as the material responds elastically.  An example of a 
viscoelastic response is shown in Figure 6.12. 
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Figure 6.12 An example of a typical viscoelastic response.  This effect is typical of the 
majority of the bead pulls, regardless of the force regime of the experiment.  Viscoelastic 
properties of the cell will be discussed in more detail in Chapter 7. 
 
In this example the force is on for 5 seconds and off for 10 seconds.  Even when applying 
low forces to stall the motors a viscoelastic response is often the characteristic 
displacement.  As with any experiment it is essential to match the timing of the video 
with the timing of the external force stimulus.  At the current moment the 3DFM software 
does not in any way communicate or sync with the microscopy software.  For these 
experiments I depend on timing the force start time with a stopwatch and then later 
determining the start time of the video with the tracked data.  The appearance of at least 
one viscoelastic curve helps me to determine the exact frame at which the magnets turn 
on, so syncing the video data with the magnet data is not an issue.  However, when 
probing low force regimes there may not be a well defined signal such as this to properly 
sync the two data sets.  In this situation the data is unusable because even though I know 
the approximate time of the magnet start time, I can’t determine it explicitly.  The 
solution to this would be to get the programs to sync from a single clock and report the 
start times of both events in a metadata file.  A second solution that I investigated was 
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connecting an LED that would turn on and add illumination to the field of view when the 
magnets are turned on or at least at the first magnet pulse.  The LED would be connected 
to a port coming from the 3DFM amplifier so that illumination and magnetization would 
be simultaneous.  In any event, probing low force regimes will require a 
magnet/microscopy synchronization to make data collection more efficient.  
Alternatively, at the end of any sequence of low force pulses, a single high force pulse 
could be applied to produce a large displacement to serve as a standard to isolate the start 
time for the low force pulses.  This high force would risk detachment of the bead from 
the microtubule or disruption of the local environment surrounding the bead, which may 
or may not be desirable depending on the experiment. 
6.5.3 Case 3: Direction Reversal 
 
 A third phenomenon that can be encountered with in vivo motor stalling will be 
the reversal of microbead direction during the period of applied force.  When the force is 
turned on the bead begins to displace in a mostly viscoelastic manner.  At some point in 
the force application, instead of continuing to displace in a viscoelastic manner, the bead 
begins to move in a direction opposite to which the force is applied.  So if a bead is being 
pulled in an anterograde direction, the dynein motors “kick in” at some point and begin to 
walk the bead back in the retrograde direction.  This phenomenon is depicted in Figure 
6.13. 
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Figure 6.13 Two examples of the microbead reversing direction during the period of 
force application.  The bead begins to displace in a mostly viscoelastic manner, but 
during the middle of the force application the dynein motors work to overcome the force 
of the magnet, and begin a retrograde excursion. 
The applied force is overcome by the force of the dynein motors allowing it to move back 
towards the nucleus.  In some sense this is a stall, in that the velocity of the bead becomes 
zero as it reverses direction.  The force application in both cases is approximately 4.75 
pN, again in the range of the stall force of a single dynein motor.  This would point to 
more than one dynein motor being active at the time of the direction reversal.  It is known 
that more than one motor can be acting on an organelle at any given time (Gagliano, 
Walb et al. 2009) and that the force applied acts in an additive, linear fashion.  To stall 
motors in vivo forces will have to range from the force of a single motor to several, 
depending on the number of motors attached.  The number of motors attached could be 
estimated based on the speed of the transport and the rheology of the cell.  A computer 
program could take these features into account to modify applied forces in real time. 
6.5.4 Case 4: Assisting Transport 
 
 When a force is applied during transport, in the direction of the transport, it may 
have the effect of assisting in the transport.  When the force is removed, the bead will 
continue along the same trajectory, but at a reduced velocity.  Normally when the force is 
 
 
132 
removed the bead’s displacement will relax in a viscoelastic manner.  But because the 
bead is still being transported after the force is removed, this relaxation is not seen.  An 
example of this is seen in Figure 6.14. 
 
Figure 6.14 A case of the magnetic force assisting transport.  During the interval of force 
application the bead begins to move towards the pole tip.  Once the force is removed the 
bead continues along on its previous trajectory but at a slower speed.  Least squares linear 
regression lines are fit to each portion, indicating a velocity of 87nm/s while the force is 
on, and a decrease to 57nm/s with the force on. 
 
The force is turned on at t = 91.5 for 5 seconds.  The applied force is quite low, only 
1.65pN, on the order of the force of an individual kinesin motor.  When the force is 
removed at time t = 96.5 there is a decrease in the velocity of the bead, although it travels 
along the same trajectory.  Least squares regression lines are fit to each region separately 
to quantify the change.  During the force application the bead moves at a rate of 87nm/s.  
Once the force is removed the velocity drops to 57nm/s, a 34% decrease.  It seems that 
these low forces are able to impact the motor driven transport with low force application.  
Probing in these low force regimes could yield interesting transport data, but the 
synchronization of magnet and video issues will have to be overcome.     
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6.5.5 Case 5: Breaking Through 
 
 As previously stated, when applying an oscillating force to the bead, the 
predominate displacement will be viscoelastic in nature.  Sometimes in the middle of the 
pull as the viscoelastic curve is flattening out, the bead will escape from its immediate 
surroundings and break through to continue its transport in the direction of the applied 
force.  This case is shown in Figure 6.15. 
 
Figure 6.15 Example of a bead breaking through the local cytoskeletal entrapment to 
continue its movement in the direction of the force.  At the point where 31pN is 
indicated, it would normally be expected that the bead displacement would flatten out.  
However because it breaks through there is an inflection point as the bead continues its 
path towards the pole tip. 
 
The force at the beginning of the pull started out at 21.9pN and at the point where the 
bead breaks through the force has increased to 31pN.  At the end of the force application 
the force has reached 38.4pN.  In Figure 6.15, where 31pN is indicated, the expectation 
would be for the displacement curve to flatten out in a classical viscoelastic manner.  
Instead, the bead breaks free of its local environment to continue its trajectory towards 
the pole tip.  The bead overcomes the elastic effects of the material, at least temporarily, 
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to achieve this.  This phenomenon is not common, but can occur with sufficient force.  It 
is a heterogeneous phenomenon, in the sense that it is dependent on where it is in the cell 
and can vary from cell to cell.  It can happen also with greater or lesser degrees of force, 
and because it happens at one force does not mean it will happen again on a subsequent 
pull.   
6.5.6 Case 6: Translation 
 
 The viscoelastic nature of the cytoplasm is well established.  On occasion, 
microbeads can be translated through the cytoplasm with sufficient force.  This is to say 
instead of the bead displacement flattening out viscoelastically, it travels in a somewhat 
linear trajectory, closer to what would be expected in a viscous medium.  The bead may 
follow a trajectory that is dependent upon the obstructions from cytoskeleton and 
organelles, but is able to go around them as it moves towards the pole tip.  An example is 
shown if Figure 6.16. 
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Figure 6.16 An example of a bead translating through the cytoplasm (bead is indicated by 
yellow circle).  The trajectory is closer to what would be expected from a more viscous 
material.  The bead moves around some of the intracellular features as it moves to the 
edge of the membrane/glass interface. 
 
The bead is initially near the periphery of the nucleus before the force is applied.  A force 
of 18.5pN is applied and the bead translates towards the pole tip.  The bead appears to 
circumnavigate some obstacles in the cell, as the trajectory bends on its path to the 
membrane/glass interface.  As is shown in the bottom left displacement plot, the bead 
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translates nearly 13.5m before stopping.  The force of 18.5pN is not greater than a 
typical force used in these experiments.  A force of this magnitude is not necessarily 
always going to provide sufficient impetus to translate a bead through any particular cell 
at any given time.  Given the right positioning in the cell and a high enough force it is 
possible to translate a bead in a cell. 
6.6 A Maximum of 6 Dynein Motors act on a Single Microbead 
 
 To effectively determine the stall force necessary to halt the progress of a 
microbead, it became clear that a pulsative application of force isn’t the most efficient 
method of data collection.  Instead I decided to apply a constant steady force to the bead 
and analyze the displacement of the bead with respect to force.  These experiments were 
performed as previously described.  The only difference is that the force was applied for a 
full 60 seconds.  The force calibration is shown in Figure 6.17. 
 
Figure 6.17 Force calibration for the long time scale force experiments.  This was 
performed with a Netic pole tip 30m above the sample. 
 
 
137 
 
The voltage signal for each experiment was ramped from 0.4V-3.0V.  Data are collected 
on 21 microbeads.  For each experiment video the positions of each microbead is 
recorded in an Excel spreadsheet.  Based on the applied 3DFM current and distance of 
the bead from the pole tip, I determine a mean force on the bead.  Using the same 
MATLAB program to analyze data from section 6.4, I determine the mean excursion 
sizes and velocities of the bead during the time of the applied force.  The results are 
shown in Figure 6.18 
  
  
Figure 6.18 Plots of displacement vs. force and velocity vs. force for motor stalling 
experiments.  Retrograde data is in the left column and anterograde data is in the right.  
The line y = 8 is plotted to show the location of the 8nm mean molecular motor step size. 
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 Because of the geometry of the experiment, the anterograde direction is towards 
the pole tip and retrograde is away from the pole tip.  Each data point on the Figure 6.18 
represents a single microbead.  The first result of note is that the retrograde displacement 
of the beads trends towards 8nm as force increases.  Eight nanometers is the length of a 
single step-size, which means that these beads are able to overcome the force of the 
3DFM enough to, on average, take a single step backwards.  We fit an exponential curve 
to the retrograde displacement data to calculate an intercept with the y = 8 line.  The 
exponential regression line is shown in Figure 6.19. 
 
Figure 6.19 An exponential regression line is fit to the retrograde displacement vs. force 
data to determine stall force.  Stall force is approximately 29pN. 
 
Calculating the intercept of the regression curve with the line y = 8 yields a result of 
29.09pN.  The work of Holzwarth and others have introduced a shared load model of 
molecular motor transport. (Shtridelman, Holzwarth et al. 2009)  Their data suggests that 
the stall force is linearly dependent upon the number of motors attached to a vesicle as 
shown in Equation 6.8: 
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         (6.6) 
where Fs is the stall force of the vesicle, N is the number of motors, and fm is the stall 
force of an individual molecular.  The stall force of kinesin has been measured to be 
approximately 6pN with values reported within a few piconewtons of this value. (Howard 
2001)  Similarly, dynein stall forces have been reported between 2 and 8 pN. (Gennerich, 
Carter et al. 2007)  The data in Figure 6.19 represents stalling force on dynein motors 
working against the 3DFM to transport the bead towards the nucleus.  Taking a mean 
stall force for dynein to be 5pN this would result in approximately 6 dynein motors at 
most acting on a microbead when the highest forces are acting on it.  I have not 
quantified the number of motors attached to the microbeads as a part of these studies.  
Fluorescence microscopy or SEM imaging of fixed cells could be used to determine the 
average number of motors attached, which would help to verify my conclusions.  
Electron micrographs of fixed cells have shown that 2-3 motors are attached to a vesicle.  
Given the relatively large size of the microbeads relative to the majority of vesicles, it is 
not unreasonable that there could be 6 motor proteins attached.  It should be noted that a 
motor protein could be attached to a vesicle or microbead, but unless it is in contact with 
a microtubule, it will not be participating in the transport process. 
 The plot of retrograde velocity versus force shows that there is no impact to the 
microbeads velocity with respect to the applied force.  The mean velocities at 0, 20, and 
30pN are 129.4 6.45, 119.3 , 124.8 1 which are all within each other’s 
standard error (velocities within 2.5pN of 20 and 30pN are averaged together).  So 
while the applied force has a definitive effect on retrograde displacement, it does not 
seem to have an effect on the velocity that the bead takes when it makes this excursion.  
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This should not be confused with the idea that a motor having a velocity of zero.  These 
data say that when a bead does take an excursion under the influence of these forces, the 
velocity is not affected.  This lends itself to a ratchet and gear type description of motor 
transport.  If the microtubule is the ratchet and the motor is the gear, the gear is moving 
along the ratchet in 8nm steps.  The stalling force holds the gear in place, until it is 
sufficiently motivated to take an excursion away from the applied force.  In spite of the 
level of force applied to the gear, when it does take this excursion, it does so at some set 
velocity, that is not dependent on the applied force.  This is comparable to a digital versus 
analog electrical signal.  If the bead velocity behaved in an analog fashion, during the 
retrograde excursions, the velocity would decrease based on the amount of opposing 
force applied.  However we see that when the excursions do occur, the velocity is not 
affected, making it a more digital, on or off feature. 
6.7 Conclusion 
 
 I have presented a protocol to introduce 1m particles into the intracellular 
environment.  Although I have not used it with other cell types I am confident that it 
would have uses for other cell types and for other forms of force application, particularly 
AFM.  Upon gaining entry to the cytoplasm, the 1m bead is enveloped in a pinched off 
portion of the cell membrane, forming an early endosome.  Molecular motors attach to 
this endosome and the bead begins to undergo active transport, similar to the bi-
directional transport of an organelle.  I have shown the temperature dependence of the 
microbead transport, with increases in mean velocity and excursions as high as 170% and 
354% respectively.  I have shown how the intracellular position of the bead can be shown 
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with stacks of fluorescently labeled cells reconstructed as 3-dimensional isosurfaces.  The 
beads can be shown to be undergoing active transport based by comparing the mean 
displacements based on the probability distribution of a diffusing bead.  The mean 
squared displacement of the beads also confirms that the beads are being actively 
transported.  There are a variety of different responses that can be observed when 
attempting to stall an actively transported microbead in vivo, which have been detailed 
here.  By ramping the forces exerted on a microbead, I have shown a decrease in 
retrograde displacement with respect to force.  By fitting an exponential curve to these 
data I have determined that forces in excess of 29.09pN are sufficient to arrest the 
retrograde transport of the bead.  This equates to a minimum of 6 dynein motors being 
attached to the microbead at one time, based on the shared load model of motor transport.  
I have also shown that when a bead does undertake retrograde excursions under the 
influence of an external opposing force, the velocity that the bead travels during that 
excursion is not affected by that force.    
 
 
 
 
  
 
Chapter 7 
Probing of Intracellular Mechanics with 1m Paramagnetic Microspheres 
7.1 Overview 
 
 This chapter will outline some of the rheological observations I have made during 
motor stalling experiments.  Though not a focus of this dissertation, there are interesting 
findings that serve as preliminary results for future study.  
 Materials can be classified based upon physical characteristics that they possess.  
For instance, a diamond is clearly understood to be a solid.  It does not exhibit any of the 
properties of a gas or liquid such as the ability to expand or flow.  Holding a diamond in 
your hand, you can exert a compressive force upon it and it will not deform in any way.  
With the use of machinery compressive, shear, or tensional forces can be exerted upon it 
and still the diamond will not deform.  The tight, regular conformation of carbon atoms 
makes this material the hardest substance known on the earth.  The vast majority of 
materials in everyday life will not exhibit this level of material integrity and will in fact 
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show a variety of effects when acted upon by outside forces.  A rubber band will deform 
when it is stretched out, and when the force is removed from the rubber band it returns to 
its original conformation.  As long as the force applied is below the point of failure the 
material should return to its native state.  This type of phenomenon is considered elastic 
behavior.  Some materials can be deformed, but do not recover from the deformation 
once the force is removed.  When a boat is pushed away from a dock, the boat does not 
return to the dock once the force has been removed, it will continue to float in the water 
some distance away from the dock.  The water is designated as a viscous material.  
Elasticity and viscosity are terms that express the behavior of a material when a force is 
acted upon it.  However many materials, especially in biological systems, do not fall 
cleanly into either of these categories.  These materials can be classified as viscoelastic 
materials, possessing properties of both viscous and elastic materials.  Viscoelastic 
materials can exhibit varying levels of viscosity and elasticity which effect how it 
responds under stress, and classifying them is done by applying forces on them and 
measuring their response.  This is the work of the field of rheology, and as it applies to 
biology, can provide explanations for phenomena, as mechanical properties become 
better characterized.  As biological rheology is further studied, it will advance the 
understanding of how the systems of the body work, the mechanisms of health and 
pathology, and elucidate novel means by which diseases can be treated and potentially 
cured. 
7.2 Mechanical Models 
 
 As previously stated, viscoelastic materials exhibit both viscous and elastic 
behavior.  To model behavior mathematically, models are comprised of springs and 
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dashpots connected in series and parallel.  Springs represent the elastic responses of the 
materials and dashpots represent the viscous components.  Arranged in different 
configurations, these models represent different types of viscoelastic response to force.     
7.2.1 Springs 
 
Elastic behavior is represented as a Hookian spring, in which the force is linearly 
dependent to the displacement of the spring, and is represented mathematically in 
Hooke’s law expressed in Equation 7.1: 
       (7.1) 
where f is force on the spring, k is Hooke’s constant, and x the displacement of the spring.  
In model diagrams springs are represented as shown in Figure 7.1.  
 
Figure 7.1 Schematic diagram of a spring.  G is the elastic modulus representing the 
stretchiness of the spring. 
 
 This relationship can be similarly expressed in terms of stress and strain, as shown in 
equation 7.2.   
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      (7.2) 
Stress ( is analogous to pressure, the amount of force exerted over a given cross-
sectional area.  Strain ( is the ratio of the extension over the length and G is the elastic 
modulus. 
7.2.2 Dashpots 
 
Dashpots or Newtonian dashpots represent the viscous component of a 
viscoelastic material.  It is an idealized element that is fixed at one end and responds to a 
force with by lengthening at a constant velocity.  Dashpots represent the characteristics of 
the material that behave like a Newtonian fluid. 
 
Figure 7.2 Schematic diagram of a dashpot.  η is the viscosity of the dashpot which 
represents the fluid (viscous) component of the material 
 
The extension of the dashpot increases linearly with time as force is applied.  The stress 
( is proportional to the strain rate (  ) as shown in equation 7.3. 
      (7.3) 
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where  represents the viscosity of the fluid.  The dashpot and spring can be connected in 
series and parallel to form systems that represent the mechanical properties of different 
viscoelastic materials.  The Kelvin-Voight model will be described in the following 
section.  
7.2.3 Kelvin-Voight Model 
 
 The Kelvin-Voight Model is modeled as a spring and dashpot connected in 
parallel.  It is represented schematically in Figure 7.3.    
 
Figure 7.3 Schematic drawing the Kelvin-Voight model, of a spring a dashpot connected 
in parallel. 
 
This system is modeled mathematically in equation 7.4. 
 
      
  
  
 (7.4) 
7.3 Intracellular Rheology Measurements 
  
 Once intracellular beads have been identified, forces can be brought to bear to 
manipulate the bead in vivo.  I use the 3DFM to apply forces to the microbeads as 
described in section 6.5.  Instead of attempting to stall the motors with the low force 
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regimes, I apply forces in the higher end of the spectrum, in the 20-150pN range or 
higher.  The Kelvin-Voight model is used to model the viscoelastic response of 
microbeads pulled with the 3DFM.  To calculate the shear modulus we first calculate the 
compliance by equation 7.5. 
 
  
 
 
 
       
 
 (7.5) 
The Kelvin-Voight model is then fit via a least squares regression to the plot of 
compliance vs. time, to determine the viscosity and elastic modulus. 
7.4 Cytoplasm Rheology 
 
 When a microbead is in between the nucleus and the membrane edge, the cell 
cytoplasm can be probed for rheology experiments.  If the bead is close to the membrane 
edge, the bead will be probing the cortical actin of the inner membrane.  If it is near the 
nucleus, depending on the position of the bead with respect to the direction of force, the 
nucleus mechanics will be probed.  An example of proper bead positioning to probe the 
cytoplasm is shown in Figure 7.4. 
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Figure 7.4 To measure cytoplasm rheology, the probe must be between the nucleus and 
the membrane boundary. 
 
Data was collected from 14 beads in a total of 6 cells.  The beads were pulled 3 
consecutive times for a 10 second on/off interval.  The measured elastic moduli and 
viscosity are shown in Figure 7.5. 
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Figure 7.5  (Top Left and Right)  The elastic moduli and viscosity of 6 cells are plotted 
for each of the 3 consecutive pulls of ten seconds each (10 seconds on/off).  There is a 
slight increase in elastic modulus from pull 1 to pull 2, but not from pull 2 to pull 3.  
Viscosity increases on pull 2 but decreases on pull 3.  (Bottom)  A typical bead pulling 
radial displacement track.  The magnets are programmed for 3 consecutive pulls after 60 
seconds. 
 
The elastic moduli increases by 55% after the first pull but does not change for the 
second and third pull.  This may indicate some strain stiffening, but only after the first 
pull.  Pulling on 3 beads within another single cell yields additional insight.  In this 
experiment the respective beads are pulled a total of 12 times, as shown in Figure 7.6. 
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Figure 7.6 Collected moduli and viscosity of 1 cell measured by 3 microbeads.  Generally 
speaking there is an upward trend in the value of the elastic moduli, showing some degree 
of strain stiffening.  The viscosity doesn’t appear to have a similarly distinctive trend. 
 
Over the course of 12 pulls the elastic modulus increases by 523% going from 0.1Pa to 
0.63Pa.  These data appear to indicate that the cytoplasm of the cell strain stiffens with 
applied external force. 
7.5 Cytoskeletal Disruption 
  
 In an instance when a bead is translated through the cytoskeleton, it distorts the 
cytoskeleton along the path that it travels.  This can be seen when on a second microbead 
is pulled along the same trajectory as the first bead.  When the second bead travels 
through the disrupted cytoskeleton, the elastic modulus as measured by the second bead 
is significantly less than what is measured from the first bead, along the same trajectory.   
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Figure 7.7 Example of microbead manipulation disrupting the cytoskeleton.  Image 1 
shows two beads prior to force application.  Image 2 shows the first force application, 
and the blue bead which is closer to the pole tip translates towards it.  In image 3 the 
second (red) bead moves towards the pole tip, eventually following the same path as the 
first bead.  The disruption of the cytoskeleton can be seen by the severe reduction in 
elastic modulus as measured by the second bead.  Data are shown in Figure 7.8. 
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Figure 7.8 Top Left: X-Y plot of two beads in proximity to one another.  Force is applied 
with 3 separate pulls of 10 seconds on and then off.  After the first bead (blue) pulls in 
front of the second bead (red), the bead follows the trajectory of the first bead on the 
second pull.  Top Right: radial plot of both beads. Bottom Left: The elastic modulus 
measured by the second bead on the second pull decreases 6 orders of magnitude to 
nearly zero, indicating that the elastic component of the material is removed.  Bottom 
Right: The viscosities are still within a similar range, as it should be, since the viscous 
component of the material is still present. 
 
In Figure 7.7 the bead marked with the blue circle measures an elastic modulus of 1.68 
Pa.  It disrupts the local cytoskeletal environment to such an extent that when the red 
bead follows along its path, it experiences an elastic modulus that has decreased to 
.0000196, a decrease of 6 orders of magnitude.  The red bead is basically travelling 
though a cytoskeletal tunnel of cytosol, vacant of structural elements.  This is seen in the 
measurements of viscosity, which does not experience a similar drop.  On the first pull, 
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the first (blue) bead measures a viscosity of 3.6 Pa·s, but on the second pull, the second 
bead (red) measures a viscosity of 7.54 along the same path as the first bead.  There is no 
decrease in viscosity, which tells us the viscous component of the cell remains in that 
region. 
7.6 Probing of the Cortical Actin of the Inner Cell Membrane 
 
 With a bead in proximity to the membrane it is possible to probe the mechanics of 
the cortical actin.  If the bead is not near the membrane, it is sometimes possible to 
translate the bead to the edge of the cell with sufficient applied force.  Such is the case in 
Figure 7.9.  The bead is near the nucleus before the force is applied, and with an applied 
force of 18.5pN the bead is transported to the edge of the cell.  Once at the edge of the 
cell the bead is pulled on an additional 13 times.  The resulting elastic moduli and 
viscosity are shown in Figure 7.9. 
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Figure 7.9 (Top Row) A bead is translated through the cytoplasm to the edge of the cell 
membrane.  The first pull translates the bead 13 microns.  Subsequent pulls probe the 
cortical actin.  (Middle Row) Membrane modulus increases by a factor of 530%, 
indicating strain stiffening.  (Bottom Left) Displacement plot of bead track. 
The first pull measures a modulus and viscosity of 0.4Pa and 0.5Pa·s, within the range of 
the results found in 7.4.  The first pull at the cell boundary yields a modulus of 6.5Pa.  
 
 
155 
The final pull yields a modulus of 41Pa, an increase of 530%.  It appears that both the 
cytoplasm and cortical actin strain stiffen, but the majority of strain stiffening is due to 
the cortical actin. 
7.7 Conclusion 
 
 This chapter describes some of the rheological phenomena that have been 
observed in the course of attempted in vivo motor stalling experiments.  Cell cytoplasm 
and cortical actin appear to strain stiffen, although to a greater extent in the cortical actin.  
A microbead appears to disrupt the local cytoskeleton, as indicated by the sharp decreases 
in elasticity in the region of the bead translation.  The introduction of microbeads to the 
interior of the cell provides a probe that is nicely uniform and sufficiently paramagnetic 
so as to permit relatively high forces for measurements.  These data provide groundwork 
for further quantification of intracellular rheology and the responses of cells to externally 
applied forces.  
 
 
 
 
  
 
Chapter 8 
Appendix 
8.1  Appendix One: Instrumentation 
 
 This section will describe the instruments that have been used in the experiments 
described in this dissertation.  These include optical microscopes, 3-dimensional force 
microscopes (3DFM), and an environmental microscope with a motorized 3DFM stage.  I 
designed the motorized stage and will describe its design and assembly. 
8.1.1 3-Dimensional Force Microscope 
 
The basic design of the 3-Dimensional Force Microscope consists of wire coils 
wrapped around an iron core.  There are 6 cores oriented in a hexagonal orientation in 
this current design of the instrument.  The 6 cores can be individually and independently 
activated by sending desired signals through the amplifier, to which it is connected.  One 
core activates to magnetize the pole tip, and the opposite 3 cores activate the flat.  The 
pole and flat are activated at opposite polarities in terms of the voltages.  For example, if 
a pole is activated at 1V, then the 3 cores on the flat would each be activated at -0.33V.  
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Alternatively six pole-flats could be positioned on each core providing force 
application in 3 dimensions.  The pole-flat geometry produces force in one direction, 
which for the purposes of many cell mechanics studies is sufficient.  For intracellular 
active transport experiments, a multidirectional array may be preferable, due to the bi-
directional transport involved.  An example 3DFM lid is shown in Figure 8.1. 
 
Figure 8.1 Image of a 3DFM lid placed on a stage.  The sample will be placed between 
the lid and the stage.  The entire unit is then screwed into the microscope stage. 
 
To activate the pole tips, MATLAB is used to communicate with a DAQ board 
that has been installed in the PC.  This board sends an appropriate signal to an amplifier 
based on the voltage, duration, and frequency programmed into MATLAB.  The 
amplifier then produces the desired voltage in the designated cores to produce the 
magnetization of the pole and flat. 
The pole and flat materials are composed of soft thin magnetic foils produced by 
Magnetic Shield Corporation.  The foils are characterized as Netic and Co-netic AA 
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based on their composition.  Each material has distinct magnetic properties that make 
them useful for distinct experiments. (Fisher, Vicci et al. 2006)  The Netic material has a 
higher magnetic saturation point than the Co-Netic material, which means that the Netic 
material is capable of higher forces.  The Co-Netic material has a lower saturation so a 
pole tip made from it will have a lower overall maximum force.  Because of its lower 
saturation the Co-Netic material will also have a lower remnant magnetization than the 
Netic material.  The Co-Netic also has a higher permeability meaning that it will achieve 
its maximum force more quickly than the Netic.  The pole tips are typically 15-20m in 
diameter.  Further sharpening by hand will decrease this radius which results in higher 
forces.  Magnetic data on the two materials is shown in Table 8.1. 
Material Saturation Induction (Tesla) Permeability Coercivity (Oersteds) 
Netic 2.1 200 1.0 
Co-Netic AA 0.8 30,000 0.015 
Table 8.1. Magnetic Materials Used in 3DFM Pole/Flat 
To calibrate the 3DFM, paramagnetic beads are placed in a solution of a 
Newtonian fluid.  The calibration is based on Stokes’ law of force applied to a bead being 
pulled through a fluid of known viscosity.  This law is expressed mathematically in 
equation 8.1:  
          (8.1) 
where    is the drag force,   is the radius of the bead,   is the viscosity of the Newtonian 
fluid, and   is the velocity of the bead.  The 1m beads to be used in the experiment are 
added to a solution of 2.5 M sucrose in water.  The viscosity of the sucrose solution is 
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characterized via a cone and plate rheometer and found to be 0.142 Pa·s.  The beads are 
added so as to comprise <5% of the total volume.  A 24X50mm 1½ glass coverslip is 
placed on the microscope stage and 30 l of the bead/sucrose solution is added to the 
coverslip.  The 3DFM lid is placed over the sample and the pole tip is brought into focus 
on the microscope.  For calibration purposes, the z-position of the in-focus pole tip is 
considered the “origin” or 0m position, and z-positions below that are referred to as 
“X”m below the sample.  For instance, if one focuses at the pole tip and then adjusts the 
microscope focus 20m below that point, then that point would be called “20m below 
the pole tip”.  While calibration of the tip is being done, it is done at distances below the 
pole tip at which experiments will be performed.  Once the microscope is focused at the 
desired z-height, the 3DFM is sent a ramp of voltages ranging from 0V to 5V.  The signal 
is shown in the Figure 8.2. 
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Figure 8.2 Top shows the voltage signal sent to the 3DFM for a typical calibration.  The 
blue line shows the voltage sent to the pole and red line shows the signal sent to the flat.  
Below is a saturation plot of force vs. current for a netic pole tip 15mm below the sample. 
 
The blue line indicates the voltage sent to the pole tip and the red line indicates the 
voltage sent to each of the 3 cores of the flat.  Beads in the sample will accelerate towards 
the pole tip is activated.  Video is captured at 120 or 60 frames per second.  The beads are 
spot tracked and edited with a MATLAB program called evt_gui.  This program enables 
tracks to be edited to remove portions of the bead motion prior to and after the tip 
magnetization. 
8.1.2 Nikon Eclipse TE 2000-E 
 
 A Nikon Eclipse TE 2000-E inverted optical microscope (Tokyo, Japan) was used 
for many of the motor transport, rheology, and transfection experiments.  These were 
used with a 100X 1.3NA CFI Plan Fluor oil objective and a 40X 0.6NA Plan Fluor 
ELWD objective.  The microscope is also equipped with a 1.5X multiplier.  Fluorescent 
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images were taken using a Photometrics Cascade II 512 electron multiplying CCD 
digital camera. (Roper Scientific, Inc., Tuscon, AZ)  This camera was also used in 
motor stalling and rheology experiments.  The camera and filters were controlled using 
IPLab 4.0. (BD Biosciences Bioimaging, Rockville, MD)  For motor stalling and 
rheology experiments a Jai-Pulnix model PTM-6710CL was used.  This camera has a 
maximum 120 frames per second at the full 648x484 pixel resolution.  This camera was 
used only for bright field applications. 
8.1.3 Environmental Microscope 
 
 The environmental microscope is an Olympus IX81 motorized inverted 
microscope.  It has been set up to provide transmitted bright field as well as 
epifluorescence illumination.  Imaging is achieved using a QImaging Rolera EM-C
2
 
emccd 14-bit digital camera.  The microscope, filters, shutters, and camera are all 
controlled via Metamorph from Molecular Devices. 
 Environmental control is achieved using an Air Therm ATX-H Heater Controller.  
This environmental chamber provides us with the ability to maintain samples at a desired 
temperature for extended periods of time during an experiment.  It is also capable of pH 
control via introduction of CO2 as well as relative humidity control. 
8.1.4 Motorized 3DFM Stage 
 
 I designed a motorized 3DFM stage to be used in the Olympus IX81 
environmental scope.  The design for the motorized stage is centered on a ½ inch travel 
translation stage from Thorlabs (MT3).  The z-axis micrometer is removed and two side-
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mounted actuator kits are attached to both sides of the translation stage.  To provide the 
motorized z-translation, I chose the Thorlabs motorized actuator (Z812B).  This device is 
a ½ inch motorized micrometer stepper motor with a 26nm calculated resolution.  The 
motor and the previously removed micrometer are attached to the translation stage via the 
actuator kits, pointed in opposite directions.  They are attached in such a way as to 
produce movement in the + and – directions along the z-axis.  When the motor is actuated 
in the –z direction the translation stage moves in the –z direction. The motor is controlled 
with a Thorlabs T-Cube DC Servo Controller (TDC001). 
 To attach the 3DFM lid to the XYZ stage an adapter had to be designed to 
accommodate the new way it was to be connected to the microscope.  I designed a new 
adapter that would connect to the XYZ stage and extend the 3DFM to the microscope 
objective.  A component of the 3DFM is a Thorlabs compact kinematic mirror mount.  
The rear of this component has a mounting hole for a #8-32 screw.  The adapter was 
designed with slot wide enough to accommodate this component and a clearance holes 
for #8-32 screws.  The 3DFM is screwed into adapter and the size of the slot is designed 
so as to not allow the kinematic mount to move once in place.  The adapter is shown in 
Figure 8.3. 
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Figure 8.3 Schematic drawings of the 3DFM lid adapter.  The bottom image is the 
adapter connected to a Thorlabs construction plate which attaches to an XYZ stage.  The 
3DFM connects through one of the holes, as shown with the mirror mount at the bottom 
of the photo. 
 
 In order to incorporate the 3DFM in the environmental chamber, I designed an 
adapter to affix to the microscope stage that would serve as a platform to mount the 
device.  To do this I designed a 1.0X0.49X8.0 inch construction rail, with clearance holes 
for 2 M4 screws.  The adapter was designed with mounting holes for #1/4-20 screws.  A 
2.5X3.5 in. construction plate is screwed into the adapter via 2 #1/4-20 screws. 
 
 
 
165 
 
 
Figure 8.4 Stage adapter for the Olympus IX81 environmental microscope.  This is 
screwed into the microscope stage and the XYZ stage is screwed into the adapter. 
 
The construction rail and adapters for the 3DFM lid were machined out of aluminum at 
the UNC Physics Department machine shop.  The XYZ Translation stage is bolted into 
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the construction plate through the stage base plate.  These three components, assembled, 
form the basic modular unit for the motorized 3DFM as shown in Figure 8.5. 
 
Figure 8.5 Assembly of the motorized 3DFM. 
 
Figure 8.6.  Assembled motorized stage.  Controller is attached to the motor.  The device 
is ready to be installed in the microscope chamber. 
 
 With the motor attached, the unit is ready to be installed onto the microscope.  
The rear of IX81 microscope stage is connected to the microscope stage with two M4 
screws.  These screws were removed, and the adapter was screwed into the microscope 
stage using 2 new M4 screws, sufficiently long enough to reach through the adapter and 
screw into the stage.  With the 3DFM stage in place, the motor can be attached to the T-
Cube DC Servo Controller.  The power supply for the motor and the 3DFM are pulled 
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through a gasket on the side of the environmental chamber and connected to the 
respective components.  The final installation is shown in Figure 8.7. 
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Figure 8.7 Final installation of the 3DFM.  The top image shows the installation inside of 
the environmental chamber.  The bottom image shows the installation on the Nikon 
Eclipse TE. 
  
 This design was also implemented on the Nikon Eclipse TE 2000-E microscopes 
with modifications to the adapter to accommodate the different dimensions of those 
scopes.  The benefit of this system is a greatly improved resolution for translating the 
pole tip along the z-axis.  The micrometers and the motor allow for a much easier and 
repeatable positioning of the pole tip.  When changing the sample, the lid can be lifted off 
and lowered back down to the same z-position in a repeatable manner.  Positioning the 
pole tip in z was previously a more time consuming, but necessary part of the experiment.  
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This device makes it incredibly quick and experiments can begin within a minute of 
placing the sample onto the microscope. 
8.2 Appendix Two: Cell Lines 
 
 There are several types of HeLa cells that are used in transfection experiments as 
well as a several specially modified to express fluorescent cytoskeletal components.  
They are described in this section.         
8.2.1 HeLa Wild Type, Luc-705 and EGFP-654 
 
The cell line used in these studies is the cervical cancer HeLa cell line, and is 
provided by Ryszard Kole and Rudy Juliano of the University of North Carolina, Chapel 
Hill Department of Pharmacology.  HeLa cells are named after Henrietta Lacks, a woman 
who died from cervical cancer in 1951 Baltimore, Maryland. (Lucey, Nelson-Rees et al. 
2009)  Cancer cells as a result of a biopsy resulted in the establishment of the first 
immortalized human cell.  Cervical cancer is a malignancy of the cervix.  There are 3 
genotypes used in the studies covered in this dissertation.  HeLa wild type cells, HeLa 
Luc-705, and HeLa EGFP-654 were used for transfection and cell mechanics studies.  
HeLa wild type cells are the characteristic cells of cervical cancer.  Cervical cancer is 
characterized as a malignant neoplasm of the cervix uteri.  HeLa Luc-705 are HeLa wild 
type cells that have been stably transfected with a luciferase gene bearing an intron 
possessing an aberrant mutation typical of the autosomal recessive disease, -
Thalassemia. (Kang, Cho et al. 1998)  Modeling the aberrant splicing of hemoglobin pre-
mRNA, the luciferase protein is aberrantly expressed, resulting in very low levels of 
fluorescence.  When the splice correcting antisense oligonucleotides are successfully 
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delivered to the cell nucleus, the aberrant splicing is corrected, resulting in properly 
expressed luciferase.  EGFP is similarly used as a marker for expression in the HeLa 
EGFP-654 cells.  The cell lines are grown at 37.0°C and 5.0% CO2.  HeLa wild type and 
HeLa EGFP-654 cells are maintained in DMEM/F12 with L-glutamine and HEPES 
buffer supplemented with 10% fetal bovine serum. Growth media was further 
supplemented with antibiotic-antimycotic. (Penicillin-Streptomyocin and Amphotericin 
B, Invtitrogen)  HeLa Luc-705 cells are grown in DMEM supplemented with 10% fetal 
bovine serum.   
-Thalassemia is an autosomal recessive disorder of the blood which is results 
from improper expression of hemoglobin in red blood cells. (Busslinger, Moschonas et al. 
1981)  That is, the trait must be carried by both the mother and father and both parents 
must pass the gene on to the child in order for the child to express the phenotype.  
Hemoglobin consists of two types of protein, a -globin and a -globin.  -Thalassemia 
is a disorder affecting the -globin component of the protein. 
8.2.2 HeLa GFP-Actin and RFP Tubulin 
 
For single cell studies, fluorescence microscopy enables us to observe 
intracellular organelle activity that is not visible via bright field microscopy.  Typically 
speaking, organelles are not visible through bright field microscopy, save for the nucleus.  
Sometimes darkly colored organelles can be observed, such as the pigment bearing 
melanosomes in Xenopus melanophores.  In general, it is necessary to fluorescently label 
cells with fluorescent stains or antibodies that are targeted to the cellular components of 
interest.  This is made possible by the wide range of fluorescent labels designed to 
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illuminate the cell since the early 1970’s.  To observe cytoskeletal behavior, HeLa cells 
were transfected with Fluorescent Protein Cellular Labels: Cellular Lights™ Reagents.  
These reagents use baculoviruses to introduce DNA into the host cell that codes for the 
cytoskeletal monomer subunits associated with fluorescent proteins.  HeLa cells were 
transfected for GFP-Actin and RFP-Tubulin in separate cell cultures. 
To transfect with the cellular lights reagents, HeLa cells were grown to ~80% 
confluence in two T-75 cell culture flasks.  One flask was designated for GFP-Actin and 
the other designated for RFP-Tubulin.  According to the manufacturer’s specifications, 
25l of DMSO was added to the provided “enhancer” solution.  Two ml of the Cellular 
Lights™ reagent was added to 3.0ml of PBS without Ca
2+
 or Mg
2+
.  The cell culture media 
from each flask was removed and Cellular Lights™ transduction reagent for GFP-Actin 
and RFP-Tubulin was added to the respective flask.  The flasks were then allowed to 
incubate at room temperature, 23.0°C, for 4 hours.  The transduction reagent was 
aspirated from the flasks, and replaced with DMEM F12 with 10% serum and 0.1% 
enhancer solution.  The cells were then incubated at 37.0°C and 5.0% CO2 for two hours.  
After the two hours, the cells were aspirated and replaced with DMEM F12 and 10% 
serum and allowed to incubate at 37.0°C and 5.0% CO2 overnight (~20 hours).  At the 
completion of the transfection, the cells were trypsinized and frozen in DMEM F12 with 
10% DMSO.  Since the transfection is not stable, it is necessary to preserve the 
fluorescence via cryopreservation.  Cells were divided into aliquots of 100l in 500l 
cryotubes.  Cell number was counted via a hemocytometer and the final concentration 
was 3000 cells/l.  The low volume in the cryotube is intended to facilitate easy plating 
of the cells for experimentation directly out of the -80.0°C freezer.  The HeLa cells were 
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found to be able to survive multiple freeze/thaw cycles, enabling usage of the majority of 
the cells in the cryotube.   
To verify the transfection results, images and z-stacks were taken of both cell 
types.  Both coverslips exhibited essentially 100% transfection.  Scanning the coverslip 
produced no examples of cells not expressing the fluorescent cytoskeletal component that 
it had been transfected for.  Cells were imaged at 40X, 60X, and 100X.  At 100X and 0% 
neutral density filtering, it was observed that the fluorescence had a tendency to fade and 
deleteriously affect the cells, resulting in blebbing of the cells.  Upon application of an 
80% neutral density filter, cell death was not observed.  Example images are shown 
below. 
  
Figure 8.8 Images to verify efficacy of fluorescent actin and tubulin transfection.  (Left) 
GFP-Actin Hela cells.  (Right) RFP-Tubulin Hela Cells 
 
 
 
. 
 
 
173 
8.3 Appendix Three: Chapter 2 
 
8.3.1 Polyethylenimine/Nanoparticle Functionalization 
 
PEI is functionalized to the particles via an EDAC (1-ethyl-3(3-
dimethylaminopropyl)-carbodiimide hydrochloride) reaction.  To prepare the carboxylic 
acid functionalized beads, a 10 mg/ml concentration of EDAC is made by adding 
crystalline powder to 1 ml of 0.1M MES (2-[N-Morpholino]ethane-sulfonic acid) buffer 
at pH 4.  Then 250 l of EDAC/MES are added to 50 l of particles in a 1.5 ml 
microcentrifuge tube.  The beads are sonicated for 15 minutes and vortexed.  
Concurrently, 60mg of PEI are measured out into another 1.5 ml microcentrifuge tube.  
To this was added 1 ml of MOPS (3-[N-Morpholino] Propane Sulfonic Acid) at a pH 12.  
It is vortexed vigorously to ensure it is well mixed.  The beads and PEI are allowed to 
rotate overnight at room temperature.  After 12 hours, 150 l of the PEI solution 
(60mg/ml) is added to the particles, vortexed, and allowed to rotate for 4 hours.  The 
particles are centrifuged into a pellet and excess PEI is decanted.  The particles are 
washed 3 times in Dulbecco’s phosphate buffered saline (PBS) to remove excess PBS.  
The particles are resuspended in 500 l of PBS for a final particle concentration of 1 
mg/ml.  This protocol was used for all particles with the exception of the Chemicell 
particles, which come from the manufacturer already functionalized for transfection, and 
the Micromod PEI 250nm particles. 
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8.3.2 Cell Plating 
 
 To test for the effectiveness of the different particle types they were used to 
transfect HeLa-Luc 705 cells.  HeLa-Luc 705 cells are grown in T-75 cell culture plates 
in DMEM to roughly 80% confluence before passaging.  The DMEM is supplemented 
with 4.5mg/ml glucose, L-glutamine, and sodium pyruvate, and further supplemented 
with 10% fetal bovine serum.  The cells are washed once with PBS, trypsin is added, and 
re-suspended with DMEM.  A sample of the cells is removed for the purpose of counting 
cells with an electronic cell cytometer, to determine the number of cells/ml.  Once this is 
done the cells are plated at a density of 125,000 cells per well in two 12-well TPP cell 
culture plates 24 hours prior to transfection.  The cells are plated in the DMEM 
formulation described above.  These plates are specially treated to facilitate cell adhesion 
and growth at the bottom of the well.  One plate is intended for magnetic transfection and 
the other is a control for nonmagnetic transfection.  The 12-well plates are incubated at 
37.0°C and 5.0% CO2. 
 For the post particle transfections, HeLa EGFP-654 cells were plated at 5000 cells 
per well 24 hours before transfection in a Nunc 384 well plate.  Before transfection cell 
media was replaced with Opti-MEM I Reduced-Serum Medium (Invitrogen, Carlsbad, 
CA). 
8.3.3 Cell Culture 
 
HeLa Luc-705 cells are grown at 36.5°C and 3.5% CO2 in Dulbecco’s Modified 
Eagle Medium with F-12 nutrient mixture (Invitrogen, Carlsbad, CA) with L-glutamine 
and HEPES buffer supplemented with 10% fetal bovine serum. 
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HeLa EGFP-654 cells are grown at 36.5°C and 3.5% CO2 in Dulbecco’s Modified 
Eagle Medium with F-12 nutrient mixture (Invitrogen, Carlsbad, CA) with L-glutamine 
and HEPES buffer supplemented with 10% fetal bovine serum.  Growth media was 
further supplemented with antibiotic-antimycotic (Penicillin-Streptomyocin and 
Amphotericin B, Invitrogen). 
8.3.4 Luciferase Assay 
 
To assay the cells the cell lysate must be collected for analysis in a luminometer 
and protein concentration.  The cells were lysed for analysis of luciferase expression in 
the manner prescribed by the Promega Luciferase Assay Kit.  Briefly, the Promega 5X 
lysis buffer is diluted 1 to 4 by volume in water, allowed to come to room temperature.  
Cell culture medium is removed and the cells are washed with PBS, after which, 200l of 
lysis buffer are added to each well.  After 15 minutes the wells are scraped and collected 
into individual 1.5ml centrifuge tubes.  These tubes are placed in a dry ice and ethanol 
bath for 5 minutes to freeze the cells and fracture the cell membrane.  After freezing, the 
tubes are allowed to come back to room temperature, vortexed, and centrifuged at 
14000×g for 2 minutes.  After properly priming and calibrating the luminometer, 20 l of 
cell lysate from each sample is transferred individually into a glass luminometer tube.  To 
this tube is added 100 l of Promega Luciferase Assay Reagent.  The tube is placed in the 
luminometer, and fluorescence is measured.  This returns a measure of luciferase 
expression in terms of Relative Light Units (RLU). 
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8.3.5 BCA Protein Assay 
 
 To normalize the values obtained from the luminometer, a BCA
TM
 (bicinchoninic 
acid) Protein Assay is performed.  Six dilutions of BSA (bovine serum albumin) are 
prepared in triplicate in the first 18 wells of a 96-well plate as a standard for protein 
concentration.  For each sample of cell lysate 10 l are placed into a well of the 96-well 
in triplicate.  To these wells, 200 l of a 50:1 solution of BCATM Reagent A to BCATM 
Reagent B are added.  The plate is placed in the incubator for 30 minutes at 37°C.  The 
plate is removed from the incubator and placed in the 96 well plate reader where 
absorbance is measured at 562nm to return the protein concentration.  Using the data 
retrieved from the luminometer reading, a calculation of RLU/g protein made, 
normalizing across all samples.  The BCA measures total protein concentration in the cell 
lysate not just the luciferase concentration.  The concentrations of the transfected cells are 
compared with that of untreated cells, and the two should be similar.  Significant 
decreases in concentration below that of the untreated cells are indications of toxicity in 
the cell culture. 
8.3.6 Transfection Reagent Preparation 
 
 For the Chemicell particles, 2.8 l of beads were combined with 5 l of 
oligonucleotide as recommended in the online protocol.  For the other 9 samples, 20 l of 
beads were mixed with 10 l of oligonucleotide.  To all were added 100 l of PBS.  
These were allowed to rotate for an hour.  After an hour Opti-MEM
®
 1 Reduced-Serum 
Medium (1X) was added to each to produce a final volume of 1 mL in each tube.  When 
added to the cell cultures the final oligo concentration was 500nM.  A sufficient amount 
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of sample was produced for both the magnetic and the non-magnetic transfection.  
Concurrent with this, Lipofectamine-2000 and oligonucleotide were mixed in Opti-MEM 
at a ratio of 5:5:90. (Ming, Sato et al. 2011)  The Lipofectamine solution was placed on a 
rotator for 30 minutes.  This solution was added to the cell culture in triplicate to achieve 
a 50nM concentration. 
8.3.7 Dose Response Reagent Preparation 
 
 To conjugate the antisense oligonucleotide to the particles, 50l of 
oligonucleotide (50M) is added to 250 l of the 130nm particles (1mg/ml) and 200 l of 
sterile PBS.  The mixture was vortexed for 5 seconds and then placed on a rotator to mix 
for 1 hour.  Concurrently, Lipofectamine-2000 and oligonucleotide were mixed in Opti-
MEM at a ratio of 5:5:90.  The Lipofectamine solution was placed on a rotator for 30 
minutes.  While the transfection reagents were being mixed the cell culture media was 
replaced with Opti-MEM low serum culture media.  The oligo/bead conjugates were 
added to individual wells of the 12 well plate to achieve oligo concentrations of 2.5, 12.5, 
25, 50, 75, 100, 125, 250, 500 nM.  A single concentration of 50 M Lipofectamine 2000 
sample was used and performed in triplicate.  At this stage of the experiments, the 
primary focus was to establish useful dosages for the bead/oligo conjugates to achieve 
optimal transfection and minimal toxicity.  Therefore the bead concentrations were not 
being directly compared with the Lipofectamine.  The Lipofectamine served as a control 
to verify that the cells would express when transfected using a previously established 
methodology. 
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8.3.8 Imaging/Segmentation 
 
 Treated and untreated cells were imaged using a Nikon Eclipse TE 2000-E 
inverted optical microscope (Tokyo, Japan) with a 40x objective.  Images were taken 
using a Photometrics Cascade II 512 electron multiplying CCD digital camera (Roper 
Scientific, Inc., Tuscon, AZ) and background fluorescence was established by performing 
segmentation imaging on highest intensity cells in untreated samples.  Imaging and 
segmentation was performed with IPLab 4.0 (BD Biosciences Bioimaging, Rockville, 
MD).  Cells measuring above this background fluorescence in treated samples were 
measured for mean intensity using segmentation.  Mean background fluorescence was 
subtracted to determine the true mean intensities above background for treated cells.  An 
average of 20 images is taken of each well and weighted mean intensities were summed 
over all images. 
8.3.9 Size Uniform 200nm Fe Post Particles 
 
 Size-uniform 200nm Fe3O4 particles were fabricated by L. Mair as described in 
our paper “Size-uniform 200nm particles: Fabrication and application to 
magnetofection”.  Briefly, these particles are lithographically defined metallic particles 
and grown via thermal deposition.  SEM images of the particles are shown in Figure 8.9. 
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Figure 8.9 Scanning electron micrograph of the size-uniform 200nm Fe3O4.  Scale bar is 
20m. 
 
To make the particles useful for transfection, the particles had to be surface 
functionalized with PEI.  PEI was bound to the Fe Post-Particles by mixing the particles 
(1mg/ml) with 0.1mg PEI for 4 hours in a DI water adjusted to pH 10 using 0.1M NaOH. 
At this pH the zeta potential of the particles is sufficiently low to electrostatically bind 
cationic PEI to the particle surface. 
8.4 Appendix Four: Chapter 4 
8.4.1 Cell Plating 
 
To perform AC transfections, HeLa EGFP-654 cells are plated at a density of 
125,000 cells per well in a 12 well plate 24 hours prior to transfection.  To test the 
frequency dependence and vibration effects, cells are plated in 96 well plates at a density 
of 12,000 cells per well.  Cells are counted with a hemacytometer and plated in 
DMEM/F12 with L-glutamine and HEPES buffer supplemented with 10% fetal bovine 
serum.  Growth media was further supplemented with antibiotic-antimycotic (Penicillin-
Streptomyocin and Amphotericin B, Invtitrogen).   Cells are grown at 37.0°C and 5.0% 
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CO2.   One hour prior to transfection, the cell culture media is replaced with Opti-MEM 
low serum media 
8.4.2 Transfection Reagent Preparation 
 
 To conjugate the antisense oligonucleotide to the particles, 130nm particles 
(1mg/ml) are mixed with the oligonucleotide (50M) and phosphate buffered saline at a 
25:5:70 volume ratio.  Total volume is adjusted to accommodate the volume needed for 
the experiment.  Simultaneously, oligos are mixed with Lipofectamine 2000 and Opti-
MEM at a 5:5:90 ratio by volume.  The nanoparticle and Lipofectamine solutions are 
added to their respective wells of the 12-well plates to achieve 50nM concentrations. 
8.4.3 Cell Imaging and Counting Assay 
 
The cells are stained with SYTO 82 nucleic acid stain and imaged for EGFP 
expression on an Olympus IX81 confocal microscope.  The cells are imaged at 10X, 
0.3NA, and imaged consecutively in the Texas Red and GFP channels using Metamorph.  
To analyze the results fluorescent cells were counted in ImageJ.  The SYTO 82 stains all 
of the cells in the sample red, enabling us to count the total number of cells in an image.  
By imaging the untransfected cells, we can establish the baseline fluorescence.  The cell 
counting protocol goes as follows.  The image is opened in ImageJ and using the color 
picker tool a bright pixel is selected.  The paintbrush tool is then used to “paint” a dot 
onto a cell with the same intensity chosen with the color picker.  A dot is placed over 
every cell in the image.  This is shown if Figure 8.10. 
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Figure 8.10 Example of SYTO 82 stained cells.  The white dots are placed in ImageJ to 
count the cells. 
 
With all of the cells labeled with a dot the image threshold is adjusted using the 
ImageAdjustThreshold tool.  This tool converts the image to black and white and 
allows the user to isolate only the pixels above or below a certain threshold.  With the 
dots at a high intensity value the threshold is adjusted to a high pixel value, leaving only 
the dots in the image.  (Figure 8.11) 
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Figure 8.11 ImageJ screenshot where threshold is adjusted cell image.  Adjusting the 
threshold removes everything from the image except the dots, which act as proxies for 
the cells. 
 
The dots serve as proxies for the counted cells.  It is possible for ImageJ to count cells 
without this step, but the non-uniformity of pixel intensities caused multiple parts of a 
single cell to be counted as individual objects, causing the cell count to be inflated.  By 
“non-uniformity of pixel intensities”, I am referring to certain features of the cell being 
brighter or darker in an uneven manner, and not in a monotonic or concentric way.  This 
technique ensured that each cell would be counted only once.  Once the threshold is 
suitably adjusted, then ImageJ is ready to count the objects in the image.  I wrote a small 
macro that would accomplish this by converting the image into a binary image and then 
count the dots.  (Figure 8.12) 
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Figure 8.12 ImageJ screenshot showing cells being counted.  The box on the right 
displays the results. 
 
In Figure 8.12 the window at the top left shows the macro for cell counting and the 
window on the right shows the results of the cell count.  Because it is counting uniform 
dots the area is uniformly 80 pixels, with a few exceptions when the paintbrush tool is 
slightly dragged in the counting process.  Also uniform are the pixel intensities as shown 
by the pixel intensities of 255.  The value at the bottom of the leftmost column of the 
results window shows the total number of cells in the image, and this value is entered into 
an Excel spreadsheet.   
To count the cells that are expressing the EGFP as a result of transfection, a 
similar process is followed.  The untreated HeLa EGFP-654 cells produce a low level of 
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background fluorescence; due to the fact that is producing an aberrantly expressed EGFP 
protein.  For untreated cells images it was found that adjusting the threshold of the image 
above a pixel intensity of 450 removed all cells from the images, indicating that the 
untreated cells did not fluoresce above this intensity.  To select for transfected cells in the 
images, the threshold was adjusted to show pixel intensities above 500.  This effectively 
isolated the fluorescent cells for counting.  An image of the threshold adjusted image and 
actual image were looked at simultaneously.  Using the threshold image as a guide, dots 
were placed on the expressing cells.  (Figure 8.13) 
 
Figure 8.13: Image of EGFP expressing cells in the cell counting pipeline 
 
With the dots placed on the cells these cells are counted as described previously and then 
the number is recorded in the same spreadsheet.  For each sample (Lipofectamine, AC, 
etc.) at least 2000 cells were counted.  A ratio of the EGFP expressing cells to the total 
cells is calculated to produce a transfection rate.  Data are presented as transfection rate 
SE, with the standard error calculated on the transfection rate among all the images.  
The images are also colorized in ImageJ to match the color of the respective fluorophore.  
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The images are merged together and in the merged examples the expressing cells can be 
seen as yellow. 
8.4.4 Oscillating Field Effects are not Due to Vibration of the Sample 
 
Any time moving components are incorporated into a device, it is logical to assume 
that there is some level of resonant vibration being produced by the moving parts.  If a 
cell culture is placed on such a device the sample will also experience a vibrational force 
due to the movement of the array.  The effects on the vibration are thus tested to verify 
that they do or do not have an effect on the transfection. 
Prior to transfection, the cell media is replaced with Opti-MEM reduced serum 
media.  Nanoparticle/oligo solution is added to the cell cultures to achieve 200M 
concentrations.  After dosing with particles, the cell media is mixed by gently pipetting 
up and down several times to evenly distribute the particles.  Both samples are placed on 
a permanent magnet to sediment the particles for 30 minutes.  After the 30 minute 
sedimentation time, the magnet is removed and the cell media is changed to DMEM/F12 
with 10% FBS to remove free nanoparticles from solution.   
To test for vibration effects, the magnet array that is used for the oscillating 
magnetic field experiments is replaced with non-magnetic aluminum components of 
approximately equivalent mass.  This is done to simulate the mass that is rotating with the 
magnet array and the level of vibration that would be produced.  After the initial particle 
sedimentation and media change, the cell culture is placed over the rotating non-magnetic 
aluminum array.  This array is rotated at a speed equivalent to the 10 Hz oscillating 
application.  One of the cell cultures undergoes this vibration test for 30 minutes, as is 
done with the magnetic transfections.  The other sample receives no additional 
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stimulation.  After the vibration application, the cells are allowed to incubate for 24 hours 
before imaging. 
The results of the vibration effects are shown in Figure 8.14. 
 
Figure 8.14 Vibration of the sample does not produce a improvement of transfection 
efficiency. 
 
The transfection efficiency of the DC only sample was 10.51%0.58 as compared to 
9.12%1.56 for the vibration test.  These data indicate that there is no impact in 
enhancing the transfection efficiency due to oscillation of the moving components of the 
array. 
8.5 Appendix Five: Chapter 5 
8.5.1 Cell Plating 
 
To perform the Latrunculin B experiments, HeLa EGFP-654 cells are plated at a 
density of 5,000 cells per well in a 384 well plate 24 hours prior to transfection.  Cells are 
counted with a hemacytometer and plated in DMEM/F12 with L-glutamine and HEPES 
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buffer supplemented with 10% fetal bovine serum.  Growth media was further 
supplemented with antibiotic-antimycotic (Penicillin-Streptomyocin and Amphotericin B, 
Invtitrogen).  Cells are grown at 37.0°C and 5.0% CO2. 
For pathway inhibition studies, HeLa EGFP-654 cells are plated on 96-well plates 
at a density of 12,000 cells per well 24 hours prior to experimentation.  Cells are cultured 
in DMEM/F12 media as described previously.  Prior to transfection experiments, cell 
culture media is replaced with Opti-MEM low serum medium.  Inhibitory drugs are 
added to Opti-MEM to achieve the desired concentrations.  Chlorpromazine (14M), 
Nystatin (200IU/mL), and Amiloride (100M) were used to inhibit the Clathrin-
mediated, lipid raft, and macropinocytosis pathways respectively.  Dynamin, a motor 
protein that is necessary for multiple endocytic pathways, was inhibited with Dynasore 
(80M). 
8.5.2 Transfection Reagent Preparation 
 
To conjugate the antisense oligonucleotide to the particles, 130nm particles 
(1mg/ml) are mixed with the oligonucleotide (50M) and phosphate buffered saline at a 
25:5:70 volume ratio.  Total volume is adjusted to accommodate the volume needed for 
the experiment.  Simultaneously, oligos are mixed with Lipofectamine 2000 and Opti-
MEM at a 5:5:90 ratio by volume.  The nanoparticle and Lipofectamine solutions are 
added to their respective wells to achieve 50nM concentrations. 
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8.5.3 Endocytic Pathway Inhibition 
 
The cell line used in these studies is the cervical cancer HeLa EGFP-654 cell line, 
provided by Ryszard Kole of the University of North Carolina, Chapel Hill Department 
of Pharmacology, described in section 8.2.1.  HeLa EGFP-654 cells have been stably 
transfected with an EGFP gene bearing an intron possessing an aberrant mutation typical 
of the autosomal recessive disease, -Thalassemia (Kang, Cho et al. 1998).  The cell lines 
are grown at 37.0°C and 5.0% CO2 and are maintained in DMEM/F12 with L-glutamine 
and HEPES buffer supplemented with 10% fetal bovine serum. Growth media was 
further supplemented with antibiotic-antimycotic (Penicillin-Streptomyocin and 
Amphotericin B, Invitrogen).  
 Twenty-four hours prior to experimentation, the cells are plated on 96-well plates 
at a density of 12,000 cells per well.  Cells are cultured in DMEM/F12 media as 
described previously.  Prior to transfection experiments, cell culture medium is replaced 
with Opti-MEM low serum medium.  For endocytosis pathway studies, inhibitory drugs 
are added to Opti-MEM to achieve the desired concentrations. 
8.5.4 Cell Staining and Imaging 
 
 The cells are stained with SYTO 82 nucleic acid stain (Invitrogen, 500nM) or 
DAPI (Invitrogen, 2.85 M) and imaged for EGFP expression on an Olympus IX81 
confocal microscope.  The stains are diluted in Opti-MEM, added to the cells, and 
incubated for 10 minutes.  The staining media is replaced with fresh Opti-MEM prior to 
imaging.  The cells are imaged with a 10X, 0.3NA, Olympus air objective.  Cell images 
are captured consecutively in the Texas Red and GFP channels using Metamorph.  To 
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analyze the results, cells were counted in ImageJ.  The total number of cells in the field of 
view is counted via the Texas Red channel and cells fluorescing above background 
fluorescent levels are counted in the GFP channel.  The untreated HeLa EGFP-654 cells 
produce a low level of background fluorescence.  To quantify the background level of 
untransfected cells, the threshold of the images is adjusted until the cells are no longer 
visible.  This intensity value is averaged over several images.  To count a cell as 
expressing above background fluorescence, it must exceed this threshold by 11%.  For 
example, if untreated cells are no longer visible by adjusting the threshold to 450, cells 
that have intensities of 500 or greater are counted as EGFP expressing.  Transfection 
efficiency is determined by calculating the ratio of EGFP expressing cells to the total 
number of cells in the field of view.  A minimum of 2000 cells were counted for each 
sample and standard error of the mean (SEM) is calculated over multiple fields of view of 
the sample. 
8.5.5 Imaging and Cell Counting   
 
 Twenty-four hours after transfection the cells are stained with SYTO 82 nucleic 
acid stain.  Cells are imaged for EGFP expression on an Olympus IX81 confocal 
microscope.  The cells are imaged at 10X, 0.3NA, and imaged consecutively in the red 
and green channels.  To analyze the results fluorescent cells were counted using ImageJ.  
The SYTO 82 stains all of the cells in the sample red, enabling us to count the total 
number of cells in an image.  By imaging the untransfected cells, we can establish the 
baseline fluorescence.  To measure for transfection in the transfected samples, the 
threshold for the images was adjusted above the intensity levels for the baseline samples.  
Cells fluorescent above this threshold were counted as the expressing cells.  For each 
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sample at least 2000 cells were counted.  The images are merged and in the merged 
examples the expressing cells can be seen as yellow. 
8.6 Appendix Six: Chapter 6 
 
8.6.1 Cell Culture and Plating 
 
 To plate cells for the active transport experiments, 22X50 mm 1½ glass coverslips 
were sterilized by removing them from a 100% ethanol bath and igniting them with a 
butane lighter.  Polystyrene cloning rings (4.7mm inner diameter, Fisher Scientific) were 
affixed to the center of the coverslips using high vacuum silicon grease, forming the cell 
culture well.  DMEM with F12, supplemented with 10% fetal bovine serum and 
antibiotic/antimycotic (Penicillin-Streptomyocin and Amphotericin B, Invtitrogen), was 
added to the inside of the cloning rings (300 l).  The DMEM is also buffered with 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) to maintain the pH when 
the sample is out of the incubator.  HeLa WT cells are seeded inside of the cloning rings 
to an approximate 10% confluence level.  The cells are allowed to incubate overnight to 
allow for the cells to come down and adhere to the cloverslip. 
8.6.2 1m Bead Dosing and Imaging  
  
 The 15l of the 1m MyOne beads with Lipofectamine are added to the cells.  
The cells are then incubated in the presence of the beads for 2-4 hours.  This allows 
enough time for the beads to sediment to the bottom of the cell culture dish and for 
endocytosis to commence.   
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 The cells are then placed into the Olympus IX81 environmental chamber.  Prior to 
imaging, the environmental chamber has been set to 37.0°C.  Imaging is performed at 
100X magnification.  The cell culture is visually scanned to find examples of cells with 
MyOnes that have undergone endocytosis and can be seen as undergoing active transport.  
Often multiple beads can be seen in a single cell.  Transport can be easily observed as bi-
directional transport characteristic of molecular motor transport.  Once a suitable 
candidate is found, time lapse video is captured at 60 frames per second. 
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